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CHAPTER I 
 
GENERAL INTRODUCTION 
 
Development of the cerebellar cortex proceeds in a remarkably controlled fashion, with 
the intersection of complex signaling pathways governing the coordinated generation of 
its laminar structure. While it has long been appreciated that the role of the cerebellum is 
to control balance and sensorimotor coordination (Ito 2006; Roussel and Hatten 2011), 
as well as take part in the vestibular ocular reflex, recent studies have revealed an even 
wider range of cognitive actions, including sensory-motor learning, speech, and spatial 
memory (De Zeeuw and Yeo 2005; Schmahmann et al. 1999; Koziol et al. 2013). 
Despite its complex functions, the cerebellum’s relatively simple architecture makes it an 
attractive model to study CNS development, neuronal connectivity, and disease. Sonic 
Hedgehog (Shh) signaling has been recognized as a critical regulator in many aspects of 
development including cerebellar morphogenesis. As a morphogen, it is secreted and 
can act over both short and long distances to affect the growth, proliferation, or 
differentiation of its receiving cell. The focus of my thesis work is to elucidate novel 
mechanisms of Shh signaling in embryonic and postnatal development of the 
cerebellum, as well as its implications for the cerebellar tumor medulloblastoma. 
 
Cerebellar Structure 
The mammalian cerebellum (Figure 1A) has a distinct, well-organized 
architecture. Through a series of dramatic cellular movements, the early cerebellar 
primordium is transformed from a smooth embryonic structure into one with complex 
lobules and folia by postnatal day 14 (P14) (Sudarov and Joyner 2007). On a gross 
anatomical level, the cerebellum is separated on the mediolateral axis into three broad 
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regions. The most medial region is called the vermis and is surrounded on either side by 
a hemisphere (Figure 1B). The anterior-posterior axis is divided into ten morphological 
folds known as lobules (Figure 1C). Each of the ten lobules is further divided into 
secondary and tertiary sublobules on the basis of species (Schmahmann et al. 1999; 
Larsell 1947). On a cellular level, the cerebellar cortex has three layers that surround an 
inner core of white matter and deep cerebellar nuclei (Sillitoe and Joyner 2007). The 
innermost layer is the internal granular layer (IGL), which largely consists of small 
granular neurons but also includes Golgi, Lugaro, and unipolar brush cells. The 
outermost layer is the molecular layer (ML), a mostly acellular layer consisting of granule 
cell axons (called parallel fibers), climbing fiber terminals, Purkinje cell (PC) dendrites, 
and stellate and basket cells. Between these two layers is the Purkinje cell monolayer 
(PCL), which consists of Purkinje cells and specialized glial cells called Bergmann glia 
(BG), which are sandwiched between the PCs. In much lower numbers, candelabrum 
cells are also present in the PCL (Figure 1C).   
 Ramon j Cajal, working over a century ago, elucidated the basic circuitry of the 
cerebellum (Cajal 1911). The central cell type around which other cerebellar synapses 
are organized is the PC. Excitatory inputs to PCs are derived from two sources—the first 
are climbing fibers, which are axonal projections from brainstem neurons. In addition, 
PCs receive excitatory input from granule cells that are transmitting input from mossy 
fibers originating in over two-dozen brainstem and spinal cord nuclei (Fu et al. 2011). 
Modulation of granule neuronal input to PCs is mediated by inhibitory signals from 
stellate and basket cells (Konnerth, Llano, and Armstrong 1990). PCs integrate the 
excitatory and inhibitory inputs to control the output of cerebellar and vestibular nuclei 
neurons. Thus, PCs can sensitively respond to incoming signals that can then be 
communicated to the brain and spinal cord. 
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Figure 1.1 
 
Figure 1.1. Cerebellar structure. 
 
 
Embryonic and Early Postnatal Cerebellar Development 
The early cerebellar anlage arises in the mouse around embryonic day 8.5 (E8.5) 
to E9.5 from a region that initially encompasses the boundary between the 
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mesencephalon and metencephalon of the neural tube (Wingate and Hatten 1999; 
Hallonet, Teillet, and Le Douarin 1990; Millet et al. 1996). An isthmus separating these 
two embryonic vesicles acts as an inductive signaling center responsible for regulating 
both cerebellum and midbrain development (Lumsden and Krumlauf 1996) (Figure 2A). 
Fate mapping studies established that the anterior boundary of the cerebellar anlage is 
delineated by Otx2 (Millet et al. 1996) and posterior boundary marked by Gbx2 (Millet et 
al. 1996). In the later embryo, this domain, which comprises the most anterior aspect of 
the hindbrain, resolves to a single defined neuromere designated as rhombomere (r) 1 
(Zervas et al. 2004).  
Around E10.5, a specialized group of cells, known as the roof plate, acts as an 
additional signaling center to regulate cellular positioning and proliferation of the entire 
cerebellar anlage (Chizhikov et al. 2006). The roof plate domain differentiates shortly 
after neural tube closure to form a distinct narrow strip of cells along the dorsal midline 
and is molecularly defined as the Lmx1a+/Gdf7+ dorsal domain throughout the anterior-
posterior extent of r1 (Chizhikov et al. 2006) (Figure 2B). Roof plate-derived inductive 
signals, such as Bmp6, Bmp7, Gdf7 (Bmp12), and Wnt1 (Chizhikov and Millen 2004; K. 
Lee, Dietrich, and Jessell 2000; K. J. Lee, Mendelsohn, and Jessell 1998), are important 
for directing differentiation of dorsal neuronal cell types (Chizhikov and Millen 2004; Lee, 
Dietrich, and Jessell 2000; Lee, Mendelsohn, and Jessell 1998; Chizhikov et al. 2006). 
In the spinal cord and telencephalon, roof plate cells not only regulate development of 
neighboring tissues through the secretion of growth factors, but also have the capacity to 
generate different cell types. However, previous fate-mapping studies have indicated 
that the hindbrain roof plate is uniquely restricted in lineage potential and its 
contributions are mostly limited to non-neural hindbrain choroid plexus epithelial (hChPe) 
cells (Chizhikov et al. 2006; Currle et al. 2005; Hunter and Dymecki 2007; Landsberg et 
al. 2005; Chizhikov et al. 2010). Hence, the capacity for hindbrain roof plate cells to 
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contribute to specific cell types in the cerebellum has not been shown. In Chapter II of 
this work, we demonstrate that hindbrain roof plate cells can contribute to diverse cell 
types in the cerebellum. 
Secreted Wnt and Fgf family members, including Wnt1, Fgf8, and Fgf15, control 
expression of transcription factors delineating r1 as well as of genes required to 
establish cerebellar territory (Roussel and Hatten 2011; McMahon and Bradley 1990; 
Chi 2003; Crossley, Martinez, and Martin 1996; Martinez et al. 1999; Joyner, Liu, and 
Millet 2000), homeobox genes En1 and Pax2/5/8 (Joyner 1996; Joyner, Skarnes, and 
Rossant 1989). Between embryonic day 9 (E9) in the mouse and E12, a 90-degree 
rotation converts the anterior-posterior axis of the dorsal neural tube to the medial-lateral 
axis of the cerebellar priomordium, which takes on the characteristic bilateral, wing-like 
morphology of the cerebellum that persists into adulthood (Sillitoe and Joyner 2007; 
Sgaier et al. 2005).   
 During cerebellar histogenesis, carefully orchestrated cellular movements and 
complex neurogenesis generate the cortical structure and cerebellar nuclei (Hatten and 
Heintz 1995; Morales and Hatten 2006). All cerebellar neurons originate from multipotent 
radial glial progenitor cells situated in one of two germinal zones (Anthony et al. 2004; 
Mori et al. 2006). First, the dorsomedial ventricular zone (VZ) along the fourth ventricle 
gives rise to inhibitory GABAergic neurons which include Purkinje cells (PC), the 
principal output neuron of the cerebellar cortex, as well as cerebellar interneurons 
including Golgi, stellate, and basket cells and neurons of the cerebellar nuclei (Dino et 
al. 2000; Laine and Axelrad 2002). Second, a germinal zone forms along the anterior 
region of the rhombic lip, which is located at the interface between the dorsal neural tube 
and the widened portion of the fourth ventricle roof plate in the most posterior region of  
r1 (Wingate 2001). The rhombic lip is responsible for the generation of excitatory 
glutamatergic neurons called cerebellar granular neurons, the most abundant neuron in 
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the brain, and a subpopulation of neurons of the cerebellar and precerebellar nuclei 
(Dymecki and Tomasiewicz 1998; Machold and Fishell 2005; Wingate and Hatten 1999; 
Wingate 2001) (Figure 2C).  
 Proliferation of VZ progenitor cells requires expression of Shh, which, although 
not endogenous to the cerebellum prior to E16 in the mouse, is delivered to the 
cerebellum by the cerebrospinal fluid of the fourth ventricle (Huang, Liu, et al. 2010). 
Studies have revealed that neurons of the cerebellar VZ are generated in three 
sequential but overlapping waves (Morales and Hatten 2006). Around E10.25, the 
earliest cerebellar progenitors exit the cell cycle to generate neurons of the deep 
cerebellar nuclei (Morales and Hatten 2006). By E11, these progenitors migrate radially 
along a nascent glial fiber system to form a superficial zone across the dorsal surface of 
the cerebellar anlage. They eventually settle in the white matter beneath internal 
granular neurons (Morales and Hatten 2006). Between E11 and E14, precursors of the 
Purkinje neuron, identified by the LIM transcription factors LHX1 and LHX5 (Morales and 
Hatten 2006), become postmitotic and migrate from the VZ along radial glial fibers to 
form symmetrical clusters (Morales and Hatten 2006; Oberdick et al. 1993; Miyata et al. 
2010). These clusters are multilayered and are situated between migrating cerebellar 
nuclei cells; they can be detected by gene expression starting at E14 in mice. Last, a 
third population of neurons, which include GABAergic interneurons of the DCN, stellate, 
basket, Lugaro, and Golgi cells, is generated during late embryonic development 
(starting at E14.5) and into early postnatal stages (Roussel and Hatten 2011).  
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Figure 1.2. 
 
Figure 1.2. Early cerebellar development. 
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 The second germinal zone of cerebellar progenitors appears by E12.5 in the 
mouse along the anterior rhombic lip. Studies have shown that specification of the 
cerebellar rhombic lip and its derivative fates is entirely dependent on the r1 roof plate 
(Machold and Fishell 2005; Wang and Zoghbi 2001). Previous genetic analyses of the 
cerebellar rhombic lip have suggested that the basic helix-loop-helix transcription factor 
Mouse atonal homolog 1 (Math1) molecularly defines this region (Machold and Fishell 
2005; Wang and Zoghbi 2001). However, more recent investigation has shown the 
rhombic lip to be molecularly heterogeneous with Lmx1a expression representing at 
least one Math1-independent rhombic lip gene (Chizhikov et al. 2010). Thus, the extent 
and contribution of Math1-negative cell types residing in the rhombic lip has yet to be 
elucidated. Our studies as detailed in Chapter II show that roof plate-lineage cells in the 
rhombic lip are Math1-negative neural progenitor cells. These findings support studies 
suggesting molecular heterogeneity within rhombic lip progenitors (Chizhikov et al. 2010) 
rather than the classical definition of the rhombic lip as a homogenous Math1+ 
progenitor population (Rob Machold and Fishell 2005; V. Wang, Rose, and Zoghbi 
2005).   
Around E14.5 in the mouse, the vast majority of rhombic lip derivatives begin to 
migrate outwards onto the dorsal surface and spread across the cerebellar anlage to 
form the external granular layer (EGL). The EGL consists of proliferative cerebellar 
granular cell precursors (CGNPs) that generate the granular neuron, a cell type that 
constitutes nearly half of all neurons in the human brain (45 billion granular neurons out 
of 110 billion neurons) (Figure 2D). As CGNPs begin migrating out of the rhombic lip, 
Math1-positive postmitotic cerebellar nuclei precursors migrate towards the rostral 
aspect of the cerebellar anlage. This migration continues until E15.5, and cerebellar 
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nuclei progenitors occupy a position beneath the emerging zone of the PC precursors to 
form the DCN (Morales and Hatten 2006; V. Wang, Rose, and Zoghbi 2005). Last, the 
anterior rhombic lip also generates neuronal precursors of the lateral pontine nucleus, 
cochlear nucleus, and hindbrain nuclei of the “cerebellar system”.  
 In mice, the EGL forms by E15 and CGNPs within the EGL continue to proliferate 
until two weeks after birth (Sillitoe and Joyner 2007). CGNPs reach their peak of 
proliferation between postnatal day 6 (P6) and P8. At approximately P0, some CGNPs 
begin to exit the cell cycle and differentiate into mature GCs as they simultaneously 
extend axons and begin tangential migration within the deep layer of the EGL. As 
CGNPs exit the cell cycle, they down regulate expression of Math1 and upregulate 
expression of NeuroD1 (J. K. Lee et al. 2000), Zic1,3 (Aruga et al. 1996; Aruga 2004), 
and the tumor suppressor cyclin-dependent kinase inhibitory protein p27Kip1 . As they 
migrate into deeper layers of the EGL, their extending axons express the GPI-linked 
axonal glycoprotein TAG1. TAG1 expression peaks during the first 3 days after CGNPs 
exit the cell cyle and decrease dramatically as their parallel fibers form synapses with 
PC dendrites. CGNPs then migrate radially along Bergmann glial fibers (Rakic 1971) into 
the developing cerebellar cortex past the developing PCs to occupy their final position in 
the internal granular layer (Wang and Zoghbi 2001). Their migration and maturation are 
complete by P20, several days after the disappearance of the EGL. 
 Many developmental signal transduction pathways important in the regulation of 
CGNP proliferation and differentiation have been identified. The Shh pathway, has been 
discovered as the master player triggering expansion of the pool of CGNPs. Shh ligand 
is secreted from Purkinje cells to signal to the EGL (Hynes et al. 1995; Vogel, Sunter, 
and Herrup 1989), and regulates CGNP proliferation through several mechanisms. First, 
Shh regulates expression of cell cycle regulators cyclin D1, cyclin D2, and cyclin E. Mice 
lacking cyclin D1 have slowed proliferation of CGNPs and impaired cerebellar growth 
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(Kenney and Rowitch 2000). Second, Shh activity upregulates expression of the 
protooncogene N-myc that when overexpressed, promotes cell autonomous 
upregulation of cyclin D1 mRNA and protein independently of Shh signaling (Kenney 
and Rowitch 2000). This mechanism involves other members of the Myc/Max/Mad family 
of basic helix–loop–helix leucine zipper (bHLHZ) DNA binding proteins, such as Mad3 
protein which has been shown to play a crucial role in CGNP proliferation (Yun et al. 
2007). Other targets of Shh mitogenic signaling in CGNPs include YAP1 (Fernandez et 
al. 2010), the microRNA miR17/92, and members of the insulin signaling pathway such 
as IRS1 (Parathath et al. 2008). 
N-myc is required for rapid expansion of CGNPs and inhibition of neuronal 
differentiation. Mice lacking N-myc in neural precursor populations have increased 
expression of cyclin-dependent kinase inhibitory proteins p27kip1 and p18Ink4c in the 
cerebellum (Knoepfler, Cheng, and Eisenman 2002) whereas engineered disruption of 
these inhibitory proteins in N-myc-null cerebella partially rescues the defects in CGNP 
proliferation and cerebellar foliation (Zindy et al. 2006). In addition, a synergistic effect of 
the Shh pathway and the phosphoinositide-3-kinase (PI3K) pathway on CGNP 
proliferation has been described, converging on N-myc. While Shh signaling drives 
expression of N-myc mRNA, the PI3K pathway stabilizes N-myc protein by inhibiting 
GSK3-dependent phosphorylation and degradation of N-myc. The PI3K agonist, insulin-
like growth factor, mimics the effects of PI3K activity (Kenney, Widlund, and Rowitch 
2004). Negative regulators of CGNP proliferation, ones that promote cell cycle exit and 
differentiation, include FGF (Fogarty et al. 2007) and BMP family members (Roussel and 
Hatten 2011; Rios et al. 2004; Zhao et al. 2008). Bmp2 and Bmp4 are expressed in 
postmitotic, differentiating CGNPs in the EGL and can inhibit Shh-induced CGNP 
proliferation in vitro via the Smad signaling pathway (Rios et al. 2004; Zhao et al. 2008). 
Bmp4 acts by inducing rapid posttranscriptional turnover of Math1 (Zhao et al. 2008).  
	   11 
 Although radial glia play integral roles in the development of the cerebellar 
neurogenesis and circuitry, relatively little attention has been given to the function of 
neuron-glial interactions. At the time of PC specification around E11 in the mouse, 
cerebellar radial glia project smooth fibers from the VZ to the pia mater where endfeet 
are formed (Kettenmann and Verkhratsky 2011). As PCs migrate through the cerebellar 
anlage, radial glial soma migrate in a synchronous fashion behind PC soma. At this 
stage, the developing Bergmann glia retain a descending process through the granular 
layer which can reach as far as the white matter (Sommer, Lagenaur, and Schachner 
1981). While postmitotic GCs migrate from the EGL to the IGL along radial Bergmann 
glial fibers, the PC dendritic tree elaborates in the opposite direction (Yamada et al. 
2000; Lordkipanidze and Dunaevsky 2005). As synapses form in the molecular layer, the 
Bergmann glial fibers begin to transform from the rod-like process to elaborate, leaf-like 
projections which ensheath newly developing synapses on PC dendrites (Yamada et al. 
2000). From P1 to P21, Bergmann glia proliferate in the PCL to attain a final ratio of 8:1 
Bergmann glia to PCs (Shiga, Ichikawa, and Hirata 1983; Reichenbach et al. 1995). The 
cellular maturation of BG, which involves process extension and transformation, is highly 
dependent on diffusible factors like neuregulin (Huang and Mei 2001) and neuronal cell 
surface contacts (Oomman et al. 2006; Hatten 1987). Activation of the Notch receptor on 
Bergmann glia by the Delta/Notch-like EGF-related receptor (DNER) ligand found on PC 
dendrites also appears to play a role in driving Bergmann glial cell maturation (Eiraku et 
al. 2005), as does caspase-3 (Oomman et al. 2006). By P21, neuronal migration, 
synaptogenesis, and differentiation of Bergmann glia into their characteristic adult form 
are complete (Bellamy 2006). 
Mice with BG defects during development exhibit severe cerebellar 
abnormalities, including altered cerebellar layering, neuronal migration, synaptic 
connectivity, and a disrupted pial membrane (Belvindrah et al. 2006; Graus-Porta et al. 
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2001; Wang et al. 2011; Eiraku et al. 2005; Komine et al. 2007; Weller et al. 2006). 
However, whether BG interactions with CGNPs influence CGNP proliferation has not yet 
been determined. In addition, genetic studies of BG function utilize either the human 
GFAP-Cre, Nestin-Cre, or Engrailed1-Cre lines (Corrales et al. 2004; Yu et al. 2011), 
which also induce widespread recombination in neuronal precursors (Zimmerman et al. 
1994; Graus-Porta et al. 2001). Thus investigations of the postnatal function of BG 
without affecting the vast majority of the neuronal population have not yet been 
performed. In Chapter III, we describe experiments in which we spatially and temporally 
alter Shh signaling activity specifically in postnatal BG and uncover a novel role for the 
BG-CGNP interaction in promoting CGNP precursor proliferation. 
 
Shh Signaling 
Shh is a member of the Hedgehog (Hh) family of secreted signaling proteins. It has 
diverse functions in vertebrates, playing an essential role in the development of many 
organs including the brain, bone, skin, GI tract, gonads, and lungs (Ruiz i Altaba 1998; di 
Magliano and Hebrok 2003). Humans or mice lacking Shh develop holoprosencephaly 
and cyclopia due to failure of the forebrain lobes to separate (Roessler et al. 1996; S. A. 
Brown et al. 1998; Chiang et al. 1996), highlighting the requirement of proper Shh 
signaling for the development of the neural tube. 
 Shh ligand is released from secreting cells following cholesterol and palmitate 
modifications, which are essential for the proper activity and distribution of the ligand 
(Zeng, Jia, and Liu 2010; Ryan and Chiang 2012). The Shh receptor, Patched1 (Ptc), is 
a 12-pass transmembrane protein with homology to the RND family of bacterial 
transporter proteins. In the absence of Shh ligand (Figure 3A), Ptc localizes to the 
primary cilium and inhibits the Shh signal transducer, seven-pass transmembrane 
protein Smoothened (Smo). Smo is maintained in an inactive conformation such that it 
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cannot enter the cilium (Rohatgi and Scott 2007). Although the mechanism of Ptc 
inhibition of Smo remains elusive, it is speculated that Ptc may regulate molecules that 
activate or inhibit Smo, a theory that is supported by the susceptibility of Smo to 
modulation by small molecules such as the steroidal alkaloid cyclopamine (Cooper et al. 
2003; Taipale et al. 2002; Chen 2002) and the fact that Ptc bears sequence similarities 
to the RND family of bacterial transporter proteins (Cooper et al. 2003; Taipale et al. 
2002; Chen 2002).  
 The zinc finger-containing Gli family of transcription factors, which are the principal 
effectors of Shh signaling, are proteolytically processed from their full-length form (Gli-
FL) into a truncated, N-terminal transcriptional repressor form (Gli-R). Vertebrates 
possess three Gli family members, Gli1-3. Gli2 and Gli3 can function as both 
transcriptional activators and repressors, whereas Gli1 exists only as an activator. 
Several proteins are necessary for efficient processing of Gli-FL into Gli-R forms. At the 
base of the primary cilium, protein kinase A (PKA) and Kif7 promote proteolytic 
processing of Gli3-FL into Gli3-R, and PKA also prohibits accumulation of Gli2-FL in the 
cilium. Suppressor of Fused (Sufu) stabilizes Gli2-FL and Gli3-FL and sequesters the 
proteins in the cytosol to prevent their nuclear translocation and activation (Wilson and 
Chuang 2010; Humke et al. 2010; Tukachinsky, Lopez, and Salic 2010; C. Wang, Pan, 
and Wang 2010). Sufu also promotes phosphorylation of Gli-FL by PKA, thus priming 
Gli-FL for further phosphorylation by GSK3β and CK1α. Phosphorylated Gli-FL is then 
ubiquitylated at the C-terminus by the E3 ubiquitin ligase β-TrCP and subsequently 
degraded to generate Gli-R. Although both Gli2 and Gli3 undergo proteolytic processing 
to repressor forms, degradation of Gli3 is more efficient than that of Gli2 (Pan et al. 
2006), thus Gli3-R serves as the main transcriptional repressor of Hh signaling whereas 
Gli2 functions as the principal activator when Hh ligand is present (Hui et al. 1994). Thus 
the Shh pathway is silenced in the absence of ligand. 
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Figure 1.3. 
 
Figure 1.3. Shh signaling pathway. 
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In the presence of Shh ligand (Figure 3B), Ptc inhibition of Smo is relieved, allowing for 
activation of Smo. Ptc reception of Shh is enhanced by co-receptors Cdo, Boc, and 
Gas1 (Allen et al. 2011; Izzi et al. 2011; Beachy et al. 2010) which, if removed, result in 
a tissue-specific decrease in Shh pathway activity (Allen et al. 2011; Beachy et al. 2010; 
Izzi et al. 2011). Smo activation involves phosphorylation of its C-terminus by CKα1 and 
GRK2, which induces conformational changes, recruitment of β-arrestin and the kinesin-
2 motor subunit Kif3a, and its subsequent translocation into the primary cilium (Ryan and 
Chiang 2012; Chen et al. 2011; Chen 2004; Kovacs et al. 2008). Smo accumulates in 
the ciliary membrane through both lateral transport and secretory pathways (Nozawa, 
Lin, and Chuang 2013). Smo then is able to inhibit Gli-FL processing into repressor 
forms, likely by promoting the disassembly of Sufu-Gli complexes that accumulate in the 
tip of the cilium following pathway activation (Humke et al. 2010; Wang, Pan, and Wang 
2010; Tukachinsky, Lopez, and Salic 2010; Zeng, Jia, and Liu 2010). Accumulation of 
Gli2/3 at the ciliary tip is associated with production of Gli activators. The Gli activators 
then translocate to the nucleus enabling activation of Hh target genes including Gli1, 
negative Hh pathway regulators Ptc and Hhip1, and other, cell-type specific genes 
involved in proliferation, differentiation, and cell-survival.  
 
Shh Signaling in the Cerebellum 
Shh is indispensable for proper early neural tube formation, and subsequently functions 
in various ways to direct formation of CNS regions including the cerebellum (Dahmane 
and Ruiz i Altaba 1999; Wallace 1999; Wechsler-Reya and Scott 1999), neocortex, 
tectum (Dahmane et al. 2001), hippocampus (Dahmane et al. 2001; Lai et al. 2002; 
Robert Machold et al. 2003), and other areas including the amygdala and septum 
(Dahmane and Ruiz i Altaba 1999; Lai et al. 2002).  
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In the cerebellum, Shh plays several important roles. First, it is now well-
established that Shh is produced by PCs and regulates CGNP proliferation. Shh 
signaling inhibition in vivo results in a marked decrease of proliferation in the EGL 
(Dahmane and Altaba 1999; Wallace 1999; Wechsler-Reya and Scott 1999). In fact, a 
widely used assay for studying the proliferation of CGNPs involves their isolation and 
purification from postnatal cerebella. Addition of Shh induces their proliferation, thus 
allowing cell-cycle associated phenomena to be studied in vitro (Dahmane and Altaba 
1999; Kenney and Rowitch 2000; Kenney, Cole, and Rowitch 2003; Wechsler-Reya and 
Scott 1999; Fernandez-L et al. 2009; Leung et al. 2004). Second, blocking Shh signaling 
in vivo leads to development of a hypoplastic cerebellum with abnormal foliation, a 
disorganized PCL, and impaired CGNP proliferation (Dahmane and Altaba 1999; Lewis 
et al. 2004). Subsequent experiments using conditional mutagenesis showed that a 
graded series of Shh signaling levels generated varying degrees of fissure formation in 
the cerebellum, showing a correlation between the levels of Shh signaling and the extent 
of cerebellar foliation (Corrales et al. 2006). Third, recent work in our laboratory has 
demonstrated its role in the expansion of VZ-derived GABAergic progenitors of the 
cerebellum (Huang, Liu, et al. 2010). Surprisingly, the source of Shh is not derived from 
the cerebellum but is rather delivered from the cerebrospinal fluid of the fourth ventricle 
(Huang, Liu, et al. 2010). Fourth, our laboratory has shown that PC-derived Shh 
signaling is required for proliferation of white matter progenitor cells and specification of 
late-born GABAergic interneurons and astrocytes (Fleming et al.) (submitted). Last, it 
has been observed that Shh signaling induces the glial differentiation of immature 
postnatal mouse astroglia in vitro (Dahmane and Altaba 1999). In addition, inhibition of 
Shh activity using 5E1 hybridoma cells injected into chick embryos at early stages 
resulted in massive perturbations of cerebellar development, including a concomitant 
reduction in BLBP+ BG (Dahmane and Altaba 1999), leading to the speculation that Shh 
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induces differentiation of Bergmann glia. However, these studies did not use in vivo glial 
specific reduction of Shh signaling (Dahmane and Altaba 1999) but rather ablated Shh 
signaling at an early embryonic stage when Shh also plays essential roles in 
development of the neural tube. Thus the role of Shh signaling activity in BG in vivo and 
its consequences for cerebellar development are not well understood. In Chapter III, we 
provide genetic evidence that Shh signaling in Bergmann glia is required for proper 
CGNP proliferation and subsequent cortical expansion. 
All three Gli genes are expressed in the developing cerebellum in the PCL and 
EGL (Corrales et al. 2004) although levels of Gli3 are low. Shh acts at a distance from its 
source—it is produced in the PCL and it diffuses several cell layers away to regulate 
proliferation of cells in the EGL. Modulation of the mitogenic effect of Shh has been 
demonstrated by several interacting pathways, including FGF (Wechsler-Reya and Scott 
1999) and IRS1. Shh is still expressed in the PCL of the adult brain well after the EGL 
disappears (Traiffort et al. 1999; Wallace 1999), although its function at that time is 
unknown. Notably, BG retain the ability to respond to PC-derived Shh into adulthood 
(Corrales et al. 2004; Corrales et al. 2006). It is possible that it plays a role related to 
survival and neurotrophic activities in other contexts (Thibert et al. 2003). 
 
Shh Signaling and Medulloblastoma 
Defects in Shh signaling have been linked to a wide variety of CNS disorders, including 
the malignancies medulloblastoma (Scales and de Sauvage 2009), glioblastoma 
(Dahmane et al. 2001; Bar et al. 2007; Clement et al. 2007; Ehtesham et al. 2007), and 
pituitary adenomas (Vila 2005; Vila 2004), as well as Parkinson’s, Alzheimer’s, 
depression, anxiety, traumatic and ischemic brain injury, and the demyelinating disorder 
multiple sclerosis (Traiffort, Angot, and Ruat 2010). Specifically in the cerebellum, 
mutations causing overactive Shh signaling occur in 25-30% of human 
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medulloblastomas (Gilbertson and Ellison 2008; Raffel 2000; Reifenberger et al. 1998), 
the most common malignant pediatric brain tumor. Activating mutations of the Shh 
pathway occurring in human medulloblastomas (Gilbertson and Ellison 2008; 
Reifenberger et al. 1998; Raffel 2000) was a phenomenon that was first identified in 
Gorlin’s Syndrome patients (Gorlin 1987). These patients have loss-of-function 
mutations in the Shh inhibitory receptor complex PTC or SUFU (Raffel 2000; Gilbertson 
and Ellison 2008; Brugieres et al. 2012), predisposing them to develop 
medulloblastomas, basal cell carcinomas, and skeletal abnormalities. On the other hand, 
cerebellar hypoplasia has been linked to reductions in Shh delivery in the cerebellum 
(Roper et al. 2006; Tam 2013; Heine et al. 2010).  
Medulloblastoma is the most common malignant pediatric brain tumor with about 
1000 new cases every year worldwide and a mean age between 3 and 7 years 
(Northcott et al. 2012). It accounts for over 20% of all CNS tumors in children (Dhall 
2009; Jozwiak, Grajkowska, and Wlodarski 2007). The current WHO classification 
recognizes four classes of medulloblastoma--classic MB, desmoplastic/nodular MB, MB 
with extensive nodularity, large cell MB, and anaplastic MB (Fuller 2008). The majority of 
medulloblastomas arise in the vermis of the cerebellum while some occupy the fourth 
ventricle and brainstem (Ellison et al. 2003; Gibson et al. 2010; Gilbertson and Ellison 
2008).  
Advances in genome analysis have very recently accelerated our understanding 
of the molecular basis of medulloblastoma. Transcriptional profiling of messenger 
mRNAs (Kool et al. 2012; Thompson et al. 2006; Kool et al. 2008) in human 
medulloblastoma have identified four molecularly distinct subgroups, each characterized 
by discrete clinical presentation, prognosis, demographics, expression profiling, and 
genomic abnormalities (Table 1). These subgroups are WNT, Sonic Hedgehog (SHH), 
Group 3, and Group 4 (Jones et al. 2012; Northcott et al. 2012; Pugh et al. 2012; 
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Robinson et al. 2012; Taylor et al. 2011). WNT-associated tumors, which occur in 
children, teenagers, and adults, are associated with disrupted WNT signaling genes 
including activating mutations in β-catenin and inactivating mutations in the negative 
regulator adenomatous polyposis coli (APC) gene (Hamilton et al. 1995). WNT MBs 
often have classic histology and have favorable outcomes compared to other subgroups 
of MB (Clifford et al. 2006; Ellison et al. 2003). SHH-associated MB can result from 
inactivating mutations PTC or SUFU, activating mutations in SMO, or amplification of 
GLI2 (Taylor et al. 2011; Brugieres et al. 2012). Many SHH-associated MBs have 
desmoplastic/nodular histology (Taylor et al. 2011) and often occurs in infants, where the 
prognosis is favorable, as well as in adults, where the prognosis is more variable (Kool 
et al. 2012). Group 3 MB often exhibit MYC overexpression or amplification whereas 
Group 4 tumors often exhibit amplification of CDK-6 or MYCN or duplication of the 
Parkinson's Disease-associated gene synuclein alpha interacting protein (SNCAIP) 
(Northcott et al. 2012; Taylor et al. 2011). The majority of Group 3 MB is found in 
children and is often associated with metastasis; it has the poorest prognosis among all 
subtypes of MB. Group 4 MB can be found in both children and adults and has more 
variable prognosis. 
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Table 1.1. Medulloblastoma subgroups. Adapted from Taylor et al, 2012. 
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As with many pediatric malignancies, medulloblastoma is thought to arise from 
progenitor cells that experience anomalies in growth- and development-associated 
genes and proteins. WNT medulloblastomas arise in lower rhombic lip progenitors of the 
dorsal brainstem and have been modeled in mice with an activated b-catenin allele and 
compounded by p53 deletion (Gibson et al. 2010). In contrast, the SHH subgroup of 
medulloblastoma has been shown to originate from CGNPs in the EGL (Behesti and 
Marino 2009; Gilbertson and Ellison 2008; Schüller, Heine, et al. 2008). Accordingly, 
several mouse models have been generated to phenocopy hedgehog-driven 
medulloblastomas. A well-established model is a mouse heterozygous for Patched, in 
which 10-15% develop spontaneous medulloblastomas within one year (Johnson et al. 
1996; Goodrich et al. 1997; Hahn et al. 1996; Berman et al. 2002). When crossed with 
p53-/- mice, the incidence of medulloblastoma rises to >95% before three months of age 
(Wetmore, Eberhart, and Curran 2001). Other established mouse models drive 
expression of a constitutively active Smoothened allele, SmoM2 or SmoA1, and when 
crossed with an appropriate Cre driver for example Math1-Cre, Nestin-Cre, or GFAP-
Cre, can result in 100% medulloblastoma incidence with an average survival of 33-41 
days (Schüller, Heine, et al. 2008). Notably, the majority of these Shh-driven mouse 
models involve transformation of a large number of neural stem cells (GFAP) (Yang et 
al. 2008), neural progenitors (Nestin) (Rao et al. 2003; Rao et al. 2004) or CGNPs 
(Math1) (Schüller, Heine, et al. 2008). To date there have been few distinct subsets of 
CGNPs identified which can be transformed to initiate medulloblastoma formation, with 
the exception of Olig2- and Tlx3-expressing precursors (Schüller, Heine, et al. 2008). In 
Chapter II, we demonstrate that a small subset of CGNPs, identified as Gdf7-lineage 
cells, can be oncogenically transformed by deregulated Shh signaling; our investigation 
demonstrates how remarkably few cells are sufficient for oncogenic transformation and 
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tumor formation. Further identification of the cellular origins of medulloblastoma may 
help to better understand early developmental pathways involved in tumorigenesis and 
focus treatment on cell types responsible for tumor initiation. 
 
Therapy for Medulloblastoma 
Current treatments for medulloblastoma typically involve surgical resection coupled with 
chemotherapy and radiation regardless of molecular subgroup, leading to a five-year 
survival of almost 90% in average-risk patients and 70% in high-risk patients (Gajjar et 
al. 2006). However, five-year disease-free survival remains low, at 36%, for patients with 
dissemination and prognosis remains poor for patients with recurrent medulloblastoma 
(Packer et al. 2006). In addition, a majority of survivors exhibit long-term cognitive and 
endocrine deficits as a complication of therapy (Mulhern 2005; Ribi et al. 2005), 
underscoring the desperate need for improved therapies. 
 Recent advances in the understanding of Shh signaling have led to the discovery 
and development of small molecule inhibitors of the pathway. Several small molecule 
inhibitors of Smoothened function have worked remarkably well to suppress 
medulloblastoma in allografts and mouse models (Berman et al. 2002; Justyna Romer 
and Curran 2005), and some have even been tested in clinical trials. One promising 
therapeutic, Visomegib, was reported in one patient to cause almost complete remission 
of the disease only to have it return at a later time with a mutation in Smo that made 
tumor cells insensitive to the drug (Rudin et al. 2009; Rudin 2012; Yauch et al. 2012). 
Thus there is great need for novel targets as well as small molecule antagonists to the 
Shh pathway that may be used in combination treatments with Smo inhibitors. Current 
studies are being directed at targeting Gli, and few Gli-level inhibitors have been 
identified, including arsenic trioxide, GANT58, and GANT61 (Lauth et al. 2007; Kim et al. 
2010). Small molecule inhibitors of the Shh pathway that act downstream of Smo have 
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the advantage of being active against MBs in which Smo is mutated and hold great 
potential as future therapeutics for medulloblastoma. In Chapter IV of this work, we 
identify a small molecule as a novel and potent inhibitor of Shh signaling at the level of 
Gli1 transcription. 
 
Novels findings as elucidated by modulation of Shh signaling 
In this work, we have modulated Shh signaling through genetic mouse models to reveal 
novel findings regarding its role in cerebellar development and medulloblastoma. 
First, in Chapter II we demonstrate that focal activation of Shh signaling in a 
distinct subset of CGNPs, specifically derived from hindbrain roof plate cells expressing 
growth differentiation factor-7 (Gdf7), is sufficient to promote cerebellar tumorigenesis. 
This is accomplished by utilizing a Gdf7Cre/+ line to drive constitutive activation of the Shh 
pathway activator Smoothened (SmoM2). Gdf7Cre/+;SmoM2 (GM2) mutant mice were 
observed to display stunted growth, cranial bulging, and impaired motor coordination; all 
GM2 mice died within three weeks of birth. Analysis of mutant cerebellar architecture 
revealed severe hyperplasia suggestive of tumor formation. Tumors from both GM2 and 
established medulloblastoma model PatchedLacZ/+ mice displayed strong expression of 
CGNP, neural progenitor, and proliferative markers. In addition, cultured GM2 cerebellar 
cells expressed multiple stem cell markers and were clonogenic and multipotent. 
Collectively, these data indicate that targeting constitutively active Shh signaling to the 
Gdf7-lineage leads to formation of medulloblastoma. Detailed fate-mapping was 
performed of the Gdf7 lineage which revealed that surprisingly, Gdf7-lineage cells 
contribute to a small subset of proliferating CGNPs. In addition, Gdf7-lineage cells also 
contribute to an extensive array of mature cerebellar cell types. The GM2 
medulloblastoma mouse model demonstrates how remarkably few cells are sufficient for 
oncogenic transformation and tumor formation. Thus hindbrain roof plate cells are 
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established as a novel source of diverse neural cell types in the cerebellum that is also 
susceptible to oncogenic transformation by deregulated Shh signaling. This work is 
published in PlosOne (April 2012) (Cheng et al. 2012). 
 Second, in Chapter III we use a tamoxifen-inducible Tenascin-CreER line to 
spatially and temporally alter Shh signaling activity specifically in postnatal BG. Mice in 
which Shh activator Smoothened (Smo) is postnatally ablated in BG demonstrate an 
obvious reduction in cerebellar size within two days of ablation of Shh signaling. 
Surprisingly, mutant CGNPs exhibit severely reduced proliferation and increased 
differentiation accompanied by a loss of Shh activity, suggesting a novel role for the BG-
CGNP interaction in promoting CGNP precursor proliferation. Interestingly, Wnt signaling 
is ectopically elevated in TNC mutant CGNPs concomitant with a reduction in EGL area, 
suggesting that this pathway is involved in cross-talk with the Shh pathway in regulating 
CGNP proliferation. In addition, loss of Shh signaling in BGs leads to disrupted PC 
laminar organization and dendritic arborization as well as BG fiber morphology, 
indicating that BG-Shh signaling activity contributes to the maintenance of proper 
cerebellar laminar formation. Collectively, these data show a previously unappreciated 
role for BG Shh signaling activity in the proliferation of CGNPs and preservation of 
cerebellar architecture, thus leading to a new level of understanding of the neuronal-glial 
relationship in the cerebellum. This work is to be submitted for publication by early 2014. 
 In Chapter IV of this work, we identify AICAR as a potent Hh pathway antagonist in 
multiple cell types, including Hh-responsive human medulloblastoma cells. Importantly, 
we show that AICAR acts downstream of Smo and regulates Gli1 transcription in a 
proteasome-independent manner. Sufu stabilizes the Gli proteins from AICAR inhibition, 
as downregulation of Shh pathway activity was more efficient in Sufu-null MEFs. Last, 
we find that although AICAR activates AMPK in these cell lines, inhibition of the Hh 
pathway by AICAR is AMPK-independent. Our findings establish AICAR as a modulator 
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of Shh signaling in both a developmentally relevant cell type as well as medulloblastoma 
cells, providing an encouraging basis to further explore its full potential as an antagonist 
in Shh-associated tumors. This work represents a collaboration between myself and a 
colleague in the Chiang lab, Jiang Liu, Ph.D. My contributions encompassed the studies 
in CGNPs and human medulloblastoma cells, as well as the written document. This work 
will be submitted for publication following completion of in vivo studies of AICAR effects 
on Shh-driven tumors. 
Although seemingly disparate projects, each of these chapters is connected to 
understanding the function of Shh signaling in a developmental context of the 
cerebellum in order to elucidate consequences of aberrant Shh signaling in the context 
of disease. A central focus of our studies is the origin and proliferative capacity of the 
CGNP, which is the cell-of-origin for hedgehog driven medulloblastomas (Yang et al. 
2008; Schüller, Heine, et al. 2008). In Chapter II, we examine the developmental origins 
of CGNPS and find that hindbrain roof plate cells can give rise to this cell type, thereby 
revealing a novel source of cerebellar cells. In Chapter III, we focus on factors regulating 
the proliferation of CGNPs, and establish the specialized glial cell Bergmann glia as a 
previously unidentified regulator of these cells. And in Chapter IV, we extend studies of 
factors regulating CGNPs and identify a small molecule as a novel Shh pathway activity 
inhibitor with consequences on proliferation of not only CGNPs but on hedgehog-driven 
medulloblastoma cells. Thus, our studies collectively elucidate cellular mechanisms 
involved in CGNP proliferation, with implications for medulloblastoma. It is our hope that 
understanding Shh-dependent signaling in the cerebellum during normal development 
and disease can provide insight into cellular relationships integral to brain growth as well 
as inform development of targeted therapies for disease processes resulting from 
deregulated signaling. 
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CHAPTER II 
 
WIDESPREAD CONTRIBUTION OF GDF7 LINEAGE TO CEREBELLAR CELL TYPES AND 
IMPLICATIONS FOR HEDGEHOG-DRIVEN MEDULLOBLASTOMA FORMATION 
 
INTRODUCTION 
The roof plate is a transient embryonic dorsal midline epithelial tissue spanning the 
entire developing central nervous system (CNS). The LIM-homeodomain transcription 
factor Lmx1a is a central regulator of roof plate development, as loss of Lmx1a resulted 
in a major absence of roof plate cells during early embryogenesis (Chizhikov and Millen 
2004; Millonig, Millen, and Hatten 2000). The roof plate consists of a distinct strip of the 
most dorsal-lateral neuroectodermal cells that collectively function as an essential 
organizing center regulating development of neighboring tissues. Roof plate-derived 
inductive signals, such as Bmp6, Bmp7, Gdf7 (Bmp12), and Wnt1 (Chizhikov and Millen 
2004; Lee, Dietrich, and Jessell 2000; Lee, Mendelsohn, and Jessell 1998), are 
important for directing differentiation of dorsal neuronal cell types (Chizhikov and Millen 
2004; Lee, Dietrich, and Jessell 2000; Lee, Mendelsohn, and Jessell 1998; Chizhikov et 
al. 2006). While regulating the development of neighboring tissues by secreted growth 
factors, the roof plate cells also have the capacity to generate different cell types. For 
example, in the spinal cord region, Gdf7-expressing roof plate progenitors give rise to 
dorsal interneurons and neural crest-derived sensory neurons and glia (Lee et al. 2000; 
Lo, Dormand, and Anderson 2005). In the telencephalon, roof plate progenitor cells have 
been implicated as a source of marginal zone neurons (Monuki, Porter, and Walsh 
2001). Although the roof plate varies in its differentiation potential along the rostral-
caudal axis of the neural tube (Awatramani et al. 2003; Currle et al. 2005; Hunter and 
Dymecki 2007), previous fate-mapping studies have indicated that the hindbrain roof 
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plate is uniquely restricted in lineage potential and its contributions are mostly limited to 
non-neural hindbrain choroid plexus epithelial (hChPe) cells (Chizhikov et al. 2006; 
Currle et al. 2005; Hunter and Dymecki 2007; Landsberg et al. 2005; Chizhikov et al. 
2010). Hence, the capacity for hindbrain roof plate Gdf7-expressing cells to contribute to 
specific cell types in the cerebellum has not been shown.  
Adjacent to the hindbrain roof plate is the cerebellar rhombic lip, which is a 
source of migratory neurons that primarily stream towards the cerebellar anlage to form 
multiple cell types. Rhombic lip derivatives include neurons of the deep cerebellar nuclei, 
granule neuron progenitors, and unipolar brush cells, each arising within a specific 
developmental time window. Previous genetic analyses of the cerebellar rhombic lip 
have suggested that the basic helix-loop-helix transcription factor Mouse atonal homolog 
1 (Math1) molecularly defines the region of the rhombic lip (Machold and Fishell 2005; 
Wang, Rose, and Zoghbi 2005). However, more recent investigation has shown the 
rhombic lip to be molecularly heterogeneous with Lmx1a expression representing at 
least one Math1-independent rhombic lip gene (Chizhikov et al. 2010). Thus, the extent 
and contribution of Math1-negative cell types residing in the rhombic lip has yet to be 
elucidated.  
Medulloblastoma, the most common malignant brain tumor in children, is 
characterized by its rapid progression and tendency to spread along the entire brain-
spinal axis with poor clinical outcome. Recent integrative transcriptional profiling studies 
have showed that medulloblastoma comprises a collection of four clinically and 
molecularly diverse subgroups (Thompson et al. 2006; Kool et al. 2008; Northcott, 
Korshunov, et al. 2011; Taylor et al. 2011; Kool et al. 2012; Cho et al. 2011). Two of 
these subgroups, molecularly defined by overactivated WNT or SHH signaling, 
consistently demonstrate distinct genetic profiles and recently were found to arise from 
different cellular origins (Gibson et al. 2010). It is now well established that Sonic 
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hedgehog (Shh) signaling stimulates proliferation of cerebellar granule neuron 
precursors (CGNPs) during cerebellar development (Wechsler-Reya and Scott 1999; 
Wallace 1999; Sillitoe and Joyner 2007; Dahmane and Ruiz i Altaba 1999). Numerous 
studies using mouse models in which the Shh pathway is constitutively activated have 
linked Shh signaling to medulloblastoma and CGNPs as a cellular origin (Gilbertson and 
Ellison 2008; Yang et al. 2008; Schüller, Heine, et al. 2008). Notably, the majority of 
Shh-driven mouse models involve transformation of a large number of neural stem cells 
(GFAP) (Z. Yang et al. 2008), neural progenitors (Nestin) (Rao et al. 2003; Rao et al. 
2004) or CGNPs (Math1) (Schüller, Heine, et al. 2008). To date there have been few 
distinct subsets of CGNPs identified which can be transformed to initiate 
medulloblastoma formation, with the exception of Olig2- and Tlx3-expressing precursors 
(Schüller, Heine, et al. 2008). Further identification of the cellular origins of 
medulloblastoma may help to better understand early developmental pathways involved 
in tumorigenesis and focus treatment on cell types responsible for tumor initiation. 
In our previous study, we observed that Gdf7Cre/+;SmoM2 mutant mice, in 
addition to demonstrating enhanced proliferation of the hindbrain choroid plexus 
epithelial progenitor cells, are runted and exhibit neurological defects (Huang et al. 
2009). Here we show that ectopic Shh signaling in the Gdf7-lineage cells invariably led 
to formation of medulloblastoma with CGNP features, indicating that focal activation of 
the Shh signaling pathway in the Gdf7-lineage cells is sufficient to promote cerebellar 
tumorigenesis. This result is at odds with previous findings that hindbrain roof plate may 
only contribute to non-neural choroid plexus epithelium. Using lineage tracing analysis, 
we demonstrate that in addition to their contribution to the choroid plexus epithelium, 
Gdf7-expressing cells are a source of distinct progenitor populations in the rhombic lip 
and dorsal midline cerebellar ventricular zone. These populations contribute to multiple 
cerebellar neuronal and glial cell types, including CGNPs, the presumed cell of origin for 
	   29 
hedgehog-driven medulloblastoma. Our findings uncover a broad contribution of Gdf7-
lineage to the cerebellum and suggest that medulloblastoma can stem from progenitor 
populations that were previously thought to be restricted to the choroid plexus lineage.  
 
RESULTS 
Targeted activation of Shh signaling pathway in Gdf7-lineage leads to rapid 
cerebellar hyperplasia 
We recently reported that the hChPe cells robustly express Shh and Shh signaling 
defines a discrete hChPe progenitor domain close to the lower rhombic lip (Huang et al. 
2009). To support a crucial proliferative role for Shh signaling during hChPe 
development, we generated Gdf7Cre/+;SmoM2 mutants in which Gdf7Cre drives 
constitutively active Shh signaling in a ligand-independent manner due to a point 
mutation in the Smo allele (Xie et al. 1998; Jeong et al. 2004). In line with the regulation 
of Shh signaling in the biogenesis of the hChP, we observed enlarged hChP in the gain-
of-function Gdf7Cre/+;SmoM2 mutant mice. Notably, Gdf7Cre/+;SmoM2 mice displayed 
stunted growth, cranial bulging in the hindbrain region, and impaired motor coordination 
(Huang et al. 2009). As reported in our previous study, all of the Gdf7Cre/+;SmoM2 mice 
died within three weeks of birth with a median survival of 13.5 days (Huang et al. 2009). 
Dissected Gdf7Cre/+;SmoM2 cerebella often lacked visible foliations, suggesting that the 
spaces between cerebellar lobules were filled with cellular material. Examination of 
hindbrain histology in surviving pups prior to P10 revealed proper development of all 
cerebellar layers and relatively normal architecture (Figure 2.1A-B’). However, 
hematoxylin and eosin staining of tissue sections from mice surviving beyond P14 
revealed tumors within 
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Figure 2.1. Shh pathway activation in Gdf7-lineage cells leads to cerebellar 
hyperplasia 
Gdf7Cre/+;SmoM2 gain-of-function mutant mice exhibit cerebellar defects. (A-B’) 
Hematoxylin-eosin staining of wild-type and Gdf7Cre/+;SmoM2 mutants. Prior to P10 
histological sections of mutants are similar to control. (C-E’) Gdf7Cre/+;SmoM2 mutants 
over 14 days old develop ectopic foci of densely packed cells within the molecular layer 
of their cerebella. Higher magnification view of these foci reveals no discernible layer 
organization and resemblance to neoplastic lesions. Arrows in (D) indicate regions of 
hypercellularity. Boxed regions E and E” are magnified and shown in the right adjacent 
panels. Arrows in D’ indicate nuclear molding. Arrowheads in D’ indicate apoptotic 
nuclei. (F-F”) The ectopic foci consist of cells of the Gdf7-lineage as indicated by their 
expression of SmoM2-YFP. (G-G”) Ectopic foci do not express differentiated neuronal 
marker NeuN. Abbreviations: EGL, external granular layer. ML, molecular layer. IGL, 
internal granular layer. T, tumor region. N, normal cerebellum.  
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the cerebellar parenchyma and leptomeninges (Figure 2.1C-E’, arrows). The cells were 
pleomorphic with a high nuclear-to-cytoplasmic ratio. Nuclear molding was a common 
feature (Figure 2.1D’, arrows), as was the presence of apoptotic cells (Figure 2.1D’, 
arrowheads). In the parenchymal lesions, areas of relatively preserved molecular layer 
architecture with hypercellularity were suggestive of persistence of the external granule  
layer (EGL) (Figure 2.1E-E’). As the membrane-localized SmoM2 protein is fused with a 
YFP reporter protein (Xie et al. 1998; Jeong et al. 2004), we determined that the 
medulloblastoma cells were all YFP-positive (Figure 2.1F-F”). Furthermore, YFP 
expression covering most of the cerebellar surface in the Gdf7Cre/+;SmoM2 mice 
suggests that the tumor cells are derived from Gdf7-expressing progenitor cells. 
Importantly, YFP-positive cells do not express the differentiated neuronal marker NeuN 
(Figure 2.1G-G”). Collectively, these data indicate that targeting constitutively active Shh 
signaling to the Gdf7-lineage leads to the formation of medulloblastoma.  
 
Gdf7Cre/+;SmoM2 medulloblastomas display cerebellar granule neuron precursor 
features and similar molecular phenotypes to medulloblastomas in PatchedLacZ/+ 
mice 
Consistent with the fact that constitutively active SmoM2 was expressed in Gdf7-lineage 
cells and the tumor cells are marked by YFP, we detected a high level of Shh signaling, 
as evidenced by robust expression of pathway target genes Gli1 and Ptch1 in 
Gdf7Cre/+;SmoM2 medulloblastomas (Figure 2.2B and 2B’). In contrast, moderate levels 
of Gli1 and Ptch1 were detected only in putative Bergmann glial cells of control cerebella 
(Figure 2.2A and A’). Emerging evidence suggests that Nmyc is an essential oncogenic 
mediator for Shh-dependent medulloblastoma (Kenney, Widlund, and Rowitch 2004; 
Hatton et al. 2006; Kenney, Cole, and Rowitch 2003; Thomas et al. 2009). More 
importantly, a recent study demonstrated that Nmyc promotes progression from  
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Figure 2.2. 
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Figure 2.2. Gdf7Cre/;SmoM2 mice develop medulloblastoma with CGNP features 
(A-B”’) In situ hybridization of wild-type and Gdf7Cre/+;SmoM2 mutants. The aberrant 
tissue foci of Gdf7Cre/+;SmoM2 cerebella display high level Shh signaling as determined 
by Gli1 and Ptch1 expression, and Nmyc and Math1 expression. (C-H”’) 
Gdf7Cre/+;SmoM2 mice develop medulloblastoma consisting of cells of the CGNP fate. 
Tumors in Gdf7Cre/+;SmoM2 mice and adult Patched1LacZ/+;SmoM2 mice appear very 
similar. Abbreviations: ML, molecular layer. PCL, Purkinje cell layer. IGL, internal 
granular layer. T, tumor region. N, normal cerebellum. 
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Figure 2.3. A subset of Gdf7-lineage cells express neural stem cell markers 
(A-B”’) Many cells within the tumor tissue of Gdf7Cre/+;SmoM2 mice coexpress neural 
stem cell marker  Nestin (red) and glial marker GFAP (green). Arrows indicate co-
localization. (C-E) Tumor cell lines can be invariably established from Gdf7Cre/+;SmoM2  
cerebella. (F-G”) These cells highly express multiple neural stem cell markers Nestin 
and Sox2 and can undergo serial passages. (H-J) Here, one representative colony is 
shown when cultured for 3 and 6 days. (K-N) Gdf7Cre/+;SmoM2 cultured cells can 
differentiate into mature cerebellar cell types upon switching to culture media containing 
10% FBS. 
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preneoplastic lesions to medulloblastoma (Kessler et al. 2009). While Nmyc expression 
was not detectable in the cerebella of control mice older than 2 weeks, robust 
expression was measured in Gdf7Cre/+;SmoM2 medulloblastoma cells (Figure 2.2A” and 
2B”), consistent with oncogenic transformation. Previous studies have shown that 
acquisition of CGNP fate is a prerequisite for medullollastoma formation (Yang et al. 
2008; Schüller, Heine, et al. 2008). As oncogenic transformation of CGNPs has been 
faithfully modeled in the PatchedLacZ/+ mice (Johnson et al. 1996; Berman et al. 2002), 
we compared medulloblastomas in these mice to those in the Gdf7Cre/+;SmoM2 mice. 
Notably, tumors from both Gdf7Cre/+;SmoM2 and PatchedLacZ/+ mice displayed strong 
expression of Math1, a marker of cells of the CGNP fate (Figure 2.2C, 2D, 2E), 
comparably low expression of calbindin-positive Purkinje neurons and parvalbumin-
positive GABAergic interneurons, and absence of Pax2-positive GABAergic interneuron 
progenitors (Figure 2.2C-E”’). Similar to PatchedLacZ/+ tumors, Gdf7Cre/+;SmoM2 
medulloblastomas expressed the neural progenitor marker Nestin and were highly 
proliferative as indicated by strong expression of Ki67, CyclinD2, and phosphorylated Rb 
and partial loss of differentiation marker p27Kip1 (Figure 2.2F-H”’). Taken together, 
these data demonstrate that Gdf7Cre/+;SmoM2 and PatchedLacZ/+ mice develop 
medulloblastomas with similar cellular and molecular phenotypes and CGNP identity.  
A subset of Gdf7-lineage tumor cells are multipotent   	  
A recent report has shown that a subset of medulloblastoma cells from Patched1LacZ/+ 
mice are multipotent progenitors and capable of differentiating into glial and neuronal 
lineages (Ward et al. 2009). To determine whether the medulloblastoma cells in 
Gdf7Cre/+;SmoM2 mice possessed similar properties, we assayed for the presence of 
potential cancer stem-cell like markers. Consistently, we were able to detect Nestin+ and 
GFAP+ cells in Gdf7Cre/+;SmoM2 tumor foci, suggestive of a tumor stem cell 
immunophenotype (Figure 2.3A-B”’, arrows). We then dissected the cerebella from 
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Gdf7Cre/+;SmoM2 mice older than 14 days and from age-matched control mice. 
Cerebellar cells were dissociated and cultured in neural stem cell medium. While we did 
not observe appreciable colony formation by the dissociated control cerebellar cells, we 
observed the formation of numerous highly proliferative colonies within days from every 
mutant cerebellum analyzed (Figure 2.3C-E). These cells expressed the neural stem cell 
markers Nestin, Sox2, and GFAP, sustained multiple serial passages (over 50) and were 
clonogenic at a plating density of 100 cells per mL culture medium (Figure 2.3F-J). 
Under stem cell culture conditions, the YFP+ cells from Gdf7Cre/+;SmoM2 
medulloblastomas were small and bipolar with large nuclei and scant cytoplasm (Figure 
2.3I). Upon switching to medium supplemented with 10% fetal bovine serum, the YFP+ 
cells displayed dramatically altered morphology within 5-7 days, withdrew from the cell 
cycle, and differentiated into Tuj1+ or NeuN+ neurons, GFAP+ astrocytes or CNPase+ 
oligodendrocytes, highlighting their multi-potency (Figure 2.3K-N). These data suggest 
that a subset of Gdf7-lineage cells in the Gdf7Cre/+;SmoM2 tumors express multiple stem 
cell markers and are clonogenic and multipotent, reported characteristics for the 
medulloblastoma-propagating cells of the PatchedLacZ/+ mouse model (Ward et al. 2009).  
 
Distinct Gdf7-expressing cells of the cerebellar vermal ventricular zone are radial 
glial cells  
The unexpected finding that Gdf7Cre/+;SmoM2 mice displayed cerebellar oncogenic 
transformation prompted us to ask whether the Gdf7-lineage cells only differentiate into 
mature hChPe cells as previously recognized, or contribute to other cerebellar cell types 
including CGNPs that are susceptible to oncogenic transformation by aberrant Shh 
signaling. Therefore, we performed detailed fate-mapping of the Gdf7 lineage in 
Gdf7Cre/+;ROSA26LacZ and Gdf7Cre/+;ROSA26eYFP mice, where LacZ or enhanced YFP 
indelibly marks cells that are, or once were, expressing Gdf7. As expected, Gdf7-lineage 
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cells were distributed at the dorsal midline along the entire cranio-spinal axis (Figure 
2.4A, 4B). In this hindbrain region, Gdf7-lineage cells emanated from the lateral edge to 
occupy the medial portion of the roof plate, a migratory pattern similar to the reported 
Ttr-expressing primitive hChPe cells (Figure 2.4B) (Hunter and Dymecki 2007). We 
observed a streak of Gdf7-lineage cells in the midline vermal cerebellar tissue where the 
two hemispheres meet (Figure 2.4C). This observation is consistent with the fact that we 
detected restricted Gdf7-expressing cells in the cerebellar midline tissue (Figure 2.4E), 
which persisted into E16.5 embryos (Figure 2.7). Interestingly, Msx1, a Bmp signaling 
target gene, was highly expressed in this cerebellar midline domain and suggestive of 
local signaling (Figure 2.4F). Furthermore, we observed that at embryonic day 14.5 
(E14.5), all Gdf7-lineage cells localized to the vermal ventricular zone expressed radial 
glial cell markers BLBP and Sox2 (Figure 2.4G-H’). Radial glial cells have been shown to 
be multipotent neural stem cells during embryogenesis (Anthony et al. 2004). These 
data suggested that the Gdf7-expressing cerebellar vermal cells are a distinct sub-
population of multipotent radial glial cells. As radial glial cells are rapidly proliferating 
during embryonic stages, we asked whether Gdf7 could act as a proliferative signal. The  
lack of apparent Gdf7 and Msx1 expression in the Math1+ tumor tissue of 
Gdf7Cre/+;SmoM2 mice argues against this possibility (Figure 2.4I-K). 
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Figure 2.4. 
 
Figure 2.4. Roof plate cells give rise to a distinct population of cerebellar vermal 
radial glia cells  
(A) Whole mount X-gal staining for ß-galactosidase in Gdf7Cre/+;ROSAlacZ embryos 
shows that Gdf7 lineage is present in the hindbrain roof plate at E10. (B) At E14.5, in 
addition to hindbrain choroid plexus, Gdf7 lineage also contributes to the ventricular 
zone of cerebellar vermis (red arrows). (C-F) In situ hybridization at E14.5 showing 
Gdf7 and its transcriptional target Msx1 are expressed in the cerebellar vermis. (G-H’) 
Fate-mapping of the Gdf7-lineage in Gdf7Cre/+;ROSAeYFP cerebella indicates that Gdf7 is 
present at E14.5 in a distinct population of vermal radial glia cells as highlighted by 
coexpression of YFP and BLBP (G-G’) or Sox2 (H-H’) Arrows indicate colocalization. (I-
K) In situ hybridization at P18 shows that the Math1+ Gdf7Cre/+;SmoM2 tumor tissue 
does not express Gdf7 or Msx1. Abbreviations: N, normal cerebellar tissue. T, tumor 
tissue. CB, cerebellum. uRL, upper rhombic lip. 
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Gdf7-lineage cells of the cerebellar rhombic lip are Lmx1a+ neural progenitor cells 
that likely give rise to CGNPs 
As expected, at stage E14.5 a second population of Gdf7-lineage cells was present in 
the laterally positioned roof plates adjacent to the choroid plexus. Surprisingly, several 
Gdf7-lineage cells delaminated from the clustered roof plate cells to enter the rhombic lip 
(Figure 2.5A). The number of delaminating Gdf7-lineage cells was few but distinct, 
amounting to no more than 20-30 cells per embryo at E14.5. In order to determine the 
identity of these cells, we sought to co-localize them with Math1, a molecular marker of 
the rhombic lip (Machold and Fishell 2005). Using Gdf7Cre/+;ROSA26LacZ;Math1GFP/GFP in 
which GFP marks cells expressing Math1 and β-gal labels cells that once were or are 
expressing Gdf7, we found that the Gdf7-lineage cells in the rhombic lip were Math1-
negative, corroborating recent evidence that molecular heterogeneity exists within the 
cerebellar RL (Figure 2.5A-A”) (Chizhikov et al. 2010). Accordingly, the cells were 
negative for Pax6, a marker for CGNPs (Figure 2.5C-C”). However, Gdf7-lineage cells 
retain the capacity to express Math1 as they migrate into the EGL (Figure 2.5B-B”). 
Because Lmx1a is currently the only known Math1-independent rhombic lip gene 
(Chizhikov et al. 2010), we sought to colocalize the Gdf7-expressing progeny with 
Lmx1a and found that they were indeed Lmx1a-positive (Figure 2.5D-D”). To further 
characterize the identity of the delaminated Gdf7-lineage cells in the rhombic lip, we 
determined their expression of Sox2, a marker for neural progenitor cells (Figure 2.5E-
E”) and also found that they are BLBP-negative (Figure 2.5F-F”). Some GFP-positive 
cells co-labeled with Tbr2 (Figure 2.5G-G”, arrows), a marker for unipolar brush cells 
(UBC) which also originate from the rhombic lip (Sotelo and Dusart 2009; Corrales et al. 
2004), suggesting that Gdf7-lineage cells can also contribute to the UBC population. We 
then analyzed the fate of Gdf7- lineage cells at postnatal stages. Consistent with the 
Math1+ YFP cells at E14.5, we detected apparent YFP signal in the EGL and other 
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tissue layers of the P6 cerebellum (Figure 2.5H, 5I, data not shown). The YFP positive 
cells in the EGL were Ki67 positive, indicating that they are cycling, proliferative CGNPs 
(Figure 2.5H-I”). These findings strongly suggest that progeny of Gdf7-expressing cells 
can enter the rhombic lip and eventually the EGL to become Math1+ CGNPs. 
Additionally, we observed YFP positive cells in the IGL that were also Tbr2 positive, 
demonstrating that Gdf7 lineage cells can become mature UBCs (Figure 2.5J-J”).  
 
Gdf7-lineage cells contribute to an extensive array of mature cerebellar cell types 
In line with their widespread distribution in P6 cerebellum, we found that the Gdf7-
lineage cells contribute extensively to various mature cerebellar cell types. In 
Gdf7Cre/+;ROSA26eYFP cerebella from adult mice, YFP-marked cells co-expressed 
granule neuron marker NeuN (~3.5%), Purkinje neuron marker calbindin (~0.1%), 
GABAergic interneuron marker parvalbumin (<0.1%), Bergmann glia marker Sox2 
(~0.2%), and white matter astrocyte cell marker GFAP (<0.1%) (Figure 2.6A-F”). It is 
interesting to note that granule neurons were the predominant cellular derivatives. A 
similar situation has been reported indicating that Gdf7-expressing roof plate cells of the 
spinal cord region preferentially become sensory neurons, a process suggested to be 
mediated by the function of Gdf7 itself (Lo, Dormand, and Anderson 2005). Granule 
neurons derived from the Gdf7-lineage were not uniformly distributed among the 
cerebellar lobes, with higher numbers found in Lobes III-V and IX (Figure 2.6G, 6H). 
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Figure 2.5. 
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Figure 2.5. Gdf7-lineage cells in the cerebellar rhombic lip are Lmx1a+ neural 
progenitor cells that give rise to CGNPs 
(A-B”) Fate-mapping studies in Gdf7Cre/+;ROSA26eYFP;Math1GFP/GFP  at E14.5 show that 
Gdf7-lineage cells (as indicated by b-gal, green) are Math1-negative (as indicated by 
GFP) in sagittal sections of the upper rhombic lip. However these cells retain the 
capacity to express Math1 in the EGL. Arrows indicate delaminating Gdf7-lineage cells 
from the upper rhombic lip en route to the EGL. (C-F”) Fate-mapping studies in 
Gdf7Cre/;ROSA26eYFP mice at E14.5 show that delaminating Gdf7-lineage cells (green, 
arrows) are present in sagittal sections of  the cerebellar rhombic lip and are Pax6- (C”, 
red), Lmx1a+ (D”, red), Sox2+ (E”, red), and BLBP- (F”, red). (G-G”) Some delaminating 
cells are also Tbr2+. Arrows indicate delaminating YFP-positive cells. (H-I”) Fate-
mapping studies in P6 sagittal sections show co-localization of YFP and Ki67 (red), 
demonstrating that Gdf7-lineage cells contribute to proliferating cells in the EGL. Arrows 
indicate double-positive cells. Rectangle in (H) indicates enlarged area in (I). (J-J”) Tbr2-
immunostaining at P8 demonstrates that Gdf7-lineage cells can also contribute to the 
cerebellar population of unipolar brush cells. Abbreviations: EGL, external granular layer. 
uRL, upper rhombic lip. RP, roof plate. Scale bar, 20 µm. 
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Figure 2.6. 
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Figure 2.6. Gdf7-lineage cells contribute to an extensive array of mature cerebellar 
cell types 
(A-F”) Fate-mapping studies in Gdf7Cre/+;ROSA26eYFP adult mice (age 5 months) show 
that Gdf7-lineage cells distribute to all the mature cerebellar tissue layers and contribute 
to granule neurons (A-B”), Purkinje neurons (C-C”), GABAergic interneurons (D-D”), 
Bergmann glia (E-E”), white matter astrocytes (F-F”), as well as non-neural hindbrain 
choroid plexus epithelial cells (data not shown). (G) Representative image of distribution 
of Gdf7-lineage cells in the adult mouse cerebellum (age 5 months). The locations of 
Gdf7-lineage cell nuclei (dots) were mapped by tracing from digital images of sagittal 
sections. Thick lines indicate the cerebellar surface; thin lines indicate the boundary 
between cerebellar cortex and white matter. Gdf7-lineage cells were located mainly in 
the internal granular layer with fewer in the PCL and ML. Cells in the IGL were 
concentrated in lobules III-V and IX. Roman numerals indicate lobules of the vermis.  (H) 
Quantification of YFP+ granule neurons in the IGL per lobule. Data are mean of n = 10 
sagittal sections of Gdf7Cre/+;ROSA26eYFP age 5 months. Abbreviations: EGL, external 
granular layer. ML, molecular layer. IGL, internal granular layer. WM, white matter. Scale 
bar, 100 µm. 
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DISCUSSION 
In this study we have discovered that Gdf7 lineage cells contribute to diverse cell types 
in the cerebellum. This observation is surprising given that previous studies using the 
same Gdf7Cre/+ driver line reported that Gdf7 lineage cells do not contribute to the 
cerebellum (Lee, Dietrich, and Jessell 2000; Chizhikov et al. 2010). The contribution of 
Gdf7 lineage cells constitutes a minor percentage of each cerebellar cell type (<0.1% to 
~3.5%), which likely explains the discrepancy in findings. Indeed, the cerebellar 
oncogenic transformation that we observed in Gdf7Cre/+;SmoM2 mice served as a 
sensitive method for uncovering the important and broader lineage potential of hindbrain 
roof plate cells. Our studies indicate that the cerebellar cell types derived from Gdf7 
lineage include both neuronal and non-neuronal cells that originate from two distinct 
Gdf7-expressing domains within rhombomere 1 (rh1). The first domain is located in the 
midline of the cerebellar ventricular zone and consists of a small cluster of cells 
expressing radial glial markers. As radial glial cells are multipotent progenitors that 
contribute to different cell types in the cerebellum (Anthony et al. 2004; Zhang et al. 
2010), and the cerebellar ventricular zone is the sole source of Purkinje cells and other 
GABAergic cell types including interneurons (Sillitoe and Joyner 2007), these midline 
cells are likely the progenitors for Purkinje cells, GABAergic interneurons, Bergman glia, 
and astrocytes that we observed in our Gdf7-lineage analysis. Our data provides 
evidence that, similar to the cortex, midbrain, and spinal cord (Lee, Dietrich, and Jessell 
2000; Monuki, Porter, and Walsh 2001; Dymecki and Tomasiewicz 1998), the hindbrain 
roof plate has a conserved role in the generation of neurons and other cell types. This 
region can be molecularly defined by the expression of Gdf7 and Msx1 (Figure 2.4). We 
propose that this cerebellar vermal region is a previously undescribed source of neurons 
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that is continuous with and extends beyond the cerebellar ventricular zone.  
Gdf7, along with other Bmps, has been shown to be capable of inducing CGNP 
marker expression in cultured neural tissue (Alder et al. 1999). In addition, genetic 
ablation of Gdf7-expressing cells using diptheria toxin results in complete loss of Math1+ 
cells and reduced numbers of Ptf1a, Lhx1/5, and Lmx1a-expressing cells and their 
improper positioning in the developing cerebellar anlage (Chizhikov et al. 2006). The fact 
that both Gdf7 and Msx1, a readout of the Bmp signaling pathway, are expressed in this 
central vermal region (Figure 2.4) suggests that continuous local signaling is occurring. 
Thus there is a strong possibility that Gdf7 is involved in providing local and perhaps 
even autocrine signals for specification of cerebellar cellular subtypes originating from 
this vermal ventricular zone, in a manner consistent with its role in the differentiation of 
dorsal interneurons in the spinal cord (Lee, Mendelsohn, and Jessell 1998) and in 
regulating the number of cortical ventricular zone progenitors in the developing 
telencephalon (Monuki, Porter, and Walsh 2001). Indeed, Gdf7 is present in the 
hindbrain dorsal midline beginning at E10.5 (Chizhikov et al. 2006) until at least E16.5 
(Figure 2.4, Supplementary Figure 2.1); Msx1 expression is present at least until E14.5 
(Figure 2.4). Purkinje precursor cells continue to proliferate in the cerebellar ventricular 
zone from E10 to E13 (Sillitoe and Joyner 2007; Inouye and Murakami 1980), after 
which they begin radial migration to form a monolayer in the adult cerebellum. 
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The other domain of Gdf7 expression occurs distal to the upper rhombic lip, in 
the hindbrain roof plate epithelial (hRPe) cells and incipient choroid plexus (Chizhikov et 
al. 2010; Hunter and Dymecki 2007)  (Figure 2.4). Recent fate mapping studies showed 
that Lmx1a activity is required to prevent Gdf7-expressing hRPe cells from acquiring 
upper rhombic lip-derived neuronal lineages including CGNPs (Chizhikov et al. 2010). 
However, Lmx1a progenitors themselves also contribute to the neuronal lineage in the 
cerebellum (Chizhikov et al. 2010). Moreover, in contrast to posterior rhombomere-
derived hRPe cells that express choroid plexus markers upon their emergence from the 
Gdf7+ lineage at E9.5, the rh1-derived hRPe cells remain molecularly naïve and do not 
begin to differentiate into hChPe until E13 (Hunter and Dymecki 2007). This observation 
suggests that Gdf7+ progenitors distal to the upper rhombic lip are not necessarily 
restricted to the choroid plexus lineage. Indeed, we found delaminating Gdf7-lineage 
cells beyond the clustered roof plate cells in the rhombic lip as well as in the EGL. These 
lineage tracing studies provide evidence that hRPe cells normally give rise to CGNPs.  
Our studies show that delaminating Gdf7-lineage cells in the rhombic lip are 
Math1-/Lmx1a+/Sox2+ neural progenitor cells. These findings support previous studies 
 
Figure 2.7. (A-B) In situ hybridization at E16.5 shows Gdf7 expression persists in the 
cerebellar vermis. 
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suggesting molecular heterogeneity within rhombic lip progenitors (Hunter and Dymecki 
2007) rather than the classical definition of the rhombic lip as a homogenous Math1+ 
progenitor population  (Machold and Fishell 2005; Wang, Rose, and Zoghbi 2005). 
These cells however retain the capacity to express Math1 and eventually contribute to 
the Math1 lineage (Figure 2.5). A previous inducible genetic fate mapping study showed 
that RL progenitors born early (E13.5) give rise to granule cells that will populate the 
anterior lobes, whereas later born RL progenitors (E15.5 to E18.5) give rise to granule 
cells that will populate the posterior lobes (Machold and Fishell 2005). Interestingly, we 
found Gdf7-lineage contribution to granule cells in all lobes with the majority being in the 
anterior lobes III-V and posterior lobe IX, suggesting that Gdf7-lineage CGNPs are 
generated unevenly throughout the duration of rhombic lip CGNP production. Another 
low-represented precursor type similar to Gdf7-lineage CGNPs is Olig2 precursor cells 
(Schüller, Ruiter, et al. 2008). Olig2 lineage cells populate lateral caudal folia (lobes IX 
and X) and Olig2-Cre;SmoM2 tumors correspondingly have a posterior lateral location.  
The factors responsible for induction of CGNP fate from hRPe progenitors requires 
further study.  
CGNP cells originate from the upper rhombic lip and migrate tangentially to 
transiently occupy the EGL, and are the cell-of-origin for Shh-dependent 
medulloblastoma (Yang et al. 2012; Schüller, Heine, et al. 2008). The Shh-dependent 
mouse medulloblastomas harbor molecular signatures associated with CGNPs. While 
several hedgehog-driven medulloblastoma mouse models have been generated and use 
Nestin, GFAP, or Math1 as driver lines for constitutive Shh pathway activity (Yang et al. 
2008; Schüller, Heine, et al. 2008; Rao et al. 2003; Rao et al. 2004), our 
Gdf7Cre/+;SmoM2 medulloblastoma mouse model demonstrates how remarkably few 
cells are sufficient for oncogenic transformation and tumor formation. Gdf7-lineage cells 
contribute to approximately 3.5% of granule neurons in the mature cerebellum; the 
	   50 
number of delaminating Gdf7-lineage neural progenitor cells in the rhombic lip is far 
fewer, amounting to no more than 20-30 cells per embryo at E14.5. Furthermore, our 
study shows that Gdf7+ lineage cells originating from hRPe are also susceptible to 
oncogenic transformation in response to deregulated Shh pathway activation. Of note, 
we emphasize that the transformed cells are Gdf7+ lineage cells and not Gdf7+ 
expressing cells. Our mouse studies demonstrate that Gdf7 is not expressed in Shh MBs 
(Figure 2.4J); it is therefore unlikely that human SHH-MBs would express GDF7. Indeed, 
this observation was corroborated by an online database search that revealed no Gdf7 
upregulation in human MBs across all molecular subgroups (Kool et al. 2008; Northcott, 
Korshunov, et al. 2011; Taylor et al. 2007; Welte 2004; Northcott, Hielscher, et al. 2011; 
Thompson et al. 2006) though this does not exclude the possibility that Gdf7 is 
expressed in a rare subset of MBs. 
The multi-lineage nature of hRPe progenitors suggests that medulloblastoma 
originating from hRPe can be associated with aberrant choroid plexus function. 
Previously we have shown that Shh signaling is essential to promote hChPe expansion 
and that constitutive Shh pathway activation in the Gdf7 lineage can lead to an 
expanded choroid plexus (Huang et al. 2009). It is estimated that about 15% children 
diagnosed with medulloblastoma also suffer from hydrocephalus (Lang et al. 2011). 
While tumor obstruction of the fourth ventricle may account for some of the cases, a 
significant portion of patients continue to suffer from hydrocephalus after tumor resection 
(Toslashnnessen and Helseth 2007). Interestingly we found that overactivation of Shh 
pathway in the choroid plexus, while leading to an expanded proliferative domain, did not 
result in choroid plexus tumor formation (this study and (Huang et al. 2009)). However 
other signaling pathways, most notably the Notch pathway, have been implicated in the 
formation of choroid plexus neoplasias, as Gdf7-Cre driven expression of the activated 
ligand NotchICD (Hunter and Dymecki 2007) led to persistent proliferation of hChPe cells 
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and retrovirus-driven expression of the ligand Notch3 (Dang et al. 2006) resulted in 
choroid plexus papillomas. As choroid plexus dysfunction is often linked to 
hydrocephalus (Fujimura et al. 2004; Filippidis, Kalani, and Rekate 2010), it is tempting 
to speculate that a subset of medulloblastoma patients may have defective choroid 
plexus function (Banka, Walsh, and Brundler 2006) and thus, a common pathological 
pathway and cellular origin of these diseases. 
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MATERIALS AND METHODS 
Ethics Statement. All animal experiments were carried in accordance to protocols (M09-
222 and M09-160) approved by the Vanderbilt University Animal Care and Use 
committee.  
 
Mouse strains. The generation of Gdf7Cre/+ mice was described previously (Lee, Dietrich, 
and Jessell 2000). SmoM2 (Jeong et al. 2004), ROSA26LacZ (Soriano 1999), and 
ROSA26eYFP (Srinivas et al. 2001) mice were obtained from the Jackson Laboratory. 
Gdf7Cre/+;SmoM2 mice were identified by their smaller size, bulging cranium and 
confirmed by genotyping. Math1GFP/GFP mice were obtained from Jane Johnson, 
University of Texas-Southwestern. Fate-mapping studies were performed on Gdf7Cre/+; 
ROSA26LacZ and Gdf7Cre/+; ROSA26eYFP mice. At least three animals from control and 
mutants were used for each morphological/molecular analysis shown in each figure.  
 
Histological analyses, immunohistochemistry and immunocytochemistry. Standard 
hematoxylin and eosin stainings were performed to compare the histological features of 
control and mutant mice. All immunohistochemical analyses were performed on sections 
collected from OCT- or paraffin-embedded tissues. Twenty minutes of antigen retrieval 
at 95Co with citrate buffer (pH 6.0) were included for all stainings on paraffin sections. 
The primary antibodies used were rabbit anti-GFP, (Molecular Probe, 1:500), chicken 
anti-GFP, (Aves Labs, 1:200), rabbit anti-Sox2, (Millipore, 1:400), rabbit anti-BLBP, 
(Millipore, 1:1000), rabbit anti-Pax6, (Covance, 1:500), mouse anti-NeuN, (Millipore, 
1:200), mouse anti-Nestin, (Developmental Studies Hybridoma Bank, DSHB, 1:50), 
mouse anti-Calbindin, (Swant, 1:500), mouse anti-Parvalbumin, (Sigma, 1:200), rabbit 
anti-Math1 (gift of Jane Johnson, 1:400), rabbit anti-Ki67 (NeoMarkers, 1:400), rabbit 
anti-GFAP (Neuromics, 1:500), mouse anti-GFAP (Neuromics, 1:200), mouse anti-Cyclin 
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D2 (NeoMarkers, 1:500), rabbit-anti-phospho-Rb (Ser807/811) (Cell Signaling, 1:300), 
mouse-anti-p27Kip1 (Transduction Laboratories, 1:1000), chicken anti-Tbr2 (Millipore, 
1:100), and rabbit anti-Lmx1a (gift of Michael German, University of California-San 
Francisco, 1:200). Immunocytochemical stainings were performed on primary 
Gdf7Cre/+;SmoM2 tumor cells (see below under Medulloblastoma cell culture) grown for 
48 hours on gelatinized glass coverslips. The primary antibodies were rabbit anti-GFP, 
(Molecular Probes, 1:2000), mouse anti-Nestin, (DSHB, 1:500), mouse anti-Sox2, 
(Millipore, 1:500) mouse anti-Tuj1, (Sigma, 1:1000), mouse anti-NeuN, (Millipore, 
1:1000), mouse anti-GFAP, (Neuromics, 1:1000) and mouse anti-CNPase, (Sigma, 
1:1000). All fluorescent images were taken using Zeiss LSM 510 confocal microscope. 
Independent stainings were performed on at least three animals for each marker and 
representative images are shown.  
 
X-gal staining and transcript detection. X-gal staining for ß-galactosidase was performed 
according to standard protocol. Section in situ hybridizations were performed on 20 
micron frozen sections as previously described (Litingtung and Chiang 2000). The 
following cDNAs were used as templates for synthesizing digoxygenin-labeled 
riboprobes: Gdf7 (Tom Jessell, Columbia University), Gli1 (C-C Hui, University of 
Toronto), Patched1 (Matthew Scott, Stanford University), Nmyc (Mary E. Palko, NCI), 
Math1 (ATCC, I.M.A.G.E. No. 6530849). 
 
Medulloblastoma cell culture. Medulloblastoma tissue dissociation and tumor cell 
culturing were performed essentially as previously described (Huang, Ketova, et al. 
2010). Specifically, tumor-bearing cerebella in Gdf7Cre/+;SmoM2 mice over 14 days old 
were dissected in sterile, ice-cold PBS, minced with 50% Accutase in PBS for 5 minutes 
followed by repetitive pipeting with Pipetman (P1000) for 3 minutes, then cell pellets 
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were collected after brief centrifugation. Pelleted cells were then resuspended in neural 
stem cell culture medium and plated in a gelatinized 60mm tissue culture dish. The stem 
cell culture medium is composed of Neurobasal medium with glutamine, N2, B27, 25 
ng/ml human EGF and 25 ng/mL basic FGF. Unattached cells were removed by 
changing medium on the following day after initial seeding, then medium was changed 
every four days. All experiments using primary mouse MB cells were performed within 3 
passages. For differentiation conditions, EGF and bFGF were withdrawn and 10% FBS 
added for 5-7 days. 
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CHAPTER III 
 
GLIAL SONIC HEDGEHOG SIGNALING ACTIVITY IS REQUIRED FOR PROPER 
CORTICAL EXPANSION AND CEREBELLAR ARCHITECTURE 
 
INTRODUCTION 
Cerebellar development proceeds in a tightly regulated manner, requiring the proper 
balance of neural progenitor cell expansion and differentiation to form a characteristically 
organized structure. However, our understanding of the cellular relationships and 
signaling pathways that contribute to this balance is incomplete. A cell type integral to 
development of the cerebellum is the cerebellar granular neuron precursor (CGNP), 
which occupies a transient layer on the outer surface of the cerebellum from embryonic 
day 14 to two weeks postnatally in mice. CGNPs proliferate in response to Sonic 
hedgehog (Shh) ligand, which is secreted by neighboring Purkinje cells (PC). The Shh 
signal is transduced in CGNPs by the Smoothened (Smo) transmembrane protein to 
initiate production of activator forms of the Gli transcription factors (Goodrich et al. 1996; 
Ingham and McMahon 2001; Marigo et al. 1996; Varjosalo and Taipale 2008; Fuse et al. 
1999). After exiting mitosis, differentiated granular neurons migrate inward, past the PC 
layer, where they populate the internal granular layer (IGL). CGNPs are the presumed 
cell-of-origin for the Shh-driven subset of the malignant pediatric brain tumor 
medulloblastoma; thus understanding the cellular and molecular factors that govern their 
proliferation is critical.  
Neuronal progenitors including CGNPs are often in close contact with glial cells 
(Shiga, Ichikawa, and Hirata 1983; Buffo and Rossi 2013), however relatively little 
attention has been given to the function of neuron-glial interactions in the cerebellum. 
Specialized, unipolar astrocytes called Bergmann glia (BG) are present in the 
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cerebellum and originate from radial glia of the cerebellar ventricular zone. As early 
postnatal cerebellar development proceeds, BGs migrate behind PCs, ultimately aligning 
their cell bodies in the same single-celled layer. Their characterized functions in the 
cerebellum are three-fold. First, BG radial fibers extend to the pial surface shortly after 
birth where their endfeet contact the basement membrane (Rakic 1971; Yamada et al. 
2000). The endfeet adhere to one another to form a glia limitans over the cerebellum 
(Das 1976), providing structural support as the cerebellar plate expands (Hausmann and 
Sievers 1985; Sievers and Pehlemann 1986; Sievers et al. 1981). Second, as granular 
neurons differentiate and begin to migrate inwards to form the internal granular layer, BG 
radial fibers function as guides to the closely aligned CGNP cell bodies (Palma et al. 
2005; Ruiz i Altaba 1998). And last, BG radial fibers synapse on PC dendrites; it has 
been proposed that BGs contribute to PC dendritic elaboration (Zecca, Basler, and 
Struhl 1995; Mullor et al. 1997) and stabilization of neuronal synaptic connections (Iino 
2001; Yue 2005).  
BGs belong to a select group of specialized astroglia that retain radial glial-like 
morphology postnatally and into adulthood; members of this group include BGs, Muller 
cells in the retina, and tanycytes of the hypothalamus (Rakic 2003). Importantly, while 
both Muller cells and tanycytes have been demonstrated to have neurogenic potential 
and contribute to neurogenesis in their respective regions (Haan et al. 2013; Surzenko et 
al. 2013; Robins et al. 2013), BGs have not been found to display such features. Rather, 
mice with BG defects during development exhibit altered cerebellar layering, neuronal 
migration, synaptic connectivity, and a disrupted pial membrane (Belvindrah et al. 2006; 
Graus-Porta et al. 2001; Wang et al. 2011; Eiraku et al. 2005; Komine et al. 2007; Weller 
et al. 2006). The contribution of BGs to neuronal specification and proliferation in the 
cerebellum has not been extensively studied.  
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Many signaling pathways are important for the formation and maintenance of 
BGs. Genetic studies using mice that lack Notch pathway components have 
demonstrated the pathway to be integral for BG specification, maturation, and monolayer 
formation (Eiraku et al. 2005; Komine et al. 2007; Weller et al. 2006). Other studies have 
shown that PTEN and integrin-linked kinase play roles in BG differentiation (Yue 2005; 
Belvindrah et al. 2006), whereas APC maintains BG morphology (Wang et al. 2011) and 
the guanine nucleotide exchange factor Ric-8a regulates BG basement membrane 
adhesion (Ma, Kwon, and Huang 2012). A recent single-cell transcriptional profiling 
study of BGs also identified the Wnt and TGFß signaling pathways as developmentally 
upregulated in BG though their function in BG has yet to be identified (Koirala and 
Corfas 2010). Interestingly, BGs have been shown to be capable of responding to 
Purkinje-derived Shh signals in postnatal stages through adulthood (Corrales et al. 2004; 
Corrales et al. 2006). It has been observed that Shh signaling induces the glial 
differentiation of immature postnatal mouse astroglia in vitro (Dahmane and Ruiz i Altaba 
1999). In addition, inhibition of Shh activity using 5E1 hybridoma cells injected into chick 
embryos at early stages resulted in massive perturbations of cerebellar development, 
including a concomitant reduction in BLBP+ BG (Dahmane and Ruiz i Altaba 1999) 
(Dahmane and Ruiz i Altaba 1999). However the role of Shh signaling activity in BG in 
vivo and its consequences for cerebellar development are not well understood. 
Understanding how Bergmann glia contribute to CGNP proliferation and thus overall 
architecture of the cerebellum can shed light on basic developmental processes and 
have implications for cerebellar diseases that derive from aberrant Shh signaling and 
neuronal-glial relationships. 
In this study, we spatially and temporally alter Shh signaling activity specifically in 
postnatal BG. Mice in which Shh activator Smoothened (Smo) is postnatally ablated in 
BG demonstrate an obvious reduction in cerebellar size within two days of ablation of 
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Shh signaling. Surprisingly, mutant CGNPs exhibit severely reduced proliferation and 
increased differentiation accompanied by a loss of Shh activity, suggesting a novel role 
for the BG-CGNP interaction in promoting CGNP precursor proliferation. Interestingly, 
Wnt signaling is ectopically elevated in TNC mutant CGNPs concomitant with a 
reduction in EGL area, suggesting that this pathway is involved in cross-talk with the Shh 
pathway in regulating CGNP proliferation. In addition, loss of Shh signaling in BGs leads 
to disrupted PC laminar organization and dendritic arborization as well as BG fiber 
morphology, indicating that BG-Shh signaling activity contributes to the maintenance of 
proper cerebellar laminar formation. Collectively, these data show a previously 
unappreciated role for BG Shh signaling activity in the proliferation of CGNPs and 
preservation of cerebellar architecture, thus leading to a new level of understanding of 
the neuronal-glial relationship in the cerebellum.  
 
RESULTS 
SmoBG mutants display a hypoplastic cerebellum 
In our experiments, we used a tamoxifen-inducible Cre line Tenascin CYFP-CreER (TNCYFP-
CreER) in order to ablate Shh signaling in BG. TNCYFP-CreER mice express CreER and YFP 
as a bicistronic message from the endogenous Tenascin C (TNC) locus (Fleming et al.), 
submitted); thus YFP can be used to mark TNC expressing cells. We first wanted to 
verify that TNC-YFP+ was indeed localized to BG cells, as previously described (Bartsch 
et al. 1992; Yuasa 1996). Using antibodies against YFP and radial glial markers Sox2 
and Blbp (Feng, Hatten, and Heintz 1994; Yamada et al. 2000) at postnatal day 1, we 
confirmed that TNC-YFP was expressed by Sox2+, Blbp+ BG (Figure 3.1A-D), whose 
cell bodies are seen in the developing cerebellar cortex with radial processes extending 
towards the pia matter. Notably, these TNC-expressing cells were proliferative as many 
of them expressed proliferative marker Ki67 (Figure 3.1E, inset and arrowheads). 
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In order to determine the role for Shh signaling in BG, we crossed TNCYFP-CreER 
mice with SmoF/- mice to generate TNCYFP-CreER; SmoF/- (SmoBG mutant) mice in which  
Shh effector protein Smoothened (Smo) is removed from TNC-expressing BG cells 
(Yuasa 1996). We chose to affect the time period when BG are closely apposed to their 
final destination between PC bodies, thus we injected one dose each of tamoxifen at P1 
and P2 (Yuasa et al. 1991). We began our analysis of tamoxifen-injected animals at P3 
and also analyzed later stages at P4, P5, P7 and P30 (Figure 3.2A).  
Interestingly, SmoBG mutant mice at P5 revealed a noticeably hypoplastic 
cerebellum, a phenotype which was observed in an obviously more severe manner at 
P30 (Figure 3.2B). H&E staining of sagittal sections demonstrated a reduction in 
cerebellar area and folia size (Figure 3.2C). By P7, a 35.8% (n = 3, p = 0.0282) 
reduction in cerebellar area was observed (Figure 3.2C, E). At P30, the smaller 
cerebellar size was accompanied by a profound decrease in internal granular layer (IGL) 
density (Figure 3.2C).  
We note that the phenotype is not as severe as other mutants with aberrant 
cerebellar Shh signaling, L7Cre;ShhF/- (Lewis et al. 2004) mice, in which Shh ligand is 
deleted from PCs, and Math1CreER; SmoF/- mice in which Smo is temporally ablated in 
CGNPs using tamoxifen at P1 and P2 (Machold and Fishell 2005).  As shown in Figure 
3.2D-E at P7, both the L7Cre;ShhF/- and the Math1CreER;SmoF/-  mutants displayed a more 
severe cerebellar hypoplasia as compared to SmoBG mutants, with a 49.7% (n = 3, p = 
0.0033) and 49.8% decrease (n = 3, p = 0.0008) in cerebellar size compared to wild-type 
littermates, respectively. In addition, L7Cre; ShhF/- and Math1CreER; SmoF/- mutants lacked 
an EGL as would be expected since Shh signaling is required for expansion of CGNPs 
(Figure 3.2D) (Dahmane and Ruiz i Altaba 1999; Wechsler-Reya and Scott 1999; 
Kenney and Rowitch 2000). Taken together, these studies demonstrate that ablation of 
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Shh signaling in the TNC-expressing BG cell population results in severe reduction of 
cerebellar size.  	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Figure 3.1. 
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Figure 3.1. TNC-YFP-expressing cells are Bergmann glia. 
 (A) YFP immunohistochemistry on sagittal sections demonstrates pattern of TNC 
expressing cells.  Boxed region denotes enlarged area in (B). Scale bar: 100 µm. (B) 
TNC-YFP expression is observed in cells that extend long processes to the pial surface. 
(C-D) TNC-YFP expressing cells are Blbp+ and Sox2+, indicating that they express 
astroglial markers. Inset shows example of co-labeled cell. (E) TNC-YFP expressing 
cells are ki67+, indicating that they are proliferative. Inset shows example of co-labeled 
cell. Abbreviation: EGL, external granular layer. Scale bar: 100 µm and 20 µm. 
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Figure 3.2 
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Figure 3.2. TNCYFP-CreER;SmoF/- (SmoBG) mutants display a hypoplastic cerebellum. 
(A) Tamoxifen injection scheme in SmoBG mutant mice. Tamoxifen was injected at P1 
and P2 in wild-type and SmoBG mutants. Mice were analyzed as early as P3 and as late 
as P30. (B) External view of Smo mutants and wild-type littermates at P5 and P30 
demonstrates the reduction in overall cerebellar size. (C) H&E staining of sagittal 
sections of Smo mutants and wild-type littermates at P5, P7, and P30 demonstrates that 
mutants have significant cerebellar hypoplasia. Boxed region shows enlarged region in 
adjacent panel. (D) H&E staining of sagittal sections of Math1CreER;SmoF/- and 
L7Cre;ShhF/- mutants at P7 demonstrates cerebellar hypoplasia. (E) Quantification of 
cerebellar area of wild-type littermates and Smo mutants, Math1CreER;SmoF/- mutants, 
and L7Cre;ShhF/- mutants. Data are mean of n=3 wild-type and littermate pairs for each 
genotype. Abbreviations: EGL, external granular layer. ML, molecular layer. PCL. 
Purkinje cell layer. IGL, internal granular layer. Scale bar: 20 µm. 
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Figure 3.3. Mutant EGL is largely agranular due to severely reduced CGNP 
proliferation. 
(A) Immunohistochemistry for pH3 at P3 and P5 in wild-type and SmoBG mutants. (B) 
Quantification of EGL area at P3 and P5 revealed a significant reduction in mutants 
compared to wild-type littermates at both stages. At P3, the SmoBG mutant EGL was 
significantly reduced in area by 24.8% (n=3, p=0.0014) and at P5, the reduction in EGL 
area was 50.3% (n=3, p<0.0001). (C) Quantification of pH3 staining as a percentage of 
total EGL cells. At P3, a 19.5% decrease (n=3, p=0.0314) in pH3 was observed. At P5, a 
51.1% decrease in pH3 (n=3, p=0.0166) was observed. (D) Immunohistochemistry for 
p27Kip1 at P3 and P5 in wild-type and SmoBG mutants. (E) Quantification of p27Kip1 
staining as a percentage of total EGL cells. At P3, an 18.9% increase (n=3, p=0.0052) in 
p27Kip1-positive cells was observed. At P5, a 39.2% increase (n=3, p=0.0026) in p27Kip1-
positive cells was observed. Abbreviations: EGL, external granular layer. Scale bar: 20 
µm. 
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Mutant EGL is largely agranular due to severely reduced CGNP proliferation 
One striking feature noted in the SmoBG mutant was that, despite all cortical layers being 
present at early postnatal stages, the external granular layer (EGL) was noticeably 
reduced in thickness at P7 (Figure 3.2C). In order to determine the earliest time point at 
which EGL area reduction could be observed, we collected SmoBG mutants at P3 and P5 
and quantified the area of the EGL. At P3, the SmoBG mutant EGL was significantly 
reduced in area by 24.8% (n = 3, p = 0.0014) (Figure 3.3A, B). By P5, the reduction in 
EGL area was 50.3% (n = 3, p<0.0001) (Figure 3.3A, B). 
In order to determine whether the reduction in EGL thickness was due to 
changes in proliferation, differentiation, or apoptosis of cerebellar granular neuron 
precursors (CGNPs), we performed immunohistochemistry of mitotic marker phospho-
histone H3 (pH3), differentiated neural marker p27Kip1, and cleaved caspase 3, 
respectively. At P3, we observed a 19.5% decrease (n = 3, p = 0.0314) in pH3 (Figure 
3.3A, C) and an 18.9% increase (n = 3, p = 0.0052) in p27Kip1-positive cells (Figure 
3.3D, E). At P5, we observed a 51.1% decrease in pH3 (n = 3, p = 0.0166) (Figure 3.3A, 
C) and a 39.2% increase (n = 3, p = 0.0026) in p27Kip1-positive cells (Figure 3.3D, E). 
No changes in apoptotic marker cleaved-caspase 3 were observed (data not shown). 
These results suggest that ablation of Shh signaling in BG surprisingly results in a 
profound reduction in CGNP proliferation with a concomitant increase in differentiation. 
As the current understanding of BG function during early postnatal development has 
been limited to their roles in CGNP migration and PC synaptogenesis (Rakic 1971; 
Yamada et al. 2000; Lordkipanidze and Dunaevsky 2005), these findings represent a 
novel role for BG in the regulation of CGNP proliferation. In addition, they demonstrate 
that Shh signaling in BG has a previously unappreciated role in maintaining the 
proliferative capacity of CGNPs.  
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Loss of Shh signaling is profound in CGNPs despite normal PC Shh production 
It is now well-established that CGNP expansion in the EGL relies on Shh signaling 
activity from PCs as a proliferative signal (Dahmane et al. 1997; Wallace 1999; 
Wechsler-Reya and Scott 1999; Kenney and Rowitch 2000; Pons et al. 2001). In the 
absence of Shh signal, CGNPs stop proliferation, withdraw from the cell cycle, and 
differentiate (Dahmane and Ruiz i Altaba 1999; Wallace 1999; Wechsler-Reya and Scott 
1999). As SmoBG mutants display a profound reduction in CGNP proliferation in the EGL 
and an increase in differentiation (Figure 3.3), we next sought to determine whether Shh 
signaling activity was affected. Therefore, we crossed SmoBG mutant and wild-type mice 
with the Gli1nlacZ knock-in mouse (Bai et al. 2002). In wild-type animals, X-gal staining 
was localized to the EGL and PC layer as previously reported (Corrales et al. 2004; 
Lewis et al. 2004) (Figure 3.4A), indicating the presence of Shh responsive cell types in 
those layers. As expected, in SmoBG mutants, X-gal staining was reduced in the PC 
layer, indicating a decrease in Shh signaling in BG (Figure 3.4A). In addition, X-gal 
staining was noticeably reduced in the EGL (Figure 3.4A) at P4. Likewise, ß-gal antibody 
staining was visibly reduced in CGNPs in the EGL in addition to the BG (Figure 3.4B). 
We corroborated these results by isolating fresh CGNPs from the cerebellum and 
blotting for Gli1 protein levels. We found that CGNPs isolated from SmoBG mutant 
cerebella demonstrated a decrease in Gli1 and Gli2 levels as compared with those from 
WT cerebella (Figure 3.4C). SmoBG mutant cerebellar lysates also demonstrated a 
decrease in Gli1 levels compared to WT cerebellar lysates (Figure 3.4D), indicating an  
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Figure 3.4. Loss of Shh signaling is profound in CGNPs despite normal PC Shh 
production  
(A) X-gal staining for ß-galactosidase in Gli1lacZ and TNCYFP-CreER;SmoF/-;Gli1lacZ mutants 
shows that X-gal is reduced in the PCL and EGL of mutants at P3 and P4. Rectangular 
region in P4 panel shows enlarged area in adjacent panel. (B) Western blotting of P5 
wild-type and mutant CGNPs shows a decrease in Gli1 and Gli2 protein levels in the 
mutant. (C) Western blotting of P5 cerebellar lysates shows a reduction in Gli2 protein 
levels in the mutant. (D) ß-galactosidase immunohistochemistry in wild-type and mutants 
reveals a decrease in antibody staining in the mutant EGL at P4. GFP and Calbindin 
staining demonstrates location of BGs and PCs, respectively. Arrowheads indicate 
presence of ß-gal+ cells in wild-type EGL, note that ß-gal expression is absent in the 
mutant EGL. Arrows indicate GFP+ BGs that no longer express ß-gal+, indicating a 
reduction in Gli1 expression in the mutant. (E) In situ hybridization at P4 showing Shh is 
similarly expressed in wild-type and mutant. Boxed region shows enlarged region in 
adjacent panel. (F) Western blotting for Shh in E14.5 wild-type and Shh-null embryos 
demonstrates the antibody specificity for Shh. Probing for Shh in P5 cerebellar lysates 
shows expression in both the wild-type and the mutant. (G) Shh immunohistochemistry 
(green) demonstrates Shh expression in both the wild-type and mutant EGL. Arrows 
indicate Shh localization to outer EGL in mutant cerebella. Secondary-only 
immunohistochemistry is shown as a negative control. Abbreviations: EGL, external 
granular layer. PCL. Purkinje cell layer. CGNPs, cerebellar granular neuron precursors. 
CB, cerebellum. Scale bar: 100 µm and 20 µm. 
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overall reduction in Shh signaling in mutant cerebella. These results demonstrate that 
reduction in proliferation of the EGL and subsequent differentiation of CGNPs in SmoBG 
mutants occurs as a result of attenuated Shh signaling activity. 
Given the reduction of Shh responsiveness in the EGL, we next sought to 
determine whether Shh production was occurring normally, and whether Shh ligand was 
properly reaching the EGL. Using in situ hybridization, we found that localization and 
intensity of Shh mRNA was unchanged in the PCL where the ligand is produced (Figure 
3.4E). Shh ligand is made as a precursor peptide that subsequently undergoes 
autocatalytic cleavage and two covalent modifications to generate a 19 kDa N-terminal 
signaling fragment called ShhN (Porter, Young, and Beachy 1996). This fragment is the 
mature fragment that is released from the producing cell and can travel long distances to 
reach its target (Varjosalo and Taipale 2008). In order to determine whether the mature, 
processed fragment was produced in SmoBG mutants, we harvested P5 cerebellar 
lysates for Western blotting and assayed for ShhN protein. The specificity of the 
antibody for Shh-N was verified using E14.5 WT and Shh-mutant embryos. As 
demonstrated in Figure 3.4F, Shh-N was present in both WT and mutant cerebellar 
lysates. An increase in Shh-N protein level was observed in the mutant, likely due to the 
fact that a higher density of Shh secreting PCs are present in a smaller cerebellum (See 
Figure 3.6A), thus increasing the concentration of the protein. Collectively, these results 
demonstrate that proper production of Shh ligand occurs in PCs of SmoBG mutant 
cerebella.  
In order to determine whether Shh ligand was reaching the EGL, we performed 
immunohistochemistry against Shh on both wild-type and mutant sections at P3. We 
found that Shh was localized to the PC layer in the wild-type and mutant, as expected 
(Figure 3.4G). Shh ligand was also localized to the EGL in the wild-type animals as 
previously reported (Lewis et al. 2004). Interestingly, we found no difference in Shh 
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ligand localization to the EGL in mutant animals. Our results suggest that Shh ligand is 
made and localized properly in the mutant cerebellum.  
 
Resident astroglial cells in the EGL do not contribute significantly to the granular 
neuron population 
In our characterization of the TNCYFP-CreER mouse, we observed a small subset of 
sparsely dispersed TNC-YFP expressing cells in the EGL (Figure 3.5A). In order to 
investigate their identity, we used Sox2 and Blbp to determine if they were astroglial 
cells because a small subset of astroglia have been described in the external granular 
layer (EGL) that express Sox2 and Blbp and are capable of giving rise CGNPs (Silbereis 
et al. 2010; Sievers et al. 1981). We found the TNC-YFP-expressing EGL cells to be 
both Sox2+ and Blbp+ (Figure 3.5A), suggesting that TNC-YFP marks these previously 
described astroglial cells (Silbereis et al. 2010).  
We next determined whether these cells, in addition to BG, were Shh signaling-
responsive, because if so, these cells would also undergo deletion of Smo, and could 
explain the reduction of CGNPs in our mutants. Using β-gal and YFP double 
immunohistochemistry in TNCYFP-CreER;Gli1lacZ mice at P5, we found that YFP-expressing  
BG located in the PC monolayer co-labeled with β-gal (Figure 3.5B), as has been 
previously described (Corrales et al. 2004). In addition, YFP-expressing astroglial cells in 
the EGL co-labeled with β-gal (Figure 3.5B), indicating that both subsets are capable of 
responding to Shh signaling.  
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Figure 3.5. 
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Figure 3.5. Resident astroglial cells in the EGL do not contribute significantly to 
the granular neuron population. 
(A) YFP immunohistochemistry of TNCYFP-CreER at P1 on sagittal sections demonstrates 
ß-gal+-expressing cells in the EGL. These are Blbp+ and Sox2+, indicating that they 
express astroglial markers. Inset shows example of co-labeled cell. (B) ß-galactosidase 
immunohistochemistry of TNCYFP-CreER; Gli1lacZ sagittal sections at P5 demonstrates that 
YFP+ cells in the EGL and PCL are ß-gal+. Arrows and arrowheads indicate cells that 
are co-labeled with YFP and ß-gal in the PCL and EGL, respectively. ß-gal+ cells in the 
PCL and EGL are Sox2+ and Blbp+. Boxed regions indicate examples of co-labeled 
cells. (C-F) Lineage tracing using TNCYFP-CreER; tdTomato sagittal sections at P11. (C) 
The majority of tdTomato+ cells are in the PCL and are Sox2+. Boxed region labeled “1” 
demonstrates example of Sox2+ TNC-lineage cell in IGL. Boxed region labeled “2” 
shows enlarged region in adjacent panel. Arrowheads indicate co-labeled cells in PCL, 
indicating that TNC-lineage cells are BGs. (D) The tdTomato+ cells in the EGL show 
GFAP+ fibers, boxed region shows enlarged region in adjacent panel. Arrowheads 
indicate tdTomato+ BGs associated with GFAP+ fibers. (E) Pax2 immunohistochemistry 
demonstrates that TNC-lineage cells found adjacent to the EGL are immature 
GABAergic interneurons. Arrowheads indicate co-labeled cells. (F) NeuN 
immunohistochemistry demonstrates that the majority of TNC-lineage cells are not 
tdTomato+, indicating that TNC-lineage cells do not contribute significantly to the 
granular neuron population. Boxed region labeled “1” shows the only example of co-
labeled cell. Boxed region labeled “2” shows enlarged region in adjacent panel, and 
arrowheads indicate tdTomato+ cells that are not NeuN+. (G) Lineage tracing using 
TNCYFP-CreER; tdTomato sagittal sections at P30 supports the data at P11 and shows that 
TNC-lineage cells do not contribute significantly to the granular neuron population. 
Arrowheads indicate tdTomato+ cells that are not NeuN+ and arrows indicate the only 
two examples of co-labeled cells that were observed in three lobes. Abbreviations: EGL, 
external granular layer. IGL, internal granular layer. PCL. Purkinje cell layer. Scale bar: 
Scale bar: 100 µm and 20 µm. 
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Because the major defect observed in SmoBG mutants was reduced CGNP 
proliferation, we wanted to determine whether the TNC-YFP+ population residing in the 
EGL could contribute significantly to CGNPs, similar to what has been reported 
(Silbereis et al. 2010). Fate-mapping of the TNC lineage using TNCYFP-CreER; tdTomato 
mice indicated that the majority of tdTomato+ cells in the P11 cerebellum were largely 
confined to Sox2+ BG (Figure 3.5C) with GFAP+ fibers (Figure 3.5D). There was a 
subset of Pax2+, tdTomato+ cells apposed to the EGL (Figure 3.5E), which were 
immature GABAergic interneurons that have not yet begun to express Parvalbumin. In 
order to determine whether tdTomato+ cells contributed to the mature granular neuron 
population, we co-labeled with granular neuron marker NeuN (Figure 3.5F). 
Approximately one or two cells per lobe co-labeled with NeuN, demonstrating that TNC-
expressing cells can contribute to the granular neuron population, this number remained 
very small (no more than 1-2 per lobe, or <0.1% of total NeuN+ cells). In fact, the 
majority of tdTomato+ cells in the IGL were Sox2+ glial cells (Figure 3.5C). These results 
were corroborated by NeuN, tdTomato double immunohistochemistry in TNCYFP-CreER; 
tdTomato mice at P30, a stage when the EGL has completely disappeared. In all lobes 
examined, no more than 2 NeuN, tdTomato double positive cells could be found (Figure 
3.5G, arrows), and the majority of tdTomato cells in the IGL were NeuN-negative (Figure 
3.5G, arrowheads). These results demonstrate that TNC-lineage cells do not contribute 
significantly to the adult granular neuron population. Therefore it is unlikely that the 
SmoBG mutant EGL phenotype occurs as a consequence of attenuated Shh signaling in 
the EGL astroglial population rather than in BG.  
 
SmoBG mutants display altered BG arrangement and cytoarchitecture 
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In order to further study whether loss of Shh signaling in BG affected the 
cytoarchitecture of BG and other cerebellar cell types, we analyzed PC and BG 
arrangement, density, and morphology. At P7, Calbindin+ PCs in WT cerebella formed 
the single-celled layer in between the molecular layer and internal granular layer that is 
characteristic of normal cerebellar architecture, but, in P7 SmoBG mutant cerebella, PC 
soma localization was disrupted with many bodies out of alignment from the single-cell 
layer (Figure 3.6A, starred). BG fibers form a well-organized scaffold and extend 
processes towards the pial membrane where their endfeet contact the pial surface, and 
cell bodies of BG are uniformly arranged between PC bodies in the PC monolayer. We 
observed that BG cell soma size, as labeled by BG cell marker Sox2, were similar 
between WT and mutant; however positioning of cell bodies in SmoBG mutants was 
irregular and aberrantly disorganized such that there was a significantly increased 
number of Sox2+ BG per mm of PCL (68.4%, n = 3, p = 0.0339) (Figure 3.6A, arrows 
and graph). Rather than being localized in between PC soma, mutant BG cell bodies 
were displaced behind PC soma.  
 In order to more extensively study SmoBG mutant BG fibers, we used 
immunohistochemistry against BLBP, GFAP, and 3-phosphoglycerate dehydrogenase 
(3-PGDH) (Furuya) to label BG at P3, P5, and P7. BLBP is strongly expressed in BG cell 
bodies and fibers at early postnatal stages and is increasingly downregulated into 
adulthood (Feng, Hatten, and Heintz 1994). On the other hand, GFAP expression cannot 
be detected in BG fibers until P5 (Piper et al. 2011) and is upregulated throughout the 
next two weeks as BG mature (Giménez Y Ribotta et al. 2000). The enzyme 3-
phosphoglycerate dehydrogenase (3-PGDH) strongly labels BG soma and fibers 
throughout postnatal development and adulthood (Furuya et al. 2000). 
Mutant BG were positive for Blbp (Figure 3.6B), indicating that differentiation 
along a glial lineage was preserved in the mutant. However, beginning at P5 we 
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observed an expansion of the endfeet upon contact with the pial surface, which was 
particularly pronounced at the fissures in BG lacking Shh signaling (Figure 3.6B, 
arrows). In addition, in wild-type cerebella, BG fibers were uniformly rod-like and parallel 
to one another as they stretched from cell body to pial surface. However in the mutant 
the rod-like domain was severely disrupted and tortuous with an increase in lateral 
branching and complexity (Figure 3.6B). 3-PGDH and GFAP expression likewise 
demonstrated an increased complexity of BG fibers and expansion of endfeet at the pial 
surface (Figure 3.6C, D, arrows), which increased in severity over time.  
Because CGNPs inwardly migrate along BG fibers to form the IGL (Rakic 1971), 
and we observed fiber morphology differences in BG fibers in SmoBG mutants, we 
wanted to determine whether SmoBG mutants had granular migration defects. We 
examined mutants and wild-type cerebella at P30, a stage when the EGL has completely 
disappeared, using immunohistochemistry for mature granular neuron marker NeuN. We 
discovered that while the majority of NeuN-positive mature granular neurons in the 
SmoBG mutant were localized to their proper location in the IGL, the molecular layer (ML) 
retained small ectopic clusters of cells (Figure 3.6E, arrows), indicating that some 
mature granular neurons had failed to migrate properly past the PC layer to the IGL. This 
suggests a granular neuron migration defect in the SmoBG mutant. As BG fibers provide 
a scaffold for inwardly migrating granular neurons (Rakic 1971), this migration defect is 
likely due to aberrant morphological BG fibers.  
Of note, the ectopic clusters were scattered throughout the ML of anterior (lobes 
I-IV), while the ML of central lobes (lobes V-VIII) retained fewer granular neuron clusters 
(Figure 3.6E). This variable phenotype by lobe is consistent with the variable expression 
of Shh signaling, as Shh mRNA and Gli1-lacZ expression are stronger in the anterior 
and posterior-most lobes compared to central lobes ((Corrales et al. 2004), see Fig. 4A).  
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Defects in BG fibers are also associated with aberrant formation or maintenance 
of the meningeal basement membrane, as has been demonstrated in several genetic 
mouse mutants with BG fiber defects (Belvindrah et al. 2006; Graus-Porta et al. 2001). 
Therefore we assayed for laminin expression, which revealed in wild-type cerebella that 
the cerebellar cortex was covered with a continuous laminin+ layer that separated 
cerebellar folia (Figure 3.6F). We did not see any differences in laminin staining in 
SmoBG mutants, indicating the basement membrane of mutant cerebella is intact (Figure 
3.6F).  
SmoBG mutants have disrupted alignment and dendritic arborization of PCs 
As the radial processes of BG provide a scaffold for the directed vertical growth of PC 
dendrites (Lordkipanidze and Dunaevsky 2005), we examined PC morphology and 
dendritogenesis using immunohistochemistry for the PC-cell specific marker Calbindin 
(Lordkipanidze and Dunaevsky 2005). At P3, the earliest timepoint collected, we did not 
see a difference in PC morphology, layering, or dendritogenesis (Figure 3.7A). However 
as mentioned above, at P7, Calbindin+ PC soma localization was disrupted (Figure 3.6A 
and 7B, starred). During early postnatal cerebellar development, clustered PCs disperse 
into the characteristic monolayer seen in the adult cerebellum in response to Reelin 
secreted by the EGL (Miyata et al. 1997; Miyata et al. 1996; Schiffmann, Bernier, and 
Goffinet 1997). As the EGL is severely disrupted in SmoBG mutants, PC soma 
mislocalization is likely due to a consequence of loss of CGNPs and subsequently 
reduced CGNP-derived Reelin signaling. Consistent with this, we found that the absolute 
number of Calbindin+ PCs were comparable between the WT and mutant  (Figure 3.7C),  
however there was a significant increase in the number of PCs per mm of PCL in SmoBG 
mutants (28.3%, n = 3, p = 0.0027) (Figure 3.7C).   
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Figure 3.6. SmoBG mutants display altered BG arrangement and cytoarchitecture 
 (A) Sox2 labeling in P7 SmoBG mutants demonstrate positioning of BG cell bodies in 
SmoBG mutants is irregular and aberrantly disorganized (arrowheads). Calbindin labeling 
indicates disrupted PC soma localization (starred). Graph shows a significantly 
increased number of Sox2+ BG per mm of PCL and absolute numbers of BG are not 
different. Data are mean of n = 3 wild-type and littermate pairs for each genotype. (B-D) 
Blbp, 3-PGDH, and GFAP staining at P3, P5, and P7 demonstrate an increased 
complexity of BG fibers and expansion of endfeet at the pial surface starting at P5 that 
increased in severity at P7. (E) NeuN staining at P30 in SmoBG mutants demonstrates 
ectopic clusters of mature granular neurons in the ML (arrowheads), suggesting a 
granular neuron migration defect. The ectopic clusters were scattered throughout the ML 
of anterior (lobes I-IV), while the ML of central lobes (lobes V-VIII) retained fewer 
granular neuron clusters. (F) Laminin staining for the basement membrane did not reveal 
any differences SmoBG mutants, indicating the basement membrane of mutant cerebella 
is intact. Abbreviations: EGL, external granular layer. ML, molecular layer. IGL, internal 
granular layer. Scale bar, 100 µm and 20 µm. 
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While PC dendritic arborization is immature at P7 (Sotelo and Dusart 2009), 
dendritic tips have begun to ascend vertically and enter the base of the EGL (Yamada et 
al. 2000), which was observed in our wild-type cerebella (Figure 3.7B). In contrast, 
mutant PCs had a severely disrupted fiber network, with stunted, thinned dendrites and 
poorly branched arbors (Figure 3.7B, arrowheads). PC dendritic outgrowth depends on 
electrical activity (Schilling et al. 1991; Baptista et al. 1994) and neurotrophins secreted 
from CGNPs, including thyroid hormone (Heuer and Mason 2003), neurotrophin-3 
(Lindholm et al. 1993), and BDNF (Shimada, Mason, and Morrison 1998). Thus, the 
disruption in PC arborization seen in SmoBG mutants could be attributed to the loss of 
EGL.  
However, neuron dendritogenesis can also depend on factors derived from glial 
cells (Martin, Brown, and Balkowiec 2012; Procko and Shaham 2010), and it has been 
proposed that BGs contribute to PC dendritic elaboration (Lippman et al. 2008; Yamada 
et al. 2000). Therefore a possibility remained that BG-Shh signaling may play a role in 
PC dendrite formation that was unable to be appreciated due to the severity of the 
reduction in EGL area in SmoBG mutants. In order to investigate BG Shh signaling 
contribution to PC dendritogenesis independent of CGNP proliferative effects, we 
ablated Shh signaling in BG at later developmental stages by injecting one dose each of 
tamoxifen at P5 and P6 and analyzed at P8 (Figure 3.7D). This later time point enabled 
us to examine the cerebellar phenotype after the first wave of CGNP proliferation has 
taken place. Changes in cerebellar size and EGL area were less severe when BG Shh 
signaling was ablated at P5 and P6 compared to ablation at P1 and P2 (Figure 3.7E). 
Notably, the PC dendrites still lacked secondary branching structures as revealed by 
Calbindin immunohistochemistry (Figure 3.7F, arrows), though a BG fiber defect was not 
observed as determined by GFAP immunohistochemistry (Figure 3.7F). Because we 
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continue to observe a PC dendrite defect in the absence of a severe EGL phenotype or 
BG fiber morphology defects, and in the absence of severe cerebellar hypoplasia, our 
results suggest that proper outgrowth of PC dendrites depends on Shh signaling activity 
to BG. 
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Figure 3.7. SmoBG mutants have disrupted alignment and dendritic arborization of 
PCs 
(A) At P3, Calbindin immunohistochemistry shows no difference in SmoBG mutant PC 
morphology, layering, or dendritogenesis. (B) At P7, Calbindin immunohistochemistry  
shows that PC soma localization is disrupted and have a severely disrupted fiber 
network, with stunted, thinned dendrites and poorly branched arbors. (C) The absolute 
number of Calbindin+ PCs were comparable between the WT and mutant. There was a 
significant increase in the number of PCs per mm of PCL in SmoBG mutants. Data are 
mean of n = 3 wild-type and littermate pairs for each genotype. (D) Tamoxifen injection 
scheme in SmoBG mutant at later timepoints. One dose of tamoxifen was injected at P5 
and P6 in wild-type and SmoBG mutants. Mice were analyzed at P8. (E) H&E staining 
shows that changes in cerebellar size and EGL area were less severe when BG Shh 
signaling was ablated at P5 and P6 compared to ablation at P1 and P2. (F) PC dendrites 
in later timepoint-injected SmoBG mutants lacked secondary branching structures as 
revealed by Calbindin immunohistochemistry (arrowheads) and no appreciable 
differences in BG fibers can be observed using Blbp and GFAP immunohistochemistry. 
Abbreviations: EGL, external granular layer. IGL, internal granular layer. PCL. Purkinje 
cell layer. Scale bar: 100 µm and 20 µm. 
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SmoBG mutants exhibit aberrant Wnt signaling 
Next we wished to determine downstream signaling pathways that could be aberrantly 
regulated by depletion of BG-Shh signaling in mutant cerebella, leading to the reduction 
in CGNP proliferation. Several studies have implicated that antagonism of the Wnt 
pathway is important for the maintenance and proliferation of CGNPs. First, Wnt 
signaling is active in the rhombic lip and early migratory CGNPs at E14.5 but not in later 
stages of CGNP development (Fiacco and McCarthy 2006; Perea and Araque 2007; 
Pascual 2005). However, while it is not detected in the EGL, Wnt signaling is active 
postnatally in the PC layer in S100β+ BG cells (Selvadurai and Mason 2011) and at 
least one Wnt ligand, Wnt3, is expressed by BGs (GENSAT Mouse Brain Atlas). 
Additionally, CGNP-specific deletion of Wnt inhibitor APC resulted in severely inhibited 
CGNP proliferation and premature differentiation (Lorenz et al. 2011) and conditional 
activation of Wnt signaling using a dominant active form of β-catenin in neural 
precursors impaired CGNP proliferation (Pöschl et al. 2013). These studies suggest that 
ectopic Wnt signaling to the EGL may inhibit CGNP proliferation. 
Since we observed impaired CGNP proliferation in SmoBG mutants, we 
hypothesized that Wnt signaling could be ectopically activated in the EGL. To test this 
hypothesis, we used a BAT-Gal transgenic reporter strain that expresses a lacZ gene 
under the control of β-catenin/T-cell factor responsive elements (Maretto et al., 2003) 
and has been widely used as a general reporter of Wnt/β-catenin activity. By crossing 
these mice with our mutants to obtain TNCYFP-CreER; SmoF/-; BAT-Gal mice, Wnt signaling 
activity could be examined in the EGL. In wild-type mice examined at P4, we observed 
very few cells expressing β-gal positivity, corroborating studies demonstrating that Wnt 
signaling is not normally active in CGNPs at that stage (Selvadurai and Mason 2011). 
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However, in the SmoBG mutant we observed the presence of ectopic β-gal+ cells in the 
EGL of mutant mice (Figure 3.8A, arrows). These results indicate that SmoBG mutant 
mice have enhanced Wnt signaling in CGNPs, suggesting that BG-derived Shh signaling 
may regulate Wnt signaling activity to the EGL.  
As several extracellular modulators of the Wnt pathway are expressed in BG and 
CGNPs, including Wnt-inhibitory factor 1 (Wif1) and Shh target gene secreted frizzled 
receptor protein-1 (Sfrp1), we hypothesized that the enhanced Wnt signaling observed in 
SmoBG mutants may be due to reduced levels of Wnt antagonist expression. Sfrp1 is a 
30-kDa secreted glycoprotein that acts as an antagonist of Wnt signaling (Finch et al. 
1997). It has been identified as a Shh signaling target gene, frequently upregulated in 
Hh-activated tumors (Romer et al. 2004), and suggested to serve as a molecular link for 
Shh-mediated Wnt inhibition (Katoh and Katoh 2006). Therefore we examined gene 
expression of Sfrp1 in SmoBG mutant cerebella using in situ hybridization. As seen in 
Figure 3.8B, Sfrp1 is localized to the EGL in the P4 wild-type cerebellum. In TNC 
mutants, there was a striking decrease in Sfrp1 expression (Figure 3.8B), a finding we 
confirmed by probing lysates of freshly isolated CGNPs via Western blotting (Figure 
3.8C). This data indicates a downregulation of Sfrp1 expression in the EGL of TNC 
mutants, suggesting one possible downstream target of BG-derived Shh signaling 
activation. The Drosophila homologue of Wif1, shifted, is required for normal Shh 
signaling in the wing imaginal disc and has been suggested to bind Drosophila co-
receptors of the Shh pathway, the BOC/CDO family members Ihog and Boi (Avanesov et 
al. 2012). This suggests that in addition to antagonizing the Wnt pathway, Wif1 may be 
involved in Shh signaling activation. Consistent with this hypothesis, Wif1 mRNA is 
expressed in the PCL of the cerebellum (Allen Brain Atlas). Thus it is also possible that 
BG-derived Wif1 expression may be normally required to inhibit Wnt activity to CGNPs 
and allow for full activation of Shh signaling. Collectively, our data demonstrates that 
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ablation of BG Shh signaling in SmoBG mutants results in ectopic Wnt activity in CGNPs 
and suggest that inhibition of the Wnt pathway is a downstream target of BG Shh 
signaling.  
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Figure 3.8. 
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Figure 3.8. SmoBG mutants exhibit aberrant Wnt signaling 
 (A) ß-galactosidase immunohistochemistry in P4 TNCYFP-CreER; SmoF/-; BAT-Gal mice 
shows the presence of ectopic β-gal+ cells in the EGL of mutant mice (arrows), 
indicating that SmoBG mutant mice have enhanced Wnt signaling in CGNPs. (B) In situ 
hybridization for Sfrp1 in SmoBG mutants at P4 indicates a downregulation of the mRNA 
in the EGL. (C) Western blotting of lysates of freshly isolated CGNPs indicates a 
downregulation of Sfrp1 expression. Abbreviations: EGL, external granular layer. 
CGNPs, cerebellar granular neuron precursors. Scale bar, 200 µm and 20 µm. 
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DISCUSSION 
In this study, we provide genetic evidence that Shh signaling in Bergmann glia is 
required for proper CGNP proliferation and subsequent cortical expansion. Our study 
therefore provides a novel role for Shh signaling in the cerebellum—that is the non-cell-
autonomous regulation of CGNP proliferation by Bergmann glia. Interestingly, Smo 
mutants have profound reductions in EGL area that can be observed starting 24 hours 
after the last tamoxifen injection (Figure 3.3A, C) and prior to observable defects in BG 
fiber formation (Figure 3.6). This rapid timecourse from initiation of Cre-mediated 
recombination to EGL size reduction in mutants demonstrates the remarkable sensitivity 
of CGNP proliferation to BG-Shh activity, underscoring its relevance for the maintenance 
of overall cerebellar size and architecture. 
BGs belong to a select group of astroglia—they are astrocytic derivatives of 
radial glia that retain radial-glial like morphology into adulthood. While the other 
members of this group, retinal Muller cells and hypothalamic tanycytes, have been found 
to be neurogenic (Haan et al. 2013; Surzenko et al. 2013; Robins et al. 2013), BGs have 
not been described as such and our lineage tracing studies demonstrate that TNC-YFP 
cells contribute very minimally to the granular neuron population (Figure 3.5C, D). Thus 
it is unlikely that BG-derived neurogenesis plays a significant role during normal 
development. Rather, our study indicates that, in addition to their well-characterized role 
in providing guidance cues for the inward migration of CGNPs (Rakic 1971), BGs have a 
previously undescribed postnatal function in modulating proliferation of the cerebellar 
neuronal precursor population. This is consistent with a role for astrocytes in providing 
factors that support neuronal growth (Vernadakis 1988) and adds to our understanding 
of the neuronal-glial relationship in the cerebellum. 
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Although a select few other Shh-responsive cell types express TNC-YFP in the 
cerebellum, we conclude that the phenotype we observe is due to Shh signaling ablation 
in BG. Several lines of evidence support this conclusion. First, our lineage tracing 
studies in TNCYFP-CreER; tdTomato mice indicate that the contribution of TNC-expressing 
cells to the granular neuron population in the IGL is insignificant, with no more than one 
or two per lobe in the cerebellum at P30 (Figure 3.5C, D). Thus, while the small TNC-
expressing Sox2+/Blbp+ astroglial population in the EGL has been demonstrated to 
contribute to CGNPs (Silbereis et al. 2010) and is Shh responsive (Figure 3.5B), their 
contribution to the total number of granular neurons is too small to cause the severe 
phenotype we observe in Smo mutants. We cannot, however, exclude the possibility that 
these Sox2+/Blbp+ EGL cells are secreting an inhibitory factor that modulates CGNP 
responsiveness to Shh ligand. The difficulty of studying these cells in isolation of other 
radial glial cells limits our ability to draw conclusions regarding this hypothesis, as 
currently there is no specific marker for this cell population and their function is unknown. 
Nevertheless, our lineage tracing studies and the sheer number of BG cells compared to 
these sparsely populated EGL cells, as well as the ability of the BG fiber to reach to the 
pial surface and contact all CGNPs, all support our conclusion that BG Shh signaling 
ablation is responsible for the phenotype of Smo mutants. Additionally, the small 
population of TNC-expressing astroglial cells in the white matter have not been 
demonstrated to contact cells in the EGL. 
It has been speculated that Shh signaling provides differentiation capacity for 
Bergmann glia (Dahmane and Ruiz i Altaba 1999). These studies were performed in 
vitro and also through the use of blocking antibodies in vivo at early stages in the chick 
embryo when Shh is important in development of the entire neural tube. Thus it has 
been difficult to distinguish between Shh regulation of radial glial cells and Shh signaling 
regulation of BG development without a BG-specific knockdown of Shh signaling. Using 
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the TNCYFP-CreER driver line to ablate Shh signaling in postnatal BG cells, we demonstrate 
that BG cell number is unchanged between the wild-type and mutant (Figure 3.6A). 
Indeed, BG mitotic activity peaks between P1 and P6 (Yuasa 1996) and our analysis 
following tamoxifen injection at P1 and P2 showed no difference in absolute numbers of 
BG at P7. Our findings suggest that Shh signaling in BG is not necessary for their 
postnatal differentiation but do not rule out the possibility that Shh signaling regulates 
their specification prior to birth. 
There are several possibilities for how BG-Shh signaling alters CGNP Shh 
responsiveness. One possibility is that BG fibers are responsible for delivery of Shh 
ligand to the outer EGL where the bulk of CGNP proliferation takes place. PC dendrites 
reach only to the most superficial part of the ML, whereas BG fibers extend to the pial 
surface (Yamada et al. 2000). Conceivably, proteins on the surface of BG fibers could 
facilitate the transfer of secreted Shh ligand to CGNPs. However, our data indicate that 
the processed Shh ligand is produced normally by PCs in Smo mutants and is able to 
localize to the outer EGL. While it is possible that the dosage and concentration of Shh 
ligand is reduced in Smo mutants at a level that cannot be assessed by 
immunohistochemistry, our results suggest that Shh delivery to CGNPs does not depend 
on BG-Shh signaling.  
Another more likely possibility is that BG Shh signaling serves to modulate levels 
of inhibitory secreted factors, allowing for full activation of the Shh pathway in CGNPs. 
Several signaling pathways have been identified that are antagonistic to Shh signaling in 
regulating CGNP proliferation. For example, extracellular matrix glycoproteins (Pons et 
al. 2001) and FGFs (Wechsler-Reya and Scott 1999) are able to differentially modulate 
but not completely suppress Shh-mediated proliferation of CGNPs. We however did not 
find differences in gene expression of FGF transcriptional target Etv5 in Smo mutants 
compared to wild-type cerebella (data not shown), suggesting that FGF signaling does 
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not occur downstream of Shh signaling in BG. BMP2 and BMP4 significantly reduce 
CGNP proliferation in organotypic slice cultures (Rios et al. 2004) via the Smad signaling 
pathway (Zhao et al. 2008), however we did not find differences in protein localization 
and intensity of BMP signaling readout phospho-Smad1 (Ser463/465) (data not shown), 
suggesting that this pathway is also not regulated by Shh signaling in BG.  
Notably, our data using BAT-gal reporter mice demonstrate that Wnt signaling 
activity is upregulated in the EGL of Smo mutants (Figure 3.8A), concomitant with a 
reduction in EGL area (Figure 3.3B). While we cannot rule out the possibility that the 
upregulation in Wnt activity is a consequence rather than a cause of BG-Shh signaling 
ablation, several studies have implicated that antagonism of the Wnt pathway is 
important for the maintenance and proliferation of CGNPs. First, Wnt signaling is active 
in the rhombic lip and early migratory CGNPs at E14.5 but not in later stages of CGNP 
development (Selvadurai and Mason 2011). Additionally, CGNP-specific deletion of Wnt 
inhibitor APC resulted in severely inhibited CGNP proliferation and premature 
differentiation (Lorenz et al. 2011) and conditional activation of Wnt signaling using a 
dominant active form of ß-catenin in neural precursors impaired CGNP proliferation 
(Pöschl et al. 2013). Interestingly, the latter study observed a comparably severe 
cerebellar phenotype in their mutant mice as that seen when blocking Shh in vivo 
(Dahmane et al. 1997), with cerebellar hypoplasia with a thinned EGL, abnormally 
positioned Purkinje cells, and reduced Bergmann glia (Pöschl et al. 2013). Thus Wnt 
signaling to the EGL is likely inhibited during normal cerebellar development to allow for 
complete Shh pathway activation. Our results indicate that BG Shh signaling is involved 
in Wnt signaling antagonism. The source of the Wnt signal to the EGL may very well be 
BGs as Wnt3 is expressed in BG (Gensat Brain Atlas). While we do not find differences 
in Wnt3 gene expression in Smo mutants (data not shown), several extracellular 
modulators of the Wnt pathway are expressed in BG and CGNPs, including Wif1 and 
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Shh target gene Sfrp1. Notably, we detect a substantial downregulation of EGL Sfrp1 
expression in Smo mutants, suggesting at least one possible mediator of Wnt inhibition 
that may be downstream of BG-Shh signaling. 
Our study of BG fiber morphology demonstrates that Shh signaling in BG is 
required for proper BG fiber expansion, as BGs of Smo mutants display expanded 
endfeet and increased lateral branching (Figure 3.6B-D). However, an EGL area 
reduction is observed prior to detection of BG fiber defects, which are noticeable at P5. 
Thus we conclude that the aberrant growth of BG fibers is secondary to the reduction in 
EGL area and subsequent hypoplasia. Consistent with this hypothesis, we observe a 
similar increase in BG lateral branching and thickening of fibers in Math1CreER;SmoF/- 
mice which lack an EGL (Figure 3.7D).  
Our results also indicate that Shh signaling in BG is necessary for proper PC 
soma localization and dendritic arborization. Post-mitotic PCs migrate from the 
ventricular zone to form clusters in the postnatal cerebellum, and cluster dispersal 
depends on CGNP-derived Reelin signaling. As the EGL in our mutants is severely 
reduced, the disorganization of PC cell bodies is most likely due to the secondary effect 
of decreased Reelin secretion. These results are corroborated by similarly disrupted PC 
soma localization in L7Cre;ShhF/- and Math1CreER;SmoF/- mutants where the EGL is 
completely absent. PC dendritogenesis is a dynamic process, with constant 
restructuring, retraction, and regrowth of fibers. It is speculated that PC dendrites 
eventually use BG fibers as a guide for synaptogenesis and subsequent arborization 
(Wang et al. 2011; Lordkipanidze and Dunaevsky 2005; Yue 2005). We find that PC 
dendrite arborization in Smo mutants is reduced compared to PCs in wild-type mice 
(Figure 3.7A). While the PC dendrite phenotype we observe could be a consequence of 
disrupted BG fiber morphology, a second possibility is that PC dendritic arborization is 
dependent on BG Shh signaling directly. Our studies in mutant animals with later stage 
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tamoxifen injections indicate that the latter explanation is more likely. In these mutants, 
we find that cerebellar hypoplasia, EGL reduction, and BG fiber morphology are 
comparable to WT, whereas PC dendritic arborization defects are strikingly apparent 
(Figure 3.7G, H) indicating that this PC phenotype precedes the observed disruption of 
BG fiber morphology. The mechanism by which Shh signaling in BG regulates PC 
dendritogenesis requires further study.  
Because CGNPs are the presumed cell of origin of MB, determining factors that 
inhibit their proliferation are central to the investigation of MB development and may 
elucidate pathways that can be exploited in the development of future therapies. Our 
study suggests that BG play a role in providing modulatory factors, likely involving Wnt 
signaling, that positively regulate Shh signaling in the postnatal EGL. Thus their potential 
contribution to medulloblastoma pathogenesis should not be ignored. Further studies are 
needed to determine the molecular mechanism by which this regulation of CGNP 
proliferation occurs. In addition, as Shh signaling is still active in the BG in the adult 
(Corrales et al. 2004), its function in BG in the adult may be very different from its early 
postnatal role of regulating proliferation and subsequent migration of CGNPs and needs 
additional investigation. Nevertheless, our mutant mouse model specifically 
demonstrates a requirement for Shh signaling in Bergmann glia for proper proliferation of 
CGNPs and multiple aspects of cerebellar architecture and lamination and therefore 
sheds light on the importance of neuron-glia communication in the cerebellum.  
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MATERIALS AND METHODS 
Animals and Tamoxifen Administration. Mice of the following genetic lines, of either sex, 
were used in the study: Gli1nlacZ (Bai et al. 2002), TNCYFP-CreER (gift of Wenjuan He, 
University of California-San Francisco, San Francisco, CA and Chuanming Hao, Fudan 
University, Shanghai, China), SmoF/F (Long et al. 2001), Bat-gal  (Maretto et al. 2003), 
Math1CreER (Rob Machold and Fishell 2005), R26ReYFP (Srinivas et al. 2001), tdTomato 
(Madisen et al. 2009), L7Cre (Lewis et al. 2004) and ShhF/F (Lewis et al. 2001). Tamoxifen 
(Sigma) was dissolved to a final concentration of 2 mg/ ml in corn oil (Sigma). Postnatal 
TNCYFP-CreER; tdTomato, TNCYFP-CreER; R26ReYFP, TNCYFP-CreER; SmoF/- (SmoBG), 
Math1CreER; SmoF/-, and wild-type littermates received 50 µL of tamoxifen by 
intraperitoneal injection on P1 and P2 or on P4 and P5 where noted. 
 
Tissue processing and Immunohistochemistry. For animals younger than P30, brains 
were dissected and fixed in 4% paraformaldehyde for either 4-6 hours or O/N at 4o C. 
Animals P30 and older received 50 µL intraperitoneal injections of Ketamine and 
received ice-cold PBS via transcardial perfusion followed by 4% paraformaldehyde. 
Brains were collected and submersion fixed in 4% paraformaldehyde O/N at 4oC. These 
tissues were either processed for frozen embedding in OCT compound or processed for 
paraffin embedding. Frozen tissues were sectioned on a Leica cryostat at 10 µm, 
paraffin embedded tissues were cut at 5 µm. Immunohistochemistry were performed as 
previously described (Huang et al. 2009; Huang, Liu, et al. 2010). The following primary 
antibodies were used on frozen and/or paraffin tissue sections: chicken α-β-Gal (ICL), 
rabbit α-β-Gal (ICL), rabbit α-BLBP (Abcam), rabbit α-GFAP (Abcam), chicken α-GFP 
(Aves), guinea pig α-Gli2 (Qin et al., 2011), rabbit α-Calbindin (Swant), rabbit α-
phospho-Histone-3 (Upstate Cell Signaling), mouse α-NeuN (Millipore), mouse α-
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Parvalbumin (Sigma), rabbit α-3-PGDH (Thermo-Scientific), rabbit α-Sox2 (Millipore), 
mouse α-Laminin (Thermo-Scientific), rabbit α-p27Kip1 (BD Transduction Labs). For 
bright-field staining, species-specific HRP-conjugated secondary antibodies (Invitrogen) 
were used followed by incubation in DAB reaction (Invitrogen) or alkaline-phosphatase 
(Invitrogen). Double-labeling fluorescence immunohistochemistry was performed using 
species-specific, AlexaFluor-tagged secondary antibodies Alexa 488, Alexa 568, and 
Alexa 647 (Invitrogen) followed by counterstaining with To-pro3 iodide (Invitrogen).  
 
X-Gal and In Situ Hybridization. X-Gal staining for β-Galactosidase activity was 
performed on post-fixed, frozen sections according to standard protocols. Section in situ 
hybridizations were performed using digoxygenin-labeled riboprobes as previously 
described (Y. Li et al. 2006; Y. Li et al. 2008). Riboprobes were synthesized using the 
digoxygenin RNA labeling kit (Roche). The following cDNAs were used as templates for 
synthesizing digoxygenin-labeled riboprobes: Shh and Sfrp1 (gift of Paula Bovolenta, 
Centro de Biologia Molecular Universidad Autonoma Madrid, Madrid, Spain).  
 
GCP and Cerebellar Isolation and Western Blotting. For GCP isolation, P4 or P5 
cerebella from CD1 or SmoBG mice were dissected into calcium-free Hanks buffered 
saline solution (Mediatech) supplemented with 6 g/L D-glucose. The meninges were 
stripped and pooled cerebella dissociated with Accutase (Gibco) and trituration. Cells 
were pelleted and resuspended in Neurobasal A-medium containing 250 µM KCl, 500 µL 
100X GlutaMAX I, 500µL 100X penicillin-streptomycin, and 10% FBS. Cells were passed 
through a 70 µm filter and incubated for two times 20 minutes on poly-d-lysine coated 
plates. Following the settling step, the cells remaining in the media were considered the 
GCP fraction and were collected, pelleted, and ready for lysis. For cerebellar isolation, 
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P4 or P5 cerebella from CD1 or SmoBG mice were dissected and tissue mechanically 
dissociated by trituration.  Cell or tissue lysis was performed in RIPA buffer containing 
2.5 mM EDTA, 1 mM PMSF, 10 mM NEM, 0.1 mM sodium orthovanadate, 0.2 mM 
sodium fluoride, and EDTA-free complete mini protease inhibitor tablets (Roche), for 
thirty minutes, followed by boiling in SDS, and resolution on 10% SDS-polyacrylamide 
gels. For cerebellar Shh ligand detection, P4 or P5 cerebella from CD1 or SmoBG mice 
were dissected and immediately boiled in SDS for 5 minutes. 
Primary antibodies used for Western blotting were mouse α-Sfrp1 (Abcam, 
1:500), rabbit α-Gli1 (Cell Signaling Technology #2534, 1:2000), guinea pig α-Gli2 (gift 
of Jonathan Eggenschwiler, 1:500), rabbit α-Shh (H160) (Santa Cruz Biotechnology, 
1:500), mouse anti-α-tubulin (Hybridoma Bank, 1:10,000), mouse α-β-actin 
(ThermoScientific BA3R, 1:10,000). 
 
Quantification and statistical analyses. Stained slides for quantification were scanned 
with the Leica SCN400 Slide Scanner and quantification was performed using the Leica 
Ariol Software. Statistical analyses were performed using Prism software (GraphPad). 
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CHAPTER IV 
 
ANTAGONISM OF THE HEDGEHOG PATHWAY AT THE LEVEL OF GLI 
TRANSCRIPTION BY THE SMALL MOLECULE 5-AMINOIMIDAZOLE-4-
CARBOXAMIDE-1-ß-4-RIBOFURANOSIDE (AICAR) 
 
INTRODUCTION 
The Hedgehog signaling pathway is essential for embryonic development (Varjosalo and 
Taipale 2008) and has been implicated in many cancers such as basal cell carcinoma, 
medulloblastoma, Ewing sarcoma, and rhabdoid tumors (Teglund and Toftgård 2010). 
As aberrant Hh signaling is involved in the initiation and maintenance of tumor progenitor 
cells for a broad variety of cancers, including ones of both sporadic and heritable origins, 
multiple pharmaceutical companies have begun large scale drug discovery and clinical 
trial efforts to develop Hh pathway antagonists for therapeutic use(Ajeawung, Wang, and 
Kamnasaran 2013). 
 Hh pathway activity occurs when mature Hh protein binds its membrane receptor 
Patched (Ptch). Patched releases its inhibitory effect on the 7-pass transmembrane 
protein Smoothened (Smo) (Jiang and Hui 2008), which then accumulates in the primary 
cilium (Corbit et al. 2005; Kim, Kato, and Beachy 2009; Rohatgi and Scott 2007). 
Activation of Smo promotes the dissociation of a Suppressor of Fused (Sufu)-Gli protein 
complex, derepressing the Gli family of transcription factors and allowing the activated 
Gli proteins to enter the nucleus. The Gli proteins bind to Hh signaling target genes, 
including Ptch and Gli1. 
 Recent clinical trials have identified several promising small molecule inhibitors of 
the Shh pathway (Ajeawung, Wang, and Kamnasaran 2013). For example, GDC-0449 
(Vismodegib), an inhibitor of the Smoothened receptor, was recently approved by the 
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Food and Drug Administration for the treatment of metastatic and surgically unresectable 
advanced basal cell carcinomas (Guha 2012). Other inhibitors currently in clinical trials 
include additional derivatives of the plant alkaloid cyclopamine (Heretsch, Tzagkaroulaki, 
and Giannis 2010; Ma, Li, and Zhang 2013) and the anti-fungal agent itraconazole 
(Antonarakis et al. 2013). However, the current arsenal of therapeutics in clinical trials 
targeting the Hedgehog pathway is limited to Smo inhibition. It is becoming apparent that 
a major pitfall of these inhibitors is the development of acquired resistance, as has been 
documented with Vismodegib among patients (Ajeawung et al. 2012; Metcalfe and de 
Sauvage 2011; Yauch et al. 2012). Among others, cancer cell resistance mechanisms 
include de novo mutations in the Smo receptor that hinder drug-binding (Yauch et al. 
2012) or gene duplications of Gli2 or Shh target gene cyclin D1 that bypass the 
requirement of Smo to inappropriately maintain Hh pathway activity (Buonamici et al. 
2010). Therefore, elucidation and development of Shh signaling inhibitors downstream of 
Smo can expand the current treatment arsenal to target the significant fraction of tumors 
that possess downstream pathway activation.	  
 Several Gli inhibitors have been identified thus far through large-scale screens of 
compound libraries. GANT58 and GANT61 are two molecules (Lauth et al. 2007) with 
similar IC50 to cyclopamine and suppress xenografts of Gli1-positive human prostate 
cancer. In addition, arsenic trioxide (ATO) acts at the level of Gli transcription, either by 
blocking Gli2 accumulation in primary cilia and reducing Gli2 protein levels (Kim et al. 
2010) or by directly binding to Gli1 and inhibiting its transcriptional activity (Beauchamp 
et al. 2011), resulting in inhibition of medulloblastoma growth in mouse models (Kim et 
al. 2010; Beauchamp and Üren 2012). ATO holds promise as a potential therapeutic 
agent as it is already in clinical use against acute promyelocytic leukemia. Identifying 
and targeting Gli modulators may thus provide strong support for the use of combined 
therapy to treat tumors that have developed resistance to Smo antagonists.  
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 The adenosine analog 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside 
(AICAR) is a natural metabolic intermediate of purine biosynthesis that is present in all 
organisms. It has been widely used as a small molecule agonist of the heterotrimeric 
metabolic sensor AMP-activated protein kinase (AMPK) (Sullivan et al. 1994; Bergeron 
et al. 2001; Song et al. 2002; Buhl et al. 2002; Sriwijitkamol and Musi 2008b). AICAR is 
taken up by cells, where it is phosphorylated to AICAR-monophosphate (ZMP) and 
mimics an increase in AMP intracellular levels (Rattan 2005). ZMP enters the de novo 
synthesis pathway for adenosine synthesis to inhibit adenosine deaminase and causes 
an increase in ATP and adenosine levels (Rattan 2005). Downstream effectors of AMPK 
include important cell cycle progression factors and tumor suppressors Tuberous 
Sclerosis Complex (TSC2) and the mammalian target of Rapamycin (mTOR) (Kemp et 
al. 2003). As a potential cancer therapeutic, studies are increasingly demonstrating 
AICARʼs effectiveness in inhibiting proliferation and inducing apoptosis of various cancer 
cell types, including multiple myeloma (Baumann et al. 2007), neuroblastoma (Garcia-Gil 
et al. 2003), glioblastoma (Guo et al. 2009), childhood acute lymphoblastic leukemia 
(ALL) (Sengupta et al. 2007), colon cancer (Su et al. 2007), prostate cancer (Swinnen et 
al. 2005), and retinoblastoma (Theodoropoulou et al. 2010). In addition, AICAR has low 
or no apparent toxicity in humans and has been shown to act as an in vivo exercise 
mimetic (Narkar et al. 2008). However, its AMPK-independent effects have largely 
remained unexplored, as well as its role in hedgehog-driven tumors including the 
pediatric malignant tumor medulloblastoma.  
 In this study we identify AICAR as a potent Hh pathway antagonist in multiple cell 
types, including Hh-responsive human medulloblastoma cells. Importantly, we show that 
AICAR acts downstream of Smo and regulates Gli1 transcription in a proteasome-
independent manner. Sufu stabilizes the Gli proteins from AICAR inhibition, as 
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downregulation of Shh pathway activity was more efficient in Sufu-null MEFs. Last, we 
find that although AICAR activates AMPK in these cell lines, inhibition of the Hh pathway 
by AICAR is AMPK-independent. Our findings establish AICAR as a modulator of Shh 
signaling in both a developmentally relevant cell type as well as medulloblastoma cells, 
providing an encouraging basis to further explore its full potential as an antagonist in 
Shh-associated tumors. 
 
RESULTS 
AICAR antagonizes Hedgehog (Hh) pathway activity in fibroblasts and CGNPs 
The effect of AICAR on Shh signaling activity was assayed using the well-established 
Gli-dependent luciferase reporter assay. NIH-3T3 fibroblasts were transfected with a Gli-
luciferase reporter and luciferase activity measured when Shh pathway agonist, 
Smoothened agonist (SAG) (Chen 2002), and other Hh pathway modulators were 
added. Cells were incubated with 50 nM SAG with or without 1 mM AICAR for 24 hours. 
As NIH-3T3 fibroblasts are Shh-responsive, we expectedly observed a significant 
increase in luciferase activity in the presence of SAG (Figure 4.1A). However, addition of 
1 mM AICAR significantly downregulated luciferase activity to 15-20% of the maximum 
level (Figure 4.1A). As AICAR is best characterized as an AMPK agonist, we also 
wanted to look at effects of other known AMPK activators. Thus we assayed for the 
effect of 2-DG and metformin on Shh signaling activity and found that both similarly 
downregulated Gli-dependent luciferase activity (Figure 4.1A).  
In order to determine whether AICAR downregulation of Gli1-mediated 
transcriptional activity was dose-dependent, we treated cells with vehicle or 0.1 mM, 0.3 
mM, 0.6 mM, or 1 mM of AICAR for 24 hours. AICAR was able to inhibit Gli1 
transcriptional activity in a dose-dependent manner compared to vehicle control, with an 
IC50 of 0.16 mM (Figure 4.1B). Cell viability was also evaluated in parallel to luciferase 
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reporters at matching doses. We did not observe any reduction in cell viability at doses 
up to 1 mM AICAR and concluded that reduction in luciferase activity was not mediated 
by cytotoxicity. In order to determine whether AICAR can downregulate Gli1 protein 
levels, we treated wild-type mouse embryonic fibroblasts (MEFs) with 1mM AICAR and 
harvested them for Western blotting at 1 hr, 3 hr, 6 hr, 9 hr, and 12 hr intervals. We 
observed a downregulation of Gli1 protein levels as early as 6 hrs (Figure 4.1C). Taken 
together, these results demonstrate that AICAR is capable of opposing Shh pathway 
activity in a dose- and time-dependent manner. 
Next we wished to determine whether AICAR had an effect on a developmentally 
relevant cell population normally responsive to Shh signaling. Cerebellar granular cell 
precursors (CGNPs) are the proposed cell-of-origin for medulloblastoma (Z. Yang et al. 
2008; Schüller, Heine, et al. 2008) and depend heavily on Hh signaling as a proliferative 
signal (Dahmane and Ruiz i Altaba 1999; Anna Kenney and Rowitch 2000; Wechsler-
Reya and Scott 1999). Primary cultures of isolated CGNPs treated with SAG are a 
widely used tool to recapitulate Shh mitogenic signaling (Dahmane and Ruiz i Altaba 
1999; Kenney and Rowitch 2000; Wechsler-Reya and Scott 1999; Leung et al. 2004; 
Kenney, Cole, and Rowitch 2003). As shown in Figure 4.1D, untreated primary CGNPs 
and those treated with AICAR alone show a low level of Gli1 and cyclin D1. However, 1 
mM AICAR was able to potently downregulate Hh signaling in SAG-induced CGNPs as 
demonstrated by significantly reduced levels of Shh target genes Gli1 and cyclin D1 in a 
similar manner to KAAD-cyclopamine. We then wished to determine the timecourse of 
Gli1 downregulation by AICAR in CGNPs. Thus we treated CGNPs with AICAR and 
harvested them for Western blotting at 6 hr, 12 hr, and 24 hr intervals. Similar to the 
timecourse of downregulation in WT MEFs, we observed a downregulation of Gli1 
protein levels as early as 6 hrs (Figure 4.1D).  
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Figure 4.1 
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Figure 4.1. AICAR antagonizes Hedgehog (Hh) pathway activity in fibroblasts and 
CGNPs 
(A) Effects of vehicle or SAG (100 nM), AICAR (1 mM), 2-deoxyglucose (2-DG) (20 mM), 
or metformin (20 mM)-treated on NIH-3T3 cells were assessed by relative Gli-luciferase 
activity. Cells were plated at ~90% confluency and treated with SAG at 10 nM for 15 hr. 
We observed significant increase in reporter activity in the presence of SAG. Addition of 
AICAR, 2-DG, or metformin significantly downregulated luciferase activity to 15-20% of 
the maximum level. Data represent mean of triplicates ± SD. (B) Effect of the addition of 
increasing doses of AICAR on NIH-3T3 cells transfected with Gli-luciferase. (C) 
Timecourse of SAG ± AICAR addition in wild-type MEFs of Gli1 protein levels. SAG and 
AICAR were added concurrently for 15 hours. (D) Timecourse of SAG ± AICAR addition 
in CGNPs of Gli1 protein levels. SAG (10 nM) was added for 24 hours followed by 
AICAR (1 mM) addition for 12 hours. (E) CGNPs were treated with SAG, AICAR, or 
KAAD (4 µM) and cell lysates subject to SDS-PAGE followed by immunoblotting with 
indicated antibodies. (F) CGNPs were treated with SAG and AICAR as in (D). Lysates 
and Caco-2 cell lysates (right lane) were subject to SDS-PAGE followed by 
immunoblotting with indicated antibodies. 
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AICAR is widely used as an activator of AMPK (Corton et al. 1995), which is 
primarily dependent on the phosphorylation of threonine-172 on the α-subunit by the 
upstream tumor suppressor LKB1 (Hawley et al. 2003; Woods 2003). Upon binding to 
AMPK, AMP or in the case of AICAR addition, ZMP, activates the enzyme up to 5-fold 
and enhances LKB1-dependent AMPK phosphorylation (Davies et al. 1995; Towler and 
Hardie 2007). In order to determine whether AICAR was capable of activating AMPK in 
CGNP cultures, we blotted for phosphorylated AMPK (Thr-172) (p-AMPK) and its direct 
substrate phosphorylated acetyl-coA carboxylase (p-ACC). We found that addition of 1 
mM AICAR upregulated both p-AMPK and p-ACC (Figure 4.1E).  
BMP signaling has been shown to inhibit CGNP proliferation and antagonize Shh 
signaling (Zhao et al. 2008), thus to examine the specificity of AICAR action, we assayed 
for the effects of AICAR on the BMP pathway in CGNPs. We found that 1 mM AICAR, a 
concentration that fully blocks SAG response, for 12 hours did not inhibit 
phosphorylated-Smad1 (Ser263/265) protein levels (Figure 4.1F). The human epithelial 
colorectal adenocarcinoma (Caco-2) cell line, which expresses high levels of BMP 
signaling (Wang, Davidow, et al. 2012), was used as a positive control for the α-
phosphorylated-Smad1 antibody. These results exclude a general suppressive effect on 
signal-dependent transcriptional events as the basis for AICAR inhibition of Hh pathway 
response. 
 
AICAR inhibits CGNP proliferation and growth of primary medulloblastoma cells 
To determine if AICAR inhibits CGNP proliferation, we used the mitotic marker 
phosphorylated Histone H3 (pH3). As CGNP proliferation is SAG-dependent, expectedly 
SAG treatment significantly increased the number of pH3-positive cells whereas AICAR 
alone had no effect on CGNP proliferation. However, AICAR significantly reduced 
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proliferation in SAG-treated samples (Figure 4.2A, B). In addition, we performed flow 
cytometric analysis of PI fluorescence in order to determine cell cycle phase distribution. 
As shown in Figure 4.2C, approximately 11.8% of cells were in S-phase in SAG treated 
cultures. However in AICAR treated samples, 8.2% of cells were in S-phase, suggesting 
an inhibition of Shh signaling in CGNPs. When we performed immunohistochemistry for 
apoptotic marker cleaved caspase-3 on AICAR-treated CGNPs, we observed a slight, 
but insignificant, increase compared to SAG-treated CGNPs (Figure 4.2A, B). Together, 
these results indicate an anti-proliferative effect of AICAR on CGNPs and that AICAR 
does not play a significant role in inducing programmed cell death of CGNPs. 
To determine if AICAR inhibits Shh signaling in a tumor context, we isolated 
primary medulloblastoma cells from freshly dissociated GFAPCre/+;SmoM2 tumors. 
GFAPCre/+;SmoM2 mice express the constitutively active, ligand-independent 
Smoothened allele (SmoM2) under control of the human GFAP-promoter; 100% of the 
mice develop medulloblastoma with an average survival of 33 days (Schüller, Heine, et 
al. 2008). Parallel to our findings in CGNPs, AICAR significantly reduced Gli1 and Gli2 
protein levels (Figure 4.2F) and caused a reduction in cell proliferation as indicated by 
pH3 staining from 10.19% in untreated tumor cells to 6.89% in AICAR-treated tumor 
cells (p = 0.012) (Figure 4.2D, E). In addition, we observed a significant increase in 
cleaved caspase-3 positive cells in tumor cells treated with AICAR, from 6.86% CC3 
positive in untreated tumor cells to 20.55% in AICAR treated cells (p = 0.002) (Figure 
4.2D, E). Collectively, these results suggest that AICAR has profound effects on tumor 
growth and survival. 
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Figure 4.2. AICAR inhibits CGNP proliferation and growth of primary 
medulloblastoma cells 
(A) CGNPs treated with SAG ± AICAR were fixed and immunostained with pH3 and 
cleaved caspase 3. (B) Quantification of percentage of pH3-positive and cleaved-
caspase 3-positive cells out of total DAPI+ cells demonstrates a significant decrease in 
pH3-positive cells in SAG and AICAR-treated samples compared to SAG-treated 
samples (n = 10, p = 0.0006) but no significant difference in cleaved caspase-positive 
samples. (C) CGNPS treated with SAG ± AICAR labeled with propidium iodide and 
subjected to flow cytometric cell cycle analysis demonstrates a decrease in S phase in 
SAG and AICAR-treated samples compared to SAG treated samples. (D) Primary 
medulloblastoma cells from Math1Cre;SmoM2 mice were treated with 1 mM AICAR for 12 
hours, then fixed and immunostained for pH3 and cleaved-caspase 3. (E) Quantification 
of percentage of pH3-positive and cleaved-caspase 3-positive cells out of total DAPI+ 
cells demonstrates a significant decrease in pH3-positive cells in SAG and AICAR-
treated samples compared to SAG-treated samples (n = 10, p < 0.05) and a significant 
increase in cleaved caspase-3 cells (n = 10, p < 0.005). (F) Lysates from 
Math1Cre;SmoM2 primary medulloblastoma cells treated with AICAR were subjected to 
SDS-PAGE followed by immunoblotting with indicated antibodies. Scale Bar, 20 µm. 
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AICAR downregulates Shh signaling in an AMPK-independent manner 
In order to determine the mechanism through which AICAR acts to downregulate Shh 
signaling, we tested the GSK3ß (Horike et al. 2008; King, Song, and Jope 2006), 
cholesterol (Wang et al. 2008; Namgaladze et al. 2013), PKA (Hallows et al. 2009), and 
sirtuin (Bai et al. 2012; Velasquez et al. 2011) pathways which have been shown to be 
activated by AICAR. We applied inhibitors for these pathways to determine whether they 
are required for AICAR inhibition of Shh response. We found that AICAR inhibition was 
sustained in the presence of GSK3ß inhibitor CH99021, cholesterol synthesis inhibitor 
simvastatin, PKA inhibitors KT5720 and H89, and sirtuin inhibitors sirtinol and salermide 
(Figure 4.3A-D), thus ruling out these pathways as mediators of AICAR action on Shh 
signal response. In addition, AICAR has been postulated to mediate its anti-growth 
effects primarily through AMPK inhibition of mTOR signaling (Guo, Chien, and Shyy 
2007; Inoki, Zhu, and Guan 2003; Gleason et al. 2007). Administration of AICAR has 
been shown to cause mTOR inhibition in vitro and in vivo in retinoblastoma tumor 
xenografts (Theodoropoulou et al. 2013; Theodoropoulou et al. 2010), and mTORC1 is 
directly inhibited by phosphorylation of raptor as a consequence of activation of the 
AMPK (Bolster 2002). Thus we also asked whether mTOR inhibition using the drug 
Rapamycin could downregulate Gli1 levels in a manner similar to AICAR. We found that 
although phosphorylated-S6 levels were decreased in both AICAR and Rapamycin-
treated samples, suggesting that mTOR pathway activity was inhibited, Gli1 levels were 
not reduced to the same level in Rapamycin treated samples as compared to AICAR-
treated samples (Figure 4.3E). These results suggest that AICAR does not function 
through mTOR inhibition to affect Shh pathway activity.  
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 We then turned to the heterotrimeric metabolic enzyme 5’-Amp-activated protein 
kinase (AMPK). AICAR has a widely documented role as an activator of AMPK (Sullivan 
et al. 1994; Bergeron et al. 2001; Song et al. 2002; Buhl et al. 2002; Sriwijitkamol and 
Musi 2008b) although signaling through AMPK-independent mechanisms have been 
reported (Santidrian et al. 2010; Jacobs et al. 2006). As shown in previous figures, 
AICAR induces the phosphorylation of AMPK in several cell types including CGNPs 
(Figure 4.1D) and primary medulloblastoma cells (Figure 4.2F), as well as its direct 
substrate ACC, suggesting its ability to activate AMPK when added to culture media. To 
determine whether AICAR acts through AMPK to downregulate Shh signaling activity, 
we added the pyrazolopyrimidine compound Compound C, which functions as an ATP-
competitive inhibitor of AMPK and other protein kinases (Bain et al. 2007), to SAG and 
AICAR-treated samples in the Gli-dependent luciferase assay. As compound C inhibits 
AMPK function, we would expect a rescue of luciferase activity in AICAR-treated cells if 
AICAR acted through AMPK to downregulate Shh signaling activity. However, we failed 
to observe rescue of AICAR-mediated inhibition of Gli-luciferase (Figure 4.4A). We 
corroborated these observations by using AMPKa-null fibroblasts (Laderoute et al. 2006; 
Jørgensen et al. 2004), and found that addition of AICAR was still able to inhibit Gli1 
levels over time in the absence of AMPK (Figure 4.1C and 4C). Collectively, these 
studies indicate that AICAR-induced Shh pathway antagonism occurs in a manner 
independent of AMPK signaling. 
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Figure 4.3. AICAR downregulates Shh signaling independently of the GSK3ß, 
cholesterol, PKA, sirtuin, and mTOR pathways 
(A-C) CGNPs were treated with SAG, AICAR, and/or inhibitors of pathways shown to be 
activated by AICAR. AICAR inhibition was sustained in the presence of GSK3ß inhibitor 
CH99021, cholesterol synthesis inhibitor simvastatin, PKA inhibitors KT5720 and H89, 
suggesting AICAR action on Shh signal response is not mediated through these 
pathways. (D) Wild-type MEFs were treated with SAG, AICAR, and/or sirtuin inhibitors 
sirtinol and salermide. AICAR does not mediate its effects on Shh signaling through the 
sirtuin pathway. (E) AICAR does not work through the mTOR signaling pathway, since 
addition of rapamycin (inhibitor of mTOR) is not able to downregulate Gli1 protein levels 
to the same extent as with AICAR. 
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Figure 4.4. AICAR downregulates Shh signaling independently of the AMPK 
pathway 
(A) Effects of AMPK inhibitor Compound C (1 and 3 µM) were evaluated in NIH-3T3 cells 
by relative Gli-luciferase activity. Compound C was unable to rescue AICAR mediated 
downregulation of Gli-luciferase activity. (B) Timecourse of SAG ± AICAR addition in 
AMPK-/- MEFs shows that AICAR is still able to downregulate Gli1 levels, similar to 
those in WT MEFs (see Figure 1C), suggesting an AMPK-independent mechanism for 
AICAR-mediated downregulation of Gli protein. 
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AICAR acts downstream of Smoothened to inhibit Shh pathway activity 
Since we had determined that AICAR acts through an AMPK-independent mechanism to 
inhibit Shh pathway activity, we wanted to assess where in the Shh pathway AICAR 
acts. Shh pathway activation is critically dependent on Smoothened activation, and we 
first sought to determine whether AICAR inhibits Smo activity. We assessed the ability of 
AICAR to inhibit Shh signaling induced by constitutively active Smo (SmoA1) in NIH-3T3 
transfected with Gli-luciferase. SmoA1 is a mutation found in sporadic basal cell 
carncinomas and has a leucine substitution at tryptophan 535, rendering the protein 
constitutively active (Xie et al. 1998). If AICAR inhibited Shh activity by impairing the 
ability of Smo to activate Gli, we would expect that Shh signaling would not be reduced 
in the presence of SmoA1. As shown in Figure 4.5A, AICAR significantly inhibited Gli-
luciferase activity induced by SmoA1, comparable to the reduction observed in SAG and 
AICAR treated samples. This finding suggests that AICAR acts downstream of or 
parallel to Smo in the Shh signaling pathway. 
Next we sought to determine whether AICAR depends on the Shh negative 
regulator Sufu to inhibit signaling activity. In the absence of Shh ligand, Sufu controls the 
level of Gli2 and Gli3 proteins by binding and stabilizing them in the cytoplasm (Wilson 
and Chuang 2010; Humke et al. 2010; Tukachinsky, Lopez, and Salic 2010; Wang, Pan, 
and Wang 2010). Shh signaling stimulates dissociation of the Sufu/Gli2 and Gli3 
complexes, permitting full activity of Gli2 (Bai et al. 2002). Thus in the absence of Sufu, 
the Shh pathway is constitutively active although Gli2 and Gli3 become more labile 
(Wilson and Chuang 2010; Humke et al. 2010; Tukachinsky, Lopez, and Salic 2010; 
Wang, Pan, and Wang 2010). If AICAR inhibits Shh signaling by modulating Sufu 
function, for example by preventing Sufu-Gli disassembly in the presence of Shh, we 
would expect the effects of AICAR to be diminished in cells lacking Sufu. We assessed 
Gli1 and Gli2 protein levels in Sufu-/- MEFs (Svärd et al. 2006) and compared protein 
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levels to those in wild-type MEFs. As shown in Figure 4.5.5B, in WT cells, 1 mM AICAR 
treatment for 12 hours reduced basal levels of Gli1 and Gli2; however, higher 
concentrations of AICAR did not appreciably reduce their levels further. 100 nM SAG 
treatment alone significantly upregulated Gli1 but Gli2 level remained unchanged, 
consistent with previous studies that Shh signaling regulates Gli2 primarily at the post-
transcriptional level by modulating its activity partly through its interaction with Sufu 
(Wilson and Chuang 2010; Humke et al. 2010; Tukachinsky, Lopez, and Salic 2010; 
Wang et al. 2010). As expected, addition of SAG had little or no effect on Gli1 and Gli2 
levels in the absence of Sufu (Figure 4.5C), consistent with near full Shh pathway 
activation in Sufu-/- MEFs. Addition of AICAR significantly reduced SAG-induced Gli1 
and Gli2 protein levels (Figure 4.5B). Given that AICAR reduces Shh signaling in Sufu-/- 
MEFs, in which Gli is constitutively activated in the nucleus, we propose that AICAR 
inhibits Shh signaling at the level of the Gli transcription factors, either by regulating Gli 
protein stability or Gli transcription. 
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Figure 4.5. AICAR acts downstream of Smoothened to inhibit Shh pathway activity 
(A) The ability of AICAR to inhibit Shh signaling induced by constitutively active Smo 
(SmoA1) was assessed in NIH-3T3 cells transfected with Gli-luciferase. AICAR 
significantly inhibited Gli-luciferase activity induced by SmoA1, comparable to the 
reduction observed in SAG and AICAR treated samples, suggesting that AICAR acts 
downstream of or parallel to Smo in the Shh signaling pathway. Data represent mean of 
triplicates ± SD. (B) 100 nM SAG ± 1 or 3 mM AICAR treatment for 12 hours in WT 
MEFs reveals that 1 mM AICAR reduces basal levels of Gli1 and Gli2 and 3 mM AICAR 
does not appreciably reduce levels further. In the absence of Sufu (Sufu-/- MEFs), SAG 
had little or no effect on Gli1 and Gli2 levels, whereas addition of AICAR significantly 
reduced SAG-induced Gli1 and Gli2 protein levels.  
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AICAR regulates Gli1 transcription  
To determine whether AICAR regulation of Gli protein levels is proteasome-mediated, 
we treated WT fibroblasts with AICAR in the presence of proteasome inhibitor MG132. 
We did not observe a rescue of Gli1 or Gli2 protein levels in AICAR-treated samples in 
the presence of 10 µM MG132 in WT (Figure 4.6A) for 2.5 hrs or Sufu-/- MEFs treated 
with MG132 for 3 or 6 hrs (Figure 4.6A). Consistent with previously published results, 
MG132 stabilized Gli2 in Sufu-/- cells in the absence of AICAR (Humke et al. 2010) 
(Figure 4.6A). This indicates that AICAR does not inhibit the Shh pathway by promoting 
proteolytic destruction of Gli and thus does not regulate Gli protein stability. 
As we determined that AICAR acts downstream of Sufu to affect Gli protein 
levels, we next wished to determine whether AICAR regulates Gli transcription. 
Therefore we treated MEFs with SAG and/or AICAR for 12 hours and performed qRT-
PCR to determine mRNA levels. As shown in Figure 4.6B, we observed no significant 
changes in Gli2 and Gli3 mRNA levels with different treatment conditions, whereas SAG-
induced Gli1 mRNA levels were reduced by nearly 40% in the presence of AICAR (from 
relative mRNA level 43 to 26). Next, we examined effects of AICAR on Gli3 protein 
levels in WT MEFs. Gli3-R serves as the principal transcriptional repressor of Shh 
signaling in the absence of ligand (Ryan and Chiang 2012); Shh pathway activation 
blocks Gli3 repressor formation and destabilizes full-length Gli3. Thus if AICAR inhibits 
the Shh pathway by stabilizing Gli3 protein or Gli3 repressor formation, we would expect 
an increase in Gli3R in AICAR treated cells. However, we found that addition of AICAR 
had no significant effect on Gli3 full-length or repressor (Figure 4.6C), suggesting that 
AICAR does not regulate Gli3 protein levels. Since AICAR does not appreciably 
decrease Gli2 or Gli3 protein levels but is able to substantially downregulate Shh 
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transcriptional target Gli1, these results suggest that AICAR acts at the level of the Gli 
transcriptional effectors. 
 
Figure 4.6. AICAR regulates Gli1 transcription 
(A) WT MEFs were treated with SAG ± AICAR were treated with proteasome inhibitor 
MG132 (10 µM) for 2.5 hours. Sufu-/- MEFs were treated with MG132 for 3 or 6 hours. A 
rescue of Gli1 and Gli2 protein levels was not observed suggesting that AICAR does not 
regulate Gli protein stability. (B) WT MEFs were treated with SAG ± AICAR for 12 hours 
and qRT-PCR performed to determine mRNA levels. No significant changes in Gli2 and 
Gli3 mRNA levels were observed with different treatment conditions, whereas SAG-
induced Gli1 mRNA levels were reduced by nearly 40% in the presence of AICAR (from 
relative mRNA level 43 to 26). (C) Effects of AICAR on Gli3 protein levels were 
examined in WT MEFs. Addition of AICAR had no significant effect on Gli3 full-length or 
repressor, suggesting that AICAR does not regulate Gli3 protein levels. 
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AICAR acts on human medulloblastoma cells to alter cell fate 
Since we had observed a decrease in Shh signaling activity by AICAR in CGNPs and in 
mouse medulloblastoma cells, we sought to determine whether AICAR could affect 
proliferation of primary human medulloblastoma cells. We obtained a frozen human 
medulloblastoma sample, dissociated the tissue, and established a cell line. We 
determined first that the primary medulloblastoma cells were responsive to Shh 
signaling, as evidenced by an upregulation of Gli1 upon addition of 50 nM SAG (Figure 
4.7B) for 24 hours. Next we assayed whether AICAR addition affected tumor cell 
morphology and Gli1 protein levels. Upon addition of 3 mM AICAR to both SAG-treated 
and untreated samples, we observed distinct morphological changes. Cells in control or 
SAG-treated wells were pleomorphic, undifferentiated cells. Upon addition of AICAR, the 
morphology changed to triangular shaped cells with extensive neurite outgrowth. 
Processes exhibited numerous bulbous protuberances along their course (Figure 4.7A, 
arrowheads). Using Western blotting, we determined that Gli1 levels were significantly 
downregulated upon addition of AICAR (Figure 4.7B). Interestingly, Gli1 levels were 
downregulated to a greater extent in SAG-treated samples upon addition of AICAR 
compared to untreated samples, suggesting that AICAR has a preferential effect on cells 
treated with SAG. These experiments demonstrate that AICAR is able to antagonize Shh 
signaling in human medulloblastoma cells, and that AICAR addition to these cells results 
in a change in fate. 
In order to determine whether AMPK affected proliferation, differentiation, or 
apoptosis of the tumor cells, we used immunocytochemistry (Figure 4.7C). We found a 
decrease in pH3 staining, indicating that AICAR affects proliferation (Figure 4.7C, 
arrowheads). Immunocytochemistry with apoptotic marker cleaved caspase-3 revealed 
an increase in AICAR treated cells. An increase was observed in neuronal marker Tuj1, 
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suggesting that AICAR-treated cells acquire a neuronal cell fate and that AICAR may 
promote neuronal differentiation in tumor cells. Sox2 is a transcription factor localized to 
both the nuclei and cytoplasm in neural progenitor cells and their progeny (Wegner and 
Stolt 2005); it shuttles between the two subcellular compartments and its nuclear 
localization regulates its transcriptional activity (Li et al. 2007). Increased expression of 
Sox2 has been reported in many tumors, particularly in highly aggressive central 
nervous system neoplasms including both glioblastoma and medulloblastoma (Sutter et 
al. 2010; Ben-Porath et al. 2008; Annovazzi et al. 2011; Leis et al. 2011). Sox2 
immunocytochemistry in control and SAG-treated cells revealed robust expression in the 
cytoplasm and nucleus, indicating a neural stem-cell-like fate. Interestingly, however, 
Sox2 expression was limited to the cytoplasm with addition of AICAR, regardless of SAG 
treatment (Figure 4.7C, arrowheads). This suggests AICAR inhibits Sox2 nuclear 
localization, preventing Sox2 transcriptional activity from occurring. As Sox2 inhibition 
leads to premature cell cycle exit and neuronal differentiation (Wegner and Stolt 2005), 
this suggests AICAR-treated cells have initiated a differentiation program. Taken 
together, our results demonstrate that AICAR antagonizes Shh signaling and promotes 
apoptosis and neuronal differentiation in cultured primary medulloblastoma cells. 
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Figure 4.7. AICAR acts on human medulloblastoma cells to alter cell fate 
(A) A primary human medulloblastoma cell line was treated with 50 nM SAG ± 3 mM 
AICAR for 24 hours. Brightfield images of cells reveal distinct morphological changes. 
Cells in AICAR treated wells change morphology to triangular shaped cells with 
extensive neurite outgrowth. Processes exhibited numerous bulbous protuberances 
along their course (arrowheads). (B) Western blotting on lysates collected from cells with 
treatment as in (A) shows Gli1 downregulation upon addition of AICAR. Interestingly, 
Gli1 levels were downregulated to a greater extent in SAG-treated samples upon 
addition of AICAR compared to untreated samples, suggesting that AICAR has a 
preferential effect on cells treated with SAG. (C) Immunocytochemistry of the human 
medulloblastoma cell line reveals a decrease in pH3 staining, increase in caspase-3, 
increase in neuronal marker Tuj1, and differential localization of Sox2 in AICAR treated 
samples. The increase in Tuj1 suggests that AICAR-treated cells acquire a neuronal cell 
fate and that AICAR may promote neuronal differentiation in tumor cells. Sox2 
immunocytochemistry in control and SAG-treated cells revealed robust expression in the 
cytoplasm and nucleus, indicating a neural stem-cell-like fate. Interestingly, however, 
Sox2 expression was limited to the cytoplasm with addition of AICAR, regardless of SAG 
treatment (arrowheads), suggests AICAR inhibits Sox2 nuclear localization. Scale Bar, 
20 µm. 
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DISCUSSION 
In this study we show that AICAR is able to downregulate Shh pathway activity and 
potently inhibits proliferation in multiple cell lines. To date, no study has demonstrated 
the effects of AICAR on Shh pathway activity. We find that AICAR modulates the Shh 
pathway by downregulating Gli1 transcription in a manner that is independent of AMPK 
activation. Identifying novel inhibitors of the Shh pathway that act at the level of the Gli 
transcriptional effectors has great clinical potential for treatments of Shh-driven tumors, 
given the recent discoveries involving tumor resistance to Smoothened inhibitors.  
Our results demonstrate that AICAR regulates Shh pathway activity downstream 
of pathway mediators Smoothened and Sufu. We find that while both Gli1 protein and 
transcript levels are downregulated by AICAR addition, Gli2 and Gli3 protein and 
transcript levels are not affected by AICAR addition (Figure 4.5A). These observations, 
together with the fact that AICAR-mediated Gli1 protein down-regulation occurs as early 
as six hours in both MEFs and GCPs (Figure 4.1C, D), suggests that AICAR targets Gli1 
via a transcription-dependent mechanism. The mechanism by which AICAR targets Gli1 
transcription requires further study. Gli2 protein functions as an upstream regulator of 
Gli1 transcription (Sasaki, Kurisu, and Kengaku 2010), and Gli2-activator levels are 
regulated by proteasomal degradation of Gli2-full length protein (Pan et al. 2006). 
Experiments using proteasomal inhibitor MG132 suggest that AICAR is unlikely to affect 
Gli2 protein stability. Thus AICAR may act by regulating Gli2 post-translational modification, 
protein translation, or activation. Specifically AICAR may affect translocation of Gli2 to the 
cilium, accumulation in the nucleus, or its phosphorylation status, all of which are 
necessary for its activation (Chen et al. 2009; Kim, Kato, and Beachy 2009). 
Alternatively, AICAR may affect Gli2 transcriptional activity, either by inhibiting binding of 
Gli2 to promoter regions of its transcriptional targets or by inhibiting the recruitment of as 
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yet undetermined cofactors necessary for Gli2 DNA binding. It is also possible that 
AICAR promotes the proteasomal-independent degradation of Gli. Indeed, AICAR is 
able to induce autophagy in a p53-dependent manner in MEFs and HCT116 colon 
cancer cells (Buzzai et al. 2007). Thus one conceivable mechanism by which AICAR 
may act to regulate Gli1 transcriptional levels may be through the lysosomal degradation 
of cofactors required for Gli binding to DNA. 
Interestingly, our study is not the first example of a small molecule affecting Shh 
signaling at the level of Gli transcription. Arsenic trioxide (ATO), an FDA-approved drug 
used for the treatment of acute promyelocytic leukemia, has recently been discovered to 
target the Gli transcriptional effectors (Beauchamp et al. 2011; Kim et al. 2010), either by 
blocking Shh-induced ciliary accumulation of Gli2 (Kim et al. 2010) or by binding directly 
to Gli1 protein to inhibit its transcriptional activity (Beauchamp et al. 2011). While several 
other compounds, including the GANT family of inhibitors (Lauth et al. 2007), natural 
products zerumbone and physalin F and B (Hosoya et al. 2008), and HPI-1 and HPI-2 
(Hyman et al. 2009) have also been shown to inhibit Gli transcriptional activity, their 
precise mechanism of action is unknown. These studies and ours may potentially be 
used as a tool for understanding events surrounding Gli transcriptional activation, which 
remains an open field of investigation. Although the activated form of Gli is believed to 
be phosphorylated (Humke et al. 2010), little else is known about additional post-
transcriptional modifications that regulate nuclear entry or transcriptional activity of Gli. In 
addition, inhibitors targeting the Shh pathway at the level of Gli hold great promise as 
adjunctive therapeutics in Shh-driven tumors, since current therapies specifically 
targeting the Shh pathway act at the level Smo. Smoothened antagonists are not 
expected to be effective for the treatment of malignancies arising from downstream 
mutations in the Shh pathway (Robarge et al. 2009; Tremblay et al. 2009; Miller-Moslin 
et al. 2009; Peukert and Miller-Moslin 2010; Roberts et al. 1989; Khatib et al. 1993; 
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Zwerner et al. 2007; Beauchamp and Üren 2012) and resistant Smo mutations have 
been documented in at least in one human medulloblastoma patient treated with the 
cyclopamine-derivative GDC-0449 (Vismodegib) (Rudin et al. 2009; Rudin 2012; Yauch 
et al. 2012). Of note, the combined effect of Gli antagonist ATO and cyclopamine in 
cultured cell-signaling assays permitted equivalent or more potent pathway inhibition at 
lower drug concentrations of both drugs (Kim et al. 2010), providing an encouraging 
rationale for combination strategies utilizing both Smo and Gli inhibitors. Such therapies 
may not only provide multi-level targeting of the pathway but also allow for lower drug 
levels and hence reduced toxic effects. Further studies are needed to determine whether 
AICAR may similarly be effective in combination with cyclopamine mimics.  
AICAR is a potent agonist of AMPK, thus it has primarily been used to study 
AMPK-dependent metabolic regulation (Sullivan et al. 1994; Bergeron et al. 2001; Song 
et al. 2002; Buhl et al. 2002; Sriwijitkamol and Musi 2008a). In the present study, we find 
that although AMPK phosphorylation is upregulated in all cell types treated with AICAR, 
the effects of AICAR on Shh signaling are AMPK-independent as AICAR is still able to 
downregulate Shh signaling in AMPK-/- cells. Thus the AMPK-independent effects of 
AICAR may have profound consequences on Shh-driven cancer cell proliferation and 
survival. At present, little is known about the AMPK-independent effects of AICAR. In 
CLL cells, AICAR induces apoptosis in an AMPK-independent manner by upregulating 
gene expression of BCL-2 family members BIM, NOXA, and PUMA in the mitochondrial 
apoptotic pathway (Santidrian et al. 2010). Furthermore, AICAR regulates key enzymes 
involved in phospholipid biosynthesis in hepatic cells independently of AMPK activation 
through an unknown mechanism (Jacobs et al. 2006). In a select few cases, direct 
binding of AICAR to specific proteins has been reported. These include 
phosphofructokinase (PFK) and fructose-1,6-biphosphatase (F1,6-BPase) which are 
inhibited in vitro by AICAR (Guigas et al. 2006; Javaux et al. 1995; Vincent, Bontemps, 
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and Van den Berghe 1992), and heat-shock protein Hsp90, whose client proteins were 
found to be destabilized in the presence of AICAR in vivo (Meli et al. 2006). As both PFK 
and Hsp90 contribute to important functions for tumor growth (reviewed in (Yalcin et al. 
2009; Siegelin 2013), it remains possible that AMPK-independent anti-proliferative 
effects of AICAR in cancer cells, including those cell lines used in our study, may be 
mediated through these proteins. These investigations and ours demonstrate that 
AICAR targets multiple pathways, including the Shh signaling pathway, unrelated to its 
ability to activate AMPK. The mechanism of action of AMPK agonists in cancer 
treatment and their true molecular targets requires further study. 
Our results demonstrate that AICAR inhibits proliferation in CGNPs, mouse 
medulloblastoma cells, and a human primary medulloblastoma cell line as well as 
promotes apoptosis in both mouse and medulloblastoma cells. AICAR has been known 
to exert various effects on cell growth, including regulation of the pro-inflammatory 
response (Hoogendijk et al. 2013), cytokine production (Katerelos et al. 2010), cell 
proliferation (Theodoropoulou et al. 2010), and apoptosis (González-Gironès et al. 
2013). AICAR has also been shown to inhibit proliferation and protect from apoptosis in 
many types of cancer, including multiple myeloma (Baumann et al. 2007), 
neuroblastoma (Garcia-Gil et al. 2003), glioblastoma (Guo et al. 2009), childhood ALL 
(Sengupta et al. 2007), retinoblastoma (Theodoropoulou et al. 2010) and colon cancer 
(Su et al. 2007), by various mechanisms. However, ours is the first study to link the anti-
proliferative and pro-apoptotic effects of AICAR to its actions on Shh signaling, therefore 
identifying a novel mechanism of action by which AICAR mediates its effects on tumor 
growth. 
Differentiation therapy describes the enforced differentiation of primary tumors 
with therapeutic compounds, and has been used successfully to achieve remission in 
patients with acute promyelocytic leukemia (Weis et al. 1994; Tallman et al. 2002). 
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Significantly, we observed that AICAR addition to the human medulloblastoma cells 
induced differentiation and neurite outgrowth (Figure 4.7A, C). Our findings corroborate 
recent evidence that AICAR induces astroglial differentiation in neural stem cells derived 
from postnatal rat hippocampus and embryonic cortex (Zang et al. 2008). Notably, the 
ability of AICAR to promote differentiation in these cells was determined to be 
independent of AMPK, and was mediated through the JAK/STAT pathway (Zang et al. 
2008). As differentiation status of tumors has been shown to have a strong correlation 
with metastatic potential (Bloom and Richardson 1957; Contesso et al. 1987; Kouros-
Mehr et al. 2008), where well-differentiated tumors tend to have a low capacity for 
metastasis formation and poorly differentiated tumors have a high capacity for 
metastasis, compounds that induce differentiation of tumor cells, such as AICAR, justify 
further investigation.  
A final note on the potential clinical utility of AICAR is that though it is not yet 
FDA-approved, AICAR has been used in clinical trials since the 1980s (Leung et al. 
1994; Bosselaar et al. 2013; Babraj et al. 2009; Cuthbertson et al. 2007; Mangano 1997) 
for its effects on reducing myocardial ischemic injury as well as in B-CLL patients, and 
has recently entered into Phase II clinical trials (Santidrian et al. 2010). While it is 
currently on the banned substances list of the World Anti-Doping Agency, investigating 
the potential for AICAR to treat cancers holds great promise because it is a natural 
metabolic intermediate normally present in the body. The penetration of AICAR across 
the blood brain barrier into medulloblastomas and other CNS tumors such as gliomas is 
not well understood (Marangos et al. 1990; Guo et al. 2009). Nevertheless, given our 
current findings, future studies involving AICAR or more potent derivatives of the 
compound in the treatment of Shh-driven cancers are warranted. 
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MATERIALS AND METHODS 
Animals and Reagents. AICAR, 2-DG, metformin, rapamycin, compound C, and MG132 
(all from Sigma) were dissolved in DMSO and SAG was dissolved in MeOH (Gift of Dr. 
Michael Cooper) for in vitro experiments. Math1Cre/+ (Helms et al. 2000) and SmoM2 
(Mao et al. 2006) mice were obtained from Jackson Laboratory.	  Mice were housed in an 
animal facility and were maintained in a temperature-controlled and light-controlled 
environment with an alternating 12-hour light/dark cycle. All protocols have been 
approved by the Vanderbilt Institutional Animal Care and Use Committee. 
 
Gli-Luciferase Assay. Gli1 and SmoA1 constructs were transfected in NIH-3T3 cells 
along with a firefly luciferase reporter construct. Luciferase assays were performed as 
previously described (Huang, Liu, et al. 2010) using the Promega Dual Luciferase 
Reporter Assay system (Promega, WI). All reporter assays were normalized using 
Renilla luciferase as an internal control. Each data point represents the mean of triplicate 
wells with error bar representing the standard deviation (SD). Cells were treated with 50 
nM SAG or 50 nM SAG and AICAR for 24 hours before being lysed in Passive Lysis 
Buffer at room temperature. 
 
Cell lines, primary human and mouse MB cell derivation, and culture. NIH-3T3 cells, 
wild-type MEFs, AMPK-/- MEFs, and Sufu-/- MEFs were grown in DMEM with 10% FBS 
and 1X penicillin-streptomycin. Primary human MB cells were derived from patients 
admitted to Vanderbilt University Medical Center (VUMC). MB specimens from patients 
treated at the VUMC were obtained in accordance with the Institutional Review Board’s 
approval. Tumor samples were dissociated with StemPro Accutase (Invitrogen) and 
plated in DMEM/F12, 10% FBS, and 1X penicillin–streptomycin. Cells from one patient, 
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REDCAP number 15289, were successfully maintained in DMEM with 10% FBS and 
propagated using standard tissue culture protocols. Primary mouse medulloblastoma 
cells were isolated from Math1Cre/+;SmoM2 mice as previously described (X. Huang, Liu, 
et al. 2010).   
 
Immunocytochemistry. All immunocytochemistry analyses were performed on cells that 
were fixed for 20min in 4% PFA on ice. Cells were washed three times in PBS, blocked 
for 20 mins with 10% goat serum, and incubated with primary antibody for 90 minutes. 
Cells were then washed three times in PBS, incubated with secondary antibody for 30 
minutes, and counterstained with DAPI or ToPro-3. Primary antibodies were rabbit anti-
phosphorylated Histone H3 (Millipore, 1:1000), rabbit anti-cleaved caspase-3 (Cell 
Signaling Technology #9661, 1:1000), mouse anti-Tuj1 (Sigma, 1:1000), and mouse 
anti-Sox2 (Millipore, 1:1000). 
 
CGNP Isolation. P4 or P5 cerebella from CD1 mice mice were dissected into calcium-
free Hanks buffered saline solution (Mediatech) supplemented with 6g/L D-glucose. The 
meninges were stripped and pooled cerebellar dissociated with Accutase (Gibco) and 
trituration. Cells were pelleted and resuspended in Neurobasal A-medium containing 250 
µM KCl, 500µL 100X GlutaMAX I, 500 µL 100X penicillin-streptomycin, and 10% FBS. 
Cells were passed through a 70 µm filter and incubated for two times 20 minutes on 
poly-d-lysine coated plates. Following the settling step, the cells remaining in the media 
were collected, pelleted, and resuspended in Neurobasal A-medium containing 1mL 50X 
B-27 serum-free supplement (Invitrogen), 250 µM KCl, 500 µL 100X GlutaMAX I, 500 µL 
100X penicillin-streptomycin. Cells were plated at a density of 3 million cells/mL onto 
poly-D-ornithine coated plates or glass coverslips. After 24 hours incubation at 37C, 10 
nM SAG was added to fresh serum-free media. 1 mM AICAR or DMSO was added 
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following 24 hour incubation in 10 nM SAG for 12 hours. Cells were then ready for 
harvesting for Western blotting or fixation for immunocytochemistry. 
 
Western Blotting. For western analysis, cells were lysed in RIPA buffer containing 2.5 
mM EDTA, 1 mM PMSF, 10 mM NEM, 1 mM sodium orthovanadate, 1 mM sodium 
fluoride, and EDTA-free complete mini protease inhibitor tablets (Roche), boiled in SDS, 
and resolved on 10% SDS-polyacrylamide gels. Primary antibodies used for Western 
blotting were mouse anti-cyclin D1 (BD Pharminogen #556470, 1:500), rabbit anti-Gli1 
(Cell Signaling Technology #2534, 1:2000), guinea pig anti-Gli2 (gift of Jonathan 
Eggenschwiler), rabbit anti-phosphorylated-AMPKα (Thr172) (Cell Signaling Technology 
#2535, 1:1000), rabbit anti-AMPKα (Cell Signaling Technology #2532, 1:1000), mouse 
anti-α-tubulin (Hybridoma Bank, 1:10,000), mouse anti-b-actin (ThermoScientific BA3R, 
1:5000), rabbit anti-phosphorylated-S6 (Cell Signaling Technology, 1:1000), rabbit anti-
phosphorylated-ACC (Ser79) (Cell Signaling Technology #3661, 1:1000), rabbit anti-
ACC (Cell Signaling Technology, 1:1000), and rabbit anti-Sufu (Cell Signaling 
Technology #2522, 1:1000), rabbit anti-Gli3 (1:500). 
 
RT-PCR. RT-PCR was performed as previously described (Huang 2010 PNAS). Primers 
used were as follows: GAPDH (5′TTCACCACCATGGAGAAGGC3′F; 
5′GGCATGGACTGTGGTCATGA3′R), Gli1 (5′CTGGAGAACCTTAGGCTGGA3′F; 
5′CGGCTGACTGTGTAAGCAGA3′R); Gli2 (For: CTTTGCCGATTGACATGAGA; REV: 
CATATGGGGGTTCACGTAGG); Gli3 (FOR:GCAATCACTATGCAGCCTCA; REV: 
TGGCATCAATTGGTACAGGA) 
 
Flow cytometry. Cellular DNA content was determined by flow cytometry. CGNPs were 
harvested and washed in ice-cold PBS, resuspended in 70% ethanol, and fixed for 2 
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hours at -20C. Cells were washed again once in PBS and resuspended in propidium 
iodide. PI fluorescence was determined by flow cytometry using a FACScan (BD 
Biosciences) and Cellquest software (Becton Dickinson) for acquisition. FlowJo was 
used for quantifying cell cycle phase distribution. 
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CHAPTER V 
 
GENERAL DISCUSSION 
 
Cerebellar development is a complex process involving the tightly regulated proliferation, 
specification, migration, and connectivity of thousands of neurons and glia. Perturbations 
in signaling pathways important for any of these processes can have drastic 
consequences, including the formation of malignancies such as medulloblastoma. In this 
dissertation work I have focused on Shh signaling and its role in cerebellar development 
and formation of medulloblastoma. Our studies have identified a novel contribution of a 
particular cell type, the multipotent hindbrain roof plate cell, to diverse lineages in the 
cerebellum. Importantly, the roof plate cell is susceptible to oncogenic transformation as 
activation of constitutive Shh signaling in this cell type leads to the formation of 
medulloblastoma. In addition, we have determined a previously unappreciated role for 
Shh signaling in specialized cerebellar glial cells, which functions to sustain proliferation 
of neighboring neuronal precursors. We find that Shh signaling in this neuronal-glial 
relationship is critical for maintenance of cerebellar size and architecture. Last, we 
identify a small molecule as a novel and potent Hh pathway antagonist in multiple cell 
types, including Hh-responsive medulloblastoma cells. My work therefore offers insight 
into the diverse roles of Shh activity in the cerebellum and provides the basis for 
interesting questions that may be addressed in the future. 
 
SUMMARY 
Widespread contribution of Gdf7 lineage to cerebellar cell types and implications 
for Sonic hedgehog-driven medulloblastoma 
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Medulloblastomas can arise from CGNPs with aberrant Shh signaling. However, the 
molecular mechanism by which Shh pathway-mediated proliferation and transformation 
of CGNPs occurs is poorly understood. Prior to this work, few distinct subsets of CGNPs 
were identified which could be transformed to initiate medulloblastoma formation. In 
Chapter II, we demonstrated that focal activation of Shh signaling in a distinct subset of 
CGNPs, specifically derived from hindbrain roof plate cells expressing Gdf7, was 
sufficient to promote cerebellar tumorigenesis. This was accomplished by using a 
Gdf7Cre/+ line to drive a constitutively active allele of Smoothened, SmoM2. We found 
that Gdf7Cre/+;SmoM2 (GM2) mutant mice displayed stunted growth, cranial bulging, and 
impaired motor coordination; all GM2 mice died within three weeks of birth. Analysis of 
mutant cerebellar architecture revealed severe hyperplasia suggestive of tumor 
formation. Tumors from both GM2 and established medulloblastoma model PatchedLacZ/+ 
mice displayed strong expression of CGNP, neural progenitor, and proliferative markers. 
In addition, cultured GM2 cerebellar cells expressed multiple stem cell markers and were 
clonogenic and multipotent. Collectively, these data indicated that targeting constitutively 
active Shh signaling to the Gdf7-lineage led to formation of medulloblastoma.  
Hindbrain roof plate cells expressing Gdf7 had previously been shown through 
fate-mapping studies to contribute mostly to non-neural choroid plexus epithelium. Our 
data provides evidence that, similar to the cortex, midbrain, and spinal cord (K. Lee, 
Dietrich, and Jessell 2000; Monuki, Porter, and Walsh 2001; Dymecki and Tomasiewicz 
1998), the hindbrain roof plate has a conserved role in the generation of neurons and 
other cell types. In our study, detailed fate-mapping was performed of the Gdf7 lineage 
which revealed that surprisingly, Gdf7-lineage cells contribute to a small subset of 
proliferating CGNPs. These were found beyond the clustered roof plate cells in the 
rhombic lip as well as the EGL. In addition, Gdf7-lineage cells also contribute to an 
extensive array of mature cerebellar cell types. These cells arise from the midline of the 
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cerebellar ventricular zone and consists of a small cluster of cells expressing radial glial 
markers, and can be molecularly defined by the expression of Gdf7 and Msx1 (Figure 
2.4). We proposed that this cerebellar vermal region is a previously undescribed source 
of neurons that is continuous with and extends beyond the cerebellar ventricular zone. 
The GM2 medulloblastoma mouse model demonstrates how remarkably few cells are 
sufficient for oncogenic transformation and tumor formation. Thus hindbrain roof plate 
cells are established as a novel source of diverse neural cell types in the cerebellum that 
is also susceptible to oncogenic transformation by deregulated Sonic hedgehog 
signaling.  
 
Glial Sonic hedgehog signaling activity is required for proper cortical expansion 
and cerebellar architecture 
While the role of BG in providing structural support for inwardly migrating 
granular cells is well known, the contribution of BGs to neuronal specification and 
proliferation in the cerebellum has not been extensively studied. In addition, genetic 
studies of BG function utilize either the human GFAP-Cre, Nestin-Cre, or Engrailed1-Cre 
lines (Corrales et al. 2004; Yu et al. 2011), which also induce widespread recombination 
in neuronal precursors (Zimmerman et al. 1994; Graus-Porta et al. 2001). Thus 
investigations of the postnatal function of BG without vastly affecting the neuronal 
population have not yet been completed. Our study as detailed in Chapter III is the first 
to examine BG function using a spatially and temporally controlled genetic system by 
utilizing the TNCCreER-YFP mouse. Furthermore, our investigation is the first to reveal 
functions of Shh signaling in BG. We found that mice in which Shh activator 
Smoothened (Smo) is postnatally ablated in BG demonstrate an obvious cerebellar 
hypoplasia within two days of ablation of Shh signaling, indicating that BG-Shh signaling 
is integral to formation of proper cerebellar structure. Perhaps most surprisingly, Smo 
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mutants exhibit severely reduced CGNP proliferation and increased differentiation 
accompanied by a loss of Shh activity, suggesting a novel role for the BG-CGNP 
interaction in promoting CGNP precursor proliferation. These profound reductions in 
EGL area can be observed starting 24 hours after the last tamoxifen injection (Figure 
3.3A, C) and prior to observable defects in BG fiber formation (Figure 3.6), a rapid 
timecourse that demonstrates the remarkable sensitivity of CGNP proliferation to BG-
Shh activity and underscores its relevance for the maintenance of overall cerebellar size 
and architecture. Interestingly, Wnt signaling is ectopically elevated in Smo mutant 
CGNPs concomitant with a reduction in EGL area, suggesting that this pathway is 
involved in cross-talk with the Shh pathway in regulating CGNP proliferation. In addition, 
we found that loss of Shh signaling in BGs leads to disrupted PC monolayer formation 
and dendritic arborization as well as BG fiber morphology, indicating that BG-Shh 
signaling activity contributes to the maintenance of proper cerebellar laminar formation. 
Collectively, these data show a previously unappreciated role for BG Shh signaling 
activity in the proliferation of CGNPs and preservation of cerebellar architecture, thus 
leading to a new level of understanding of the neuronal-glial relationship in the 
cerebellum.  
 
Antagonism of the hedgehog pathway at the level of Gli transcription by the small 
molecule 5-aminoimidazole-4-carboximide-1-ß-4-ribofuranoside (AICAR) 
 In Chapter IV of this work, we identify AICAR as a potent Hh pathway antagonist in 
multiple cell types, including Hh-responsive medulloblastoma cells. Importantly, we show 
that AICAR acts downstream of Smo and regulates Gli1 transcription in a proteasome-
independent manner. Sufu stabilizes the Gli proteins from AICAR inhibition, as 
downregulation of Shh pathway activity was more efficient in Sufu-null MEFs. Last, we 
find that although AICAR activates AMPK in these cell lines, inhibition of the Hh pathway 
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by AICAR is AMPK-independent. Our findings establish AICAR as a modulator of Shh 
signaling in both a developmentally relevant cell type as well as medulloblastoma cells, 
providing an encouraging basis to further explore its full potential as an antagonist in 
Shh-associated tumors. 
 
IMPLICATIONS 
The overall goals of this work were to 1) advance the understanding of Shh signaling in 
the cerebellum and 2) determine how aberrant Shh signaling can influence cerebellar 
disease. The first goal sought to understand functions of Shh signaling in the cerebellum 
at a cellular level; revealing these processes can increase our appreciation for cell-cell 
communication within biological systems and signaling processes that govern proper 
growth of organs. The second goal was to understand how mutations in the Shh 
pathway can influence cerebellar disease. We and others have found that abnormalities 
in the Shh pathway can result in medulloblastoma tumorigenesis when cells experience 
overactive signaling, whereas lack of Shh pathway activity can cause cerebellar 
hypoplasia. It is our hope that understanding Shh-dependent signaling in the cerebellum 
during normal development and disease can provide insight into cellular relationships 
integral to brain growth as well as inform development of targeted therapies for disease 
processes resulting from deregulated signaling. 
 
Elucidation of roles of Shh signaling in development 
Growth control mechanisms in multicellular organisms ensure that organs attain their 
proper final size, and control of these mechanisms dictates cell fate specification, 
proliferation, and differentiation. Thus, how distinct signals are emitted and integrated by 
cells within a growing organ is a major focus of cellular and developmental biology 
research today. Importantly, the study of the Shh pathway has not only provided 
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essential and basic paradigms by which cell to cell communication occurs, but has 
demonstrated how a key mediator of fundamental morphogenetic processes can pattern 
embryonic growth and development. A notable feature of Shh signaling is that in some 
contexts, Shh acts as a morphogen in the dose-dependent induction of distinct cell fates 
(Gritli-Linde et al. 2001; Ko and Eggenschwiler 2011; Ingham and McMahon 2001), 
whereas in other contexts it acts as a mitogen regulating proliferation of cells or as an 
inductive factor controlling organ development (Behesti and Marino 2009; Ingham and 
McMahon 2001). However, the precise mechanisms by which Shh exerts its 
morphogenetic and mitogenic activities on responsive cells are still being uncovered.  
Using a cerebellar BG-specific knockdown of Shh signaling, we demonstrate that 
ablation of BG Shh signaling results in downregulation of the pathway in neighboring 
neuronal precursors, with profound implications on proliferation and growth of the organ. 
The notion that Shh signaling regulates two adjacent but distinct cell populations (ie, BG 
astroglia and CGNPs) appears to be a unique and novel mechanism by which Shh acts. 
Although Shh can signal directly to two cell populations in the adult SVZ of the mouse 
forebrain, the GFAP+ periventricular astrocytes and the more abundant GFAP- early 
precursors (Palma et al. 2005; Ruiz i Altaba 1998), the former population gives rise to 
the latter, whereas BGs and CGNPs are not of related lineages and situated in distinct 
cortical layers. Interestingly, an analogous scenario to that in the cerebellum may occur 
in Drosophila, where Shh employs two different strategies to pattern larval wing imaginal 
discs: it locally induces a secondary signal (Decapentaplegic [Dpp], the Drosophila 
homolog of vertebrate BMPs), and Shh itself diffuses over several cell diameters to act 
as a morphogen (Zecca, Basler, and Struhl 1995; Mullor et al. 1997). It is possible that 
signaling to two neighboring cell populations allows for greater modulatory control of its 
mitogenic/morphogenetic activities, which may be subject to physiologic fluctuations 
depending on stressors, injury, etc. Elucidating cellular relationships important for Shh 
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function in the cerebellum can provide novel insights into fundamental ways in which the 
pathway signals and thereby, affects processes fundamental for proper development of 
the organism. 
A major thrust of developmental biology is to understand the mechanisms by 
which Shh signaling and other developmental pathways regulate cell fate decisions; that 
is how cells know where they are within a tissue and how this information is translated 
so that they form the appropriate structures for their positions (Barolo 2002; Briscoe et 
al. 2000). These issues are of particular relevance in early patterning of the cerebellar 
anlage, where several distinct classes of neurons and glia must be generated at specific 
timepoints (Hatten et al. 1997; Wingate 2001). Our investigation using mice in which Shh 
is activated in roof-plate cells illustrates the importance of positional identity for 
progenitor cells and how this determines subtype identity: we found that roof plate cells 
not only generate the choroid plexus, as previously known, but also contribute to 
divergent cerebellar neuronal and glial cell types. The ability of the roof plate cell to 
generate such diverse lineages must stem from differential integration of molecular and 
positional cues received by the common progenitor cell. Interestingly, this phenomenon 
is mirrored in the neighboring lower rhombic lip territory, which, though defined by Wnt1 
expression, is subdivided into molecular subdomains predictive of cell fate (Landsberg et 
al. 2005). As lower rhombic lip derivatives generate similar cell lineages as those derived 
from the roof plate and upper rhombic lip, including choroid plexus and Math1+ neurons 
(Landsberg et al. 2005), parallel molecular mechanisms for the specification of cells may 
be employed for both regions. For example, in the lower rhombic lip, the homeodomain 
transcription factor Pax6 is responsible for promoting expression of the Math1 progenitor 
cell domain and generation of two neuronal cell types, the precerebellar mossy fiber 
neurons and climbing fiber neurons (Landsberg et al. 2005). In addition, Pax6 exerts its 
patterning action through interactions with the BMP signaling pathway in a cell non-
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autonomous fashion (Landsberg et al. 2005). As Pax6 expression is exclusive to the 
hindbrain (Landsberg et al. 2005), and the roof plate and choroid plexus epithelium 
produce similar sets of BMPs (Chizhikov and Millen 2004), it is possible that the upper 
rhombic lip similarly depends on Pax6 for regulation of Math1 expression. Determination 
of how signals are integrated into cellular networks is crucial to our understanding of 
normal cell behavior and can provide clues into mechanisms by which fate decisions are 
made to produce the complex cellular specialization needed for a functioning organ. 
 
Elucidation of roles of Shh signaling in disease 
A basic tenet in cancer biology is that tumors stem from errors in the carefully regulated 
balance of cellular processes required to maintain tissue homeostasis. This is 
exemplified in the case of hedgehog-driven medulloblastoma, where studies in 
transgenic mouse models have shown that Shh pathway activation must occur in a 
lineage-specific cellular context to manifest biological effects and cause full malignant 
transformation (Schüller, Heine, et al. 2008; Yang et al. 2008). We further demonstrate 
the sensitivity of these cells to oncogenic events through our GM2 mouse model, where 
the transformation of remarkably few cells was sufficient for tumor formation. Other 
distinct subsets of CGNPs that can be transformed to initiate medulloblastoma include 
Olig2- and Tlx3-expressing precursors (Schüller, Heine, et al. 2008), which, consistent 
with their location within the cerebellum, cause tumorigenesis in posterior cerebellar 
lobes (Schüller, Heine, et al. 2008). Notably, the notion that tumorigenesis is initiated by 
transformation of a subset of lineage-restricted progenitor cells can occur in cancers of 
other organs, including in epithelial ovarian cancer, which can derive from 
xenoengraftment of fewer than 100 CD44+/CD117+ cells (Zhang et al. 2008). The 
identification of normal cell populations targeted for transformation will inform future 
studies directed at understanding how processes important during normal physiological 
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development become deregulated in tumor initiation and progression. Insight into the 
cellular context in which neoplastic transformation occurs is critical to the understanding 
of cancer biology, and will enable development of therapeutic strategies aimed at 
eliminating these cells in patients. 
While cerebellar tumorigenesis can arise from overactive Shh signaling, a 
depletion of Shh signaling can result in significant reductions in organ size. There is 
currently increasing awareness that neurodevelopmental disorders are associated with 
cerebellar deficits and learning impairments (Manto and Jissendi 2012). In fact, the 
cerebellum is likely to become a major platform for studying how development and 
learning are associated, because of the modular nature of cerebellar circuits and the 
marked morphological changes still occurring after birth, allowing for detailed 
assessment of developmental abnormalities. Moreover, cerebellar development occurs 
in successive waves of proliferation and migration throughout embryonic and postnatal 
stages, allowing for the possibility of selectively targeting these developmental waves. 
Prior to our study, reduced Shh signaling had been linked to cerebellar hypoplasia in a 
few instances (Roper et al. 2006; Tam 2013; Dehart et al. 1997), including its classic 
association with Smith–Lemli–Opitz syndrome, an autosomal recessive syndrome that is 
due to defects in cholesterol homeostasis and results in multiple congenital 
malformations (Dehart et al. 1997). Other examples of Shh association with cerebellar 
hypoplasia include the case of glucocorticoid exposure in preterm infants (Haldipur et al. 
2011; Manto and Jissendi 2012), as well as a mouse model of Down’s syndrome that 
demonstrates a defective CGNP response to Shh signaling (Roper et al. 2006). Our 
SmoBG mutants are an example of the important role of Shh signaling in regulating 
cerebellar size, and we add that a critical component of its ability to impact overall 
cerebellar growth is through its actions in astroglial cells. The identification of pathways 
and cell types which are potential targets for novel therapies of neurodevelopmental 
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disorders is important since these diseases are heterogeneous and in most cases, will 
span the entire life of patients. 
In Chapter IV we show that small molecule AICAR is able to downregulate Shh 
pathway activity and potently inhibits proliferation in multiple cell lines. Interestingly, our 
study is not the first example of a small molecule affecting Shh signaling at the level of 
Gli transcription. Arsenic trioxide (ATO), an FDA-approved drug used for the treatment of 
acute promyelocytic leukemia, has recently been discovered to target the Gli 
transcriptional effectors (Beauchamp et al. 2011; Kim et al. 2010), either by blocking 
Shh-induced ciliary accumulation of Gli2 (Kim et al. 2010) or by binding directly to Gli1 
protein to inhibit its transcriptional activity (Beauchamp et al. 2011). While several other 
compounds, including the GANT family of inhibitors (Lauth et al. 2007), natural products 
zerumbone and physalin F and B (Hosoya et al. 2008), and HPI-1 and HPI-2 (Hyman et 
al. 2009) have also been shown to inhibit Gli transcriptional activity, their precise 
mechanism of action is unknown. These studies and ours may potentially be used as a 
tool for understanding events surrounding Gli transcriptional activation, which remains 
an open field of investigation. Although the activated form of Gli is believed to be 
phosphorylated (Humke et al. 2010), little else is known about additional post-
transcriptional modifications that regulate nuclear entry or transcriptional activity of Gli. In 
addition, inhibitors targeting the Shh pathway at the level of Gli hold great promise as 
adjunctive therapeutics in Shh-driven tumors, since current therapies specifically 
targeting the Shh pathway act at the level Smo. Smoothened antagonists are not 
expected to be effective for the treatment of malignancies arising from downstream 
mutations in the Shh pathway (Robarge et al. 2009; Tremblay et al. 2009; Miller-Moslin 
et al. 2009; Peukert and Miller-Moslin 2010; Roberts et al. 1989; Khatib et al. 1993; 
Zwerner et al. 2007; Beauchamp and Üren 2012) and resistant Smo mutations have 
been documented in at least in one human medulloblastoma patient treated with the 
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cyclopamine-derivative GDC-0449 (Vismodegib) (Rudin et al. 2009; Rudin 2012; Yauch 
et al. 2012). Of note, the combined effect of Gli antagonist ATO and cyclopamine in 
cultured cell-signaling assays permitted equivalent or more potent pathway inhibition at 
lower drug concentrations of both drugs (Kim et al. 2010), providing an encouraging 
rationale for combination strategies utilizing both Smo and Gli inhibitors. Such therapies 
may not only provide multi-level targeting of the pathway but also allow for lower drug 
levels and hence reduced toxic effects. The elucidation and development of Shh 
signaling inhibitors downstream of Smo can expand the current treatment arsenal to 
target the significant fraction of tumors that possess downstream pathway activation.	  
 
FUTURE DIRECTIONS 
Investigation of functions of Gdf7-lineage cells 
Our lineage tracing results in Gdf7Cre;R26R mice demonstrate that a subset of Gdf7-
lineage cells delaminate from the upper rhombic lip, acquire a CGNP cell fate, and 
migrate into the external granular layer. Previously it has been shown that the majority of 
hindbrain roof plate Gdf7-lineage cells contribute to choroid plexus epithelial cells (Currle 
et al. 2005). Thus, while our study has shed light on the cellular origins of 
medulloblastoma, we have not identified the factors controlling Gdf7-lineage cell fate; 
that is, the factors that dictate whether the roof plate cell becomes a choroid plexus 
epithelial cell or whether it delaminates into the upper rhombic lip to become a cerebellar 
Math1+ CGNP.  
The delaminating Gdf7-lineage cells in the upper rhombic lip are very small in 
number, with no more than 20-30 per E14.5 embryo (see Discussion, Chapter II), thus it 
is possible that their ability to escape the choroid plexus fate rests on imprecise 
molecular boundaries that delineate the roof plate from the rhombic lip. It has recently 
been shown in chick embryos through a combination of in ovo transplantation, co-
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culture, and electroporation that both maintenance of a Math1+ rhombic lip and 
expression of choroid plexus genes in roof plate cells are acutely dependent on the 
integrity of the rhombic lip/roof plate boundary (Broom et al. 2012). Notably, lack of strict 
lineage restriction boundaries in other parts of the developing embryo also allow for 
intermingling of small numbers of derivative cells. For example, in the midbrain/hindbrain 
junction of the mouse embryo, lack of a strict dorsal posterior mesencephalic lineage 
boundary allows cells derived from Wnt1-expressing mesencephalic cells to populate the 
neighboring isthmus (Zervas et al. 2004). Additionally, lineage restriction boundaries 
between rhombomeres allow approximately 8% of rhombomere cells to freely 
intermingle with adjacent compartments (Birgbauer and Fraser 1994; M. Fraser et al. 
2004). Therefore, the small number of delaminating Gdf7-lineage cells observed in the 
upper rhombic lip in our study may be a product of an inexact lineage boundary between 
the roof plate and rhombic lip.  
 Alternatively, an intriguing possibility is that the delaminating Gdf7-lineage cells in 
the rhombic lip may have a specific function. One hypothesis is that they may act as 
multipotent cerebellar progenitor cells. Our lineage studies indicate that the delaminating 
Gdf7-lineage cells retain multipotency since they express radial glial marker Sox2+ and 
have the capacity to generate known rhombic lip derivatives CGNPs and Tbr2+ unipolar 
brush cells (Figure 2.5). Notably, we find that Gdf7-lineage cells also give rise to a small 
subset of diverse cerebellar cell types, including Bergmann glia, Purkinje neurons, white 
matter astrocytes, and molecular layer GABAergic interneurons. While we postulated 
that these cells derive from the midline of the ventricular zone, our studies do not rule 
out the possibility that some of them may originate from the rhombic lip, which would be 
consistent with the notion that the rhombic lip possesses a population of Math1-
independent cells giving rise to multiple cell types including Bergmann glia and Golgi 
cells of the IGL (Jensen 2004). Interestingly, recent genetic fate mapping studies have 
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shown that a class of cells expressing astroglial and neural stem cell markers reside in 
the external granular layer (EGL) ((Silbereis et al. 2010) and this study, Chapter III). 
Whether or not the delaminating Gdf7-lineage cells contribute to this astroglial 
population remains to be tested. In order to investigate this possibility, we can determine 
whether a subset of Gdf7-lineage cells in the EGL express neural stem cell markers, in 
addition to those expressing Math1-GFP (Figure 2.5). This would suggest that some 
delaminating Gdf7-lineage cells in the rhombic lip retain multipotency as they migrate to 
the EGL. To further study the function of the delaminating Gdf7-lineage cells, we would 
need to specifically ablate them as they migrate out from the rhombic lip and determine 
phenotypic differences of the cerebellum. While the developmental contribution of Gdf7-
lineage cells to the cerebellum may be small, our investigation demonstrates the 
importance of these cells in a tumor context, as aberrant Shh signaling in these cells 
invariably results in medulloblastoma formation. Therefore, further understanding the 
function of the delaminating Gdf7-lineage rhombic lip cells would not only contribute to 
our knowledge of hindbrain patterning and subsequent cerebellar development, but to 
our understanding of the cellular origins of cerebellar disease processes. 
 A recently published study has noted distinct developmental origins for 
medulloblastoma subgroups (Gibson et al. 2010) and defined cells of the dorsal brain 
stem as the cellular origin for the Wnt subgroup of medulloblastoma (Gibson et al. 2010). 
Interestingly, the dorsal brain stem and the cerebellum have several parallel molecular 
mechanisms that regulate their development. First, the primary neuronal cell type of both 
the cerebellum and brain stem derive from Math1+ progenitor cells (Landsberg et al. 
2005). Second, these Math1+ progenitor cells are generated in the rhombic lip: the 
upper rhombic lip for the cerebellum (Chizhikov et al. 2010) and the lower rhombic lip for 
the brain stem (Landsberg et al. 2005). Third, both the upper and lower rhombic lip 
regions possess a domain of Gdf7-expressing cells which have been demonstrated to 
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contribute to the fourth ventricle choroid plexus (Landsberg et al. 2005; Currle et al. 
2005; Huang et al. 2009). Although Gdf7-lineage cells in the lower rhombic lip have not 
been demonstrated to contribute to the dorsal brain stem (Landsberg et al. 2005), it is 
possible that a few cells escape the choroid-plexus fate and have the capacity to 
generate multiple cell types, as we found in our investigation of Gdf7-lineage cells in the 
upper rhombic lip. It is thus interesting to speculate whether mutations in the Wnt 
signaling pathway in Gdf7-expressing cells may also cause medulloblastoma, this time 
localized to the dorsal brain stem. Furthermore, additional studies involving mutations in 
other signaling pathways implicated in medulloblastoma formation such as Notch or 
Myc, in Gdf7-expressing cells may also be studied, though their cell of origin has not yet 
been defined. If medulloblastoma formation is observed, this would suggest that different 
medulloblastoma subtypes, though expressing high levels of distinct signaling pathways, 
could stem from a common, early progenitor cell. These studies would increase our 
understanding of the cellular origins of medulloblastoma, in the hopes of finding 
improved treatments for this disease. 
  
Investigations of Bergmann glial Sonic hedgehog signaling 
 
Mechanistic studies of regulation of CGNP proliferation by Bergmann glial Shh signaling  
Our studies using TNCCreER;SmoF/- mice demonstrated that Shh signaling in TNC-
expressing cells is critical to the formation of the cerebellum, as mutants display 
profound cerebellar hypoplasia, reductions in EGL area and CGNP proliferation, defects 
in BG and PC fiber morphology, and impaired migration of post-mitotic granule cells. The 
TNCCreER driver line is a powerful tool for the study of BGs and their contribution to 
cerebellum, as it induces recombination specifically in three subsets of cerebellar 
astroglial cells with the most widespread population by far being BG (Figure 3.1, 3.5). 
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Notably, other transgenic mouse lines that may target same or similar populations 
include the GFAPCreER mouse line (Silbereis et al. 2010) and GlastCreER line  (Wang, 
Rattner, et al. 2012), but have yet to be exploited for the study of BGs. In contrast, 
previous Cre driver lines used for the study of BGs have affected cells early in cerebellar 
development and induce widespread recombination not only in astroglial cells but also in 
all neuronal precursors (Corrales et al. 2006; Zimmerman et al. 1994; Graus-Porta et al. 
2001). While we attribute our cerebellar phenotype to ablation of Shh signaling in BGs 
for reasons stated in the text (Figure 3.5 and Discussion, Chapter 3), we however cannot 
rule out the possibility that the two other, smaller populations of TNC-expressing 
astroglia play a role as well. In order to definitively rule them out, we would need to 
identify a specific marker for BG that is not present in the other populations; this would 
enable generation of a more specific BG-driven Cre transgenic line than currently 
available and could be used to study BG function independent of other cerebellar 
astroglia. Interestingly, studies performed in our lab indicate that BGs and EGL astroglia 
express high levels of TNC-YFP whereas postnatal white matter progenitor cells express 
low levels such that flow cytometry can be used to differentiate these two populations 
(Fleming et al.) (submitted). Gene expression differences can then be determined via 
microarray or RNAseq experiments.  
 We demonstrate that in TNCCreER-YFP;SmoF/- mice, Wnt signaling upregulation is 
concomitant with a reduction in EGL area. We hypothesize that this link may be through 
Shh-mediated activation of Wnt inhibitors, or Shh-mediated suppression of Wnt 
activators. In addition to secreted Wnt inhibitor Sfrp1, which we show is downregulated 
in the EGL of TNC mutants (Figure 3.8), one candidate gene that may be involved in 
Shh-mediated activation of Wnt inhibitors is Wnt inhibitory factor 1, Wif1, which is 
expressed in the Purkinje cell layer where Bergmann glia reside. The Drosophila 
homologue of Wif1, shifted, is required for normal Shh signaling in the wing imaginal disc 
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and has been suggested to bind BOC/CDO family members Ihog and Boi (Avanesov et 
al. 2012). Thus it is possible that Wif1 expression may be required for normal CGNP Shh 
signaling because of its ability to inhibit Wnt pathway activity. In order to test this 
hypothesis, we would need to assess for Wif1 gene expression differences in our mutant 
and wild-type animals. If expression differences are observed, we could further test the 
hypothesis using genetic means to knockdown expression of Wif1 in BG and compare 
the CGNP and cerebellar phenotype to our SmoBG mutants. A floxed Wif1 transgenic 
mouse is under development at the International Knockout Mouse Consortium. These 
studies would assist us in elucidating the mechanism by which BG Shh signaling affects 
CGNP proliferation. 
It is important to note that our studies do not rule out the possibility that 
deregulated Wnt signaling is a consequence of EGL reduction, rather than a cause. 
While there are several reasons why we believe BG Shh signaling is involved in Wnt 
antagonism as stated above (Figure 3.8 and Discussion, Chapter 3), further studies are 
needed to determine whether Wnt signaling is a cause of rather than a secondary effect 
of EGL size reduction. To determine whether Wnt antagonism plays a role in CGNP 
proliferation, we can add the Porcupine inhibitor C59 (Proffitt et al. 2013) to slice cultures 
of mutant cerebella. The membrane-bound O-acyltransferase Porcupine is a key 
enzyme in Wnt biosynthesis and is required for Wnt secretion and activity (Biechele, 
Cox, and Rossant 2011). Because of its enyzmatic role in the production of all active 
Wnts, and the fact that small changes in Porcupine activity can have significant effects 
on developmental phenotypes (Proffitt et al. 2013; Proffitt and Virshup 2012), Porcupine 
makes an attractive target for the inhibition of Wnt signaling. We can examine CGNP 
proliferation and overall EGL thickness using immunohistochemistry of proliferative 
markers to determine whether the mutant phenotype can be rescued upon Wnt 
inhibition. Slice culture experiments with small molecule addition have been routinely 
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used to examine changes in CGNP proliferation in the field (Wechsler-Reya and Scott 
1999). In addition, a genetic approach using a floxed allele of Porcupine (Liu et al. 2012) 
to knockdown expression in BGs with the TNCYFP-CreER line can be used. These studies 
would assist in clarifying the mechanism through which BG Shh signaling acts on CGNP 
proliferation. Using a more global approach to determining downstream targets of Shh 
signaling in BG, TNC-YFP+ BG can be isolated from mutant and wild type cerebella 
using flow cytometry and analyzed for microarray or RNAseq analysis to determine gene 
expression differences.  
 
Studies of a potential role for Bergmann glial Shh signaling in Purkinje cell 
dendritogenesis 
Our results demonstrated that, in later time-point injected mutants, PC dendritic 
arborization may rely upon BG Shh signaling. A more detailed analysis of PC dendrites 
in both wild-type and mutant animals will help to support this notion and should include 
analysis of dendritic length, number of branches, and dendritic thickness. In addition, the 
mechanism by which Shh signaling in BGs regulates PC dendritogenesis requires 
further investigation. Recent studies have implicated Shh signaling in the guidance of 
growing axons (Sarnat and Alcalá 1980; Yam et al. 2009) and emerging evidence 
suggests that it may play a role in dendritogenesis as well (Petralia et al. 2011; Sasaki, 
Kurisu, and Kengaku 2010). Specifically, Shh has been shown to regulate dendritic 
spine formation of hippocampal neurons via Tiam1-Rac1-mediated remodeling of the 
actin cytoskeleton (Sasaki, Kurisu, and Kengaku 2010). Additionally, many studies have 
demonstrated the dependence of neuronal dendritogenesis on astrocytes or glia in the 
brain (Martin, Brown, and Balkowiec 2012; Eroglu and Barres 2010; Haber 2006; 
Nishida and Okabe 2007; Verbich et al. 2012), a regulation that involves several factors 
including BDNF (Martin, Brown, and Balkowiec 2012), eph-ephrin signaling (Eroglu and 
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Barres 2010; Nishida and Okabe 2007), and glutamate uptake (Verbich et al. 2012). BG 
Shh signaling may therefore be involved in activation of these pathways to influence PC 
dendritic arborization; whether any of these pathways known to affect neuronal 
dendritogenesis are downstream of BG Shh signaling can be determined by comparing 
indicators of their expression in mutant and wild-type BGs. Delineating mechanisms by 
which BGs impact PC dendritic arborization can help understand development of basic 
cerebellar circuitry and synapse formation, and may increase our knowledge of 
processes involved in cerebellar-dependent learning. 
 
Studies of Bergmann glial Shh signaling in the adult cerebellum 
Our studies in Smo mutant mice demonstrate that early postnatal Shh signaling 
in BG is required for proper CGNP proliferation with profound consequences on 
development of cerebellar architecture. This finding adds to our knowledge of early 
postnatal BG function, as previous understanding has largely been confined to its role in 
providing migratory cues for postmitotic granule cells as they move inwards to form the 
IGL (Rakic 1971). Interestingly, Shh responsiveness remains in BG in the adult 
cerebellum (Garcia et al. 2010), after the EGL has disappeared; however, its function at 
that stage remains unknown. It is possible that Shh signaling in BG contributes to their 
survival in a stressed environment, for example during starvation, as it does in cultured 
rat cerebral astrocytes (Yoshimura, Kawate, and Takeda 2010). Another intriguing 
possibility is that Shh signaling in BG is responsible for proper synaptic activity and 
intracellular communication between BG and their neighboring neurons. Consistent with 
this hypothesis, BGs are increasingly being recognized as critical components of 
synaptic function (Martínez-Lozada et al. 2013), as they are located close to 
glutamatergic synapses and participate actively in the recycling of glutamate (Martínez-
Lozada et al. 2013). Additionally, astrocytic G-protein-coupled receptor (GPCR) 
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activation elicits Ca2+-dependent release of various gliotransmitters, including the 
neuromodulators glutamate, ATP, and D-serine (Fiacco and McCarthy 2006; Perea and 
Araque 2007; Pascual 2005). Notably, Smoothened was very recently determined to 
belong to the class F family of GPCRs (Wang et al. 2013) and Shh can increase 
intracellular Ca2+ in mouse embryonic stem cells and rat gastric mucosal cells 
(Belgacem and Borodinsky 2011). Thus Shh signaling in adult BG may have a normal 
physiological role in mediating glial-neuronal communication. Our mutant mouse model 
provides the basis for carrying out such a study, as tamoxifen can be injected at later 
stages after the EGL has disappeared. In addition to phenotypic analysis, 
electrophysiological studies can be performed whereby neuronal firing activity is 
monitored and compared in SmoBG mutant CGNPs and wild-type CGNPs to determine 
whether their electrical activity is altered in the setting of BG Smo ablation. These 
studies would improve our understanding of the role of Shh signaling in BG as well as of 
the contribution of BG to cerebellar function in the adult cerebellum. 
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